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1 General introduction 

General introduction II 
Introduction 
Macrophages were described by Elie Metchnikoff in 1884 as a population of phago-
cytic cells present in loose connective tissue'. Initially macrophages were classified as 
members of the reticuloendothelial system2, which included reticular cells, endothelial 
cells, fibroblasts, histiocytes and monocytes. However, after recognition of the bone 
marrow origin of macrophages3 the concept of the mononuclear phagocyte system has 
been developed which comprises mature macrophages as well as their precursors in 
peripheral blood and bone marrow45 The cells of the mononuclear phagocyte system 
form a heterogeneous popUlation of cells which are widely distributed throughout the 
body (Table I) and which have been shown to play essential roles in a broad variety of 
biological functions (Table 2) (reviewed in 6-9). To date, there is no single characteris-
tic which marks all members of the mononuclear phagocyte system. Cells are instead 
assigned to the system on the basis of a combination of several characteristics. The lack 
of a definite mononuclear phagocyte marker and the extensive heterogeneity among 
members of the system has sometimes made it difficult to detennine whether a 
particular cell type belongs to the mononuclear phagocyte system or not. For example, 
in the past there has been much debate whether dendritic cells (Langerhans cells, inter-
digitating cells, veiled cells, and ill vitro dendritic cells 10) should be included in the 
mononuclear phagocyte system (reviewed in 11). Recently, an increasing amount of 
data has accumulated supporting the view that at least part of the dendritic cells do 
indeed belong to the mononuclear phagocyte system (reviewed in 12). This will be 
discussed in more detail later in this chapter. 
Considering the extensive functional and phenotypic heterogeneity of the mononu-
clear phagocyte system, the question arises how this system develops and how diversity 
within the system is generated. In the study described in this thesis we set out to 
examine if heterogeneity is generated already at the level of precursor cells in the bone 
marrow. Therefore, a search was conducted for cell surface markers allowing the 
identification and isolation of subsets of bone marrow macrophage progenitor cells, 
among which may be separate progenitor cells for different types of mature 
macrophages. In addition, markers allowing the discrimination of macrophage-commit-
ted progenitors will be useful tools for the determination of branch points between the 
various hematopoietic lineages. 
This chapter considers the current understanding on the development of the 
mononuclear phagocyte system. In the first part of this chapter the development and 
maintenance of mononuclear phagocytes during adult 1ife will be addressed, with a 
focus on the data available on the development from hematopoietic stem cells. The 
second part will cover the development of macrophages in ontogeny, which di ffers 
from macrophage development in the adult. Third, the currently available data regard-
ing the multiple mechanisms by which mature macrophage heterogeneity arises are 
considered. The chapter concludes with an introduction to the experimental work 
described in this thesis. 
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Table 1 Distribution of mononuclear phagocytes 
Bone marrow 
Monoblasts 
Promonocytes 
Monocytes 
Macrophages 
Peripheral blood 
Circulating and marginating monocytes 
Tissues 
Liver (Kupffer cells) 
Lung (alveolar macro phages) 
Connective tissue (histiocytes) 
Spleen 
Lymph nodes 
111ymus 
Bone marrow 
Bone (osteoclasIs) 
Synovium (type A cells) 
Mucosa~associated lymphoid tissue 
Gastrointestinal tract 
Genitourinary tract 
Endocrine organs 
Central nervous system (microglia) 
Skin (histiocyte/Langerhans cells) 
Serous cavities 
Pleural macrophages 
Peritoneal macrophages 
Inflammatory tissues 
Epithelioid ceUs 
Exudate macrophages 
Multinucleated giant cells 
Adapted from van Furth ct m.s. 
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1 Development of mononuclear phagocytes in the adult mouse 
In the concept of the mononuclear phagocyte system all macrophages arc the progeny 
of monocytes which develop via exudate macrophages into resident macrophages. 
Monocytes are derived from hematopoietic progenitor cells in the bone marrow and 
enter the blood within 24 hours after their formation 13• They have a half-time in 
circulation of approximately 18 hours l4 before entering the tissues to mature into the 
various types of macrophages. However, in the tissues a small proportion (less than 
5%) of DNA-synthesizing macrophages have also been found, thought to be able to 
undergo one morc round of ceB divisionis, These cells were shown to be of bone 
marrow origin. but do not belong to the resident macrophage population as they were 
found to be recent immigrants in the tissues l5. Thus, a small part of tissue macrophages 
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Table 2 Major mononuclear phagocyte functions 
Host defence against microorganisms and tumor cells 
- endocytosis of microorganisms, effete cells, and cell debris 
- cytotoxic activity against microorganisms, virally infected cells, and tumor cells 
Regulation of the inflammatory response 
- production of inflammatory mediators, such as interleukin 1 and prostaglandin E2 
- secretion of molecules which attract other leukocytes, such as leukotriene B4 
- secretion of complement components 
Regulation of the immune response 
- antigen presentation and T cell activation 
- accessory and regulatory function for T, B, and NK cells 
Regulation of hematopoiesis 
- production of hematopoiesis-stimulating factors 
- regulation of iron metabolism 
- removal of effete erythrocytes 
- B lymphopoiesis (bone marrow) 
- T lymphopoiesis (thymus) 
- inhibition of hematopoiesis 
Regulation of endocrine response 
- ovary and testis 
- bone 
- anterior pituitary 
\Vound healing 
- regulation of coagulation and fibrinolysis 
- tissue debridement 
- regulation of angiogenesis 
- regulation of fibroblast proliferation and secretory activity 
Adapted from Ginsee. 
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may be derived from local division of such cel1s 15. In contrast to the view of bone 
marrow-derived macrophage popUlations, self-maintained mature macrophage subsets 
have also been reported, e.g. in the lung, peritoneal cavity and Iiver I6. 19. These subsets 
appeared to be independent of bone marrow monocyte production, and are either main-
tained by local macrophage precursors or by proliferation of resident macrophages. 
Thus, in the adult mouse mature macrophage subsets can be maintained by local 
precursors, influx of precursors (monocytes) from the circulation, or local proliferation 
of mature macrophages. In the following sections the development of macrophages 
from bone maITOW and from local precursors will be discussed. Also lineage rela-
tionships with other hematopoietic cells will be considered. The role of mature macro~ 
phage proliferation in maintenance of the system will not be addressed, as this falls 
beyond the scope of this thesis (reviewed in 20). 
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Development of 1JI00101l1iclear phagocYfes from bone marrow precursors 
Development from bone manvw hematopoietic stem cells: The generation of mature 
blood cells from hematopoietic stem cells is a continuous process throughout life. In the 
adult mouse. bone marrow and splcen are the main sites of hernatopoiesis21 , All blood 
cells have a limited lifespan and need to be replaced by newly fomled cells. The 
number of blood cells generated each day approximates the total number of cells 
present in primary hematopoietic tissues (in the mouse approximately 240 x 106 cells in 
bone marrow and 10 x 106 cells in spleen)2!. All these cells are derived from a small 
pool of hematopoietic stem cells with a large proliferative and broad differentiation 
potential. The most primitive pluripotent hematopoietic stem cells (PHSC) have been 
defined as cells with the capacity for self-renewal and long-term repopulation of all 
blood cell lincages22, The frequency of these cells in bone marrow has been estimated 
to be 1 per 104_105 cells23.24. Under steady state conditions only a small fraction of 
these cells are in cycle, the others are quiescent. 
When PHSC start to proliferate and differentiate, they gradually lose their self-
renewal and proliferative capacity and become restricted to one of the hematopoietic 
lineages (Fig. 1). The main hematopoietic progenitor compartments recognized along 
the various differentiation pathways are multi potent stem cells, committed progenitor 
cells, and morphologically identifiable cells which finally become the mature cells 
entering the blood2!. As stem and progenitor cells are defined on the basis of functional 
attributes, the different stem and progenitor cell subsets are named by the functional 
assays in which they arc detected; ill vivo e.g. multi-lineage long-term repopulating 
cells (LTRC)25.26, cells with maITOw-repopulating ability (MRA)27.28, and cells forming 
colonies in the spleen (colony-forming unit in spleen, CFU-SP9, ill vitro e.g. cobble-
stone area-fonning cell (CAFe) subsets, representing variolls classes of hematopoietic 
stem and progenitor cells30,3!, relatively immature high proliferative potential colony-
fOlming cells (HPP-CFC)32, and committed cells forming colonies in culture (colony-
fomling unit in culture, CFU-C)'3. This way of defining cells may lead to difficulties in 
comparing results from different studies, as stem and progenitor cell popUlations 
isolated by phenotypic or physiological characteristics are heterogeneous in their self-
renewal, proliferative and differentiation potential, and as yet no markers arc available 
which unambiguously discriminate between the various classes of hematopoietic 
eells34.35 • 
In myeloid development the multipotent CFU-GEMM (eolony-fomling unit-granulo-
cyte, erythrocyte, macrophage, megakaryocyte) is the earHest cell that can be detected. 
This stem cell gives rise to the more committed bipotent progenitors of the granulocyte-
macrophage lineages, the granulocyte-macrophage colony-forming cell (GM-CFC), and 
to committed progenitors of the erythroid and megakaryocytic lineages25 ,33,36,37. The 
GM-CFC is generally accepted to be the last common progenitor for macrophages and 
granulocytes38,39. Upon further commitment, the granulocyte and mononuclear phago-
cyte lineages diverge into the distinct granulocyte and macrophage colony-forming cells 
(G-CFC and M_CFC)38.40. Development beyond the M-CFC stage is paralleled by the 
acquisition of typical mononuclear phagocyte characteristics41 ,42. The most immature 
cel1 in the bone marrow recognized by these characteristics is the monoblast'.\3,44. ll1ese 
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Figure 1. Schematic representation of hematopoiesis in adult bone marrow. LTRC: long-term repopulating 
cell; STRC: short-term repopulating cell; CFC: colonY-fonning cell; Eo: Eosinophil; GM: granulocyte! 
macrophage; G: granulocyte; PMN: polymorphonuclear phagocyte; M: macrophage; Mo: monocyte; M$: 
macrophage; BFU·E: burst-forming unit-erythroid; CFU-E: colony-fonning unit-erythroid; E: erythrocyte; 
Meg: megakaryocyte; pro-B: progenitor B cell; HSC: hematopoietic stem cell. 
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cells are thought to divide once and give rise to promonocytes45. Promonocytes also 
divide once and generate monocytes, the last stage of mononuclear phagocyte develop-
ment in the bone marrow46,47. 
Isolatiol/ of early stages of mOI/Ol/llelear phagocyte developmelll: The study of the 
mechanisms involved in myeloid lineage commitment requires the identi~cation of 
lineage-specific markers which permit the isolation of different subsets of committed 
progenitor cells. The currently available cell separation protocols combine multiple cell 
characteristics in order to obtain bone marrow cell populations highly enriched in 
hematopoietic stem cell activity'"'8-53. Although primitive hematopoietic stem cells can 
be separated from more committed progenitor cells in this way, the different classes of 
committed progenitor cells are still difficult to dissect3'. Using density separation and 
counterflow centrifugal elutriation a highly enriched population of GM-CFC has been 
isolated from the bone marrow of cyclophosphamide-treated mice54.55. However, isola-
tion of committed progenitors on the basis of cell surface antigen expression has the 
advantage that information on phenotypic changes associated with commitment may 
provide insight into molecules, genes, and ultimately mechanisms crucial in lineage 
commitment. Recently Trevisan and Iscovc3-4 reported on the phenotypic similarity of 
progenitor cells detected in a variety of short-term assays (CFU-multi, CFU-ElMeg, 
CFU-GIM, and short-term repopulation ill vivo) for the expression of H-2K, CD45, 
AA4.1, HSA, CD7I and the lineage markers B220, Mac-I, Gr-I and CD8. This 
indicates that none of these markers allow separation of myeloid-committed progenitor 
cells from other hematopoietic activities. In addition to the markers mentioned above, 
the macrophage marker F4/80 also cannot be used for identification of myeloid-
committed progenitor cells, as bone man-ow M-CFC do not express this antigen56 , 
Recently, Antica et al. 57 reported that Linjhy-11oHSA+Sca-2+ progenitor cells have the 
capacity to differentiate into the Band T and myeloid lineages, indicating that Sca-2 
docs not discriminate between early myeloid and lymphoid progenitors either. Thus, at 
present no markers are available to isolate specifically myeloid progenitors from the 
bone man-O\Y. 
Relationships with olher hematopoietic lineages: Although the development of mononu-
clear phagocytcs from hematopoietic stem cells is relatively well described, a number 
of questions remain concerning the lineage relationships of these cells with other 
hematopoietic cells. These include the lineage relationships between mononuclear 
phagocytes and granulocytes, B cells, dendritic cells, osteoclasts, and natural killer 
cells. Particularly the stage at which diversification from putative common precursors 
into the differentiated end cells occurs, remains a topic of investigation, 
The granulocyte-macrophage colony-forming cell (GM-CFC) has generally been 
accepted as the most mature common progenitor of mononuclear phagocytes and 
granulocytes21 , However, several data suggest that granulocytic cells as mature as 
promyelocytes can under certain ill vitro conditions still differentiate into macrophages6, 
This has been shown for leukemic cell lines as well as for normal human bone marrow 
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derived promyelocytes6,5s, Thus, the branch point of the granulocyte and macrophage 
lineages appears to be less clearly defined than initially thought. 
In the generally accepted scheme of hematopoiesis (Fig, I), myeloid and lymphoid 
lineages already diverge early. However, several data point to a close relationship 
between macrophages and B cells (reviewed in 59). TransfOlmed CDS+ early B cell 
lines which acquire macrophage characteristics upon ill vitro maturation have been 
described59,6o. These cells differ from conventional macrophages in that they coexpress 
B ce11 and macrophage characteristics. Recently, the nOl1nal counterpart of the trans-
formed B/macrophage cell has been reported in cultures of bone marrow and spleen of 
mice61 ,62, indicating that the double phenotype is not caused by inappropriate gene 
expression due to transformation, These data, together with the identification of a 
bipotent fetal liver progenitor for B cells and macrophages63,64, have led to the proposal 
of a new model of macrophage relationships to B ce11s59. In this model conventional 
macrophages are derived from adult bone marrow 1110nocytes, whereas the 
B/macrophage cells are derived from CDS+ B cells generated in ontogeny from the 
bipotent fetal liver progenitor for B cells and macrophages. However, recently 
precursors for CDS+ B cells of adult rather than fetal origin have also been detected in 
adult bone marrow65 . Thus, the precise developmental origin of the precursor for 
B/macrophage cells still remains to be established, 
The question whether dendritic cells (DC) belong to the mononuclear phagocyte 
system has been a topic of much debate. The dendritic cell system is widely distributed 
throughout the body and comprises Langerhans cells in the skin, veiled cells in the 
lymph, interdigitating cells in the lymphoid organs and interstitial DC in the connective 
tissue of non-lymphoid organs lO. After the bone marrow origin of DC was established 
in 197966.67, many studies have addressed the lineage relationship of DC with other 
hematopoietic lineages, Three possible origins for DC have been suggested, which may 
exist next to each other. First, in the last decade a still increasing amount of data has 
been published in favor of a myelomonocytic origin of DC (reviewed in 12, 68, 69). 
These include (a) the expression of myeloid antigens by dendritic cells7o.73 , (b) 
expression of GM-CSF receptors and dependence on GM·CSF for ;1/ vitro deve-
lopment74-77 , (c) phagocytic and macropinocytic activity in defined differentiation stages 
(reviewed in 78), (d) growth of mixed myeioidlDC colonies from bone marrow pre-
cursors7., (e) development of dendritic cells from peripheral blood monocytesSO,SI, and 
(f) the identification of a CDla-CDI4+ post-CFU intermediate cell type in cultures of 
CD34+ bone marrow or cord blood cells which can differentiate into either macro-
phages or dendritic cells82,8J, Thus, DC have been generated in GM-CSF·dependent 
cultures from different stages of myeloid development. ranging from early common 
progenitors for DC, granulocytes and macro phages in bone marrow to monocytes in 
peripheral blood, Second, several studies report on a lymphoid origin of DC. In human 
bone man-ow, a common progenitor population for DC, T, NK and B cells has been 
identified, lacking erythroid and myeloid differentiation capacity"4, Similarly, in the 
human thymus, a population capable of generating DC, T and NK cells has been 
reported85,86, The myeloid and/or B cell differentiation capacity of this thymic cell 
population remains to be tested. Also in mouse thymus an early precursor population 
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has been identified with the capacity to develop along the T, NK, DC and B cell 
lineages, but hardly or not along the myeloid Iincage87+ 89. In none of these studies 
direct evidence was given for the existence of a common muHipotent progenitor cell for 
T. DC, NK and B cells in either the thymic or bone marrow progenitor populations, 
due to a lack of suitable clonal assays, So far, only multi potent BlNKlDC progenitors 
could be demonstrated", Yet, a recent study on mouse thymic DC precursors strongly 
supports the existence of a common precursor of DC and T cells, with CD8a as a 
marker of the lymphoid-related DC lineage90, 111ird, apart from the reported lineage 
relations with the myeloid and lymphoid lineages, evidence for a separate DC 
progenitor has also been reported8,,83,9,,9', In GM-CSF- and TNF-a-stimulated cultures 
of human CD34+ bone marrow cells progenitor cells have been detected that give rise 
to pure DC colonies (CFU-DC)9', The cells generated in these colonies resemble 
epidermal DC91 . Likewise, in liquid cultures of CD34+ human bone marrow Of cord 
blood cells a CDla+CDI4- precursor has been detected which finally gives rise to 
Birbeck granule-positive DC"''', These data suggest that epidemlal Langerhans cells 
are derived from a separate lineage of DC which is independent of monocytes83,92, In 
conclusion, the precise lineage relationships of dendritic cells with other hematopoietic 
lineages are complex. On the basis of current data different pathways for DC 
development appear to exist, leading to different types of mature DC, One of these 
pathways is clearly linked to the monocyte/macrophage lineage. 
The hematopoietic origin of osteoclasts has been well established93-97 , Although 
generally accepted to be of myeloid origin93, the exact divergence point of the osteo-
clast and myeloid lineages is stiH unclear. On the basis of experimental evidence 
several possible branch points have been suggested, ranging from early in myeloid 
differentiation (before the CFU-GM stage) till the stage of mature macrophages 
(reviewed in 98). However, the precise identification of one or more stages at which 
the osteoclast and myeloid lineages diverge, awaits the further identification and 
isolation of myeloid progenitor stages. 
Despite their undisputed bone marrow origin99-J01 the precise relationship of natural 
killer (NK) cells with other hematopoietically derived cells has remained controversial. 
Detailed phenotypic characterization of NK cells did not lead to an unambiguous 
classification of NK cells to a defined lineage, since NK cells share surface markers 
with T lymphocytes, granulocytes and cells of the mononuclear phagocyte system J02• It 
has been suggested that at least part of the NK cells are related to the mononuclear 
phagocyte system'03-106, In addition, it has also been suggested that NK cells are 
derived from an early NKlT cell progenitor from which they branch off before 
rearrangement of the T cell receptor lO7 , Still another possibility is that NK cells 
constitute a separate lineage and are thus derived from NK-committed progenitors. 
Neither such NK-committed nor NKlT progenitors have thus far been reported for 
normal adult bone marrow, Rather, the cells identified in bone marrow as NK progen-
itors seem to be part of a (multi potent) cell popUlation that has the capacity to 
differentiate into both the myeloid and lymphoid Iineages lO', In summary, the lineage 
relationships of NK cells with other hematopoietic cells are still obscure, Similar to the 
situation for DC, different pathways for NK development may exist. 
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In conclusion, due to the limited identification of the precursor stages in the bone 
malTOW and the great diversity of cells belonging to the mononuclear phagocyte system, 
the lineage relationships of the mononuclear phagocyte system with other cell types are 
still unclear. 
Development of mononuc/ear phagoc)'/es from local tissue precursors 
Spleen: In rodents the spleen continues to be a hematopoietic organ throughout life. 
Under conditions of impaired bone malTOW hematopoiesis, e.g. in leukemic mice, 
splenic hematopoiesis is augmented as a compensatory mechanism. In the mouse spleen 
erythroid cells are produced in the red pulp while myeloid progenitors are located under 
the capsule and scattered in the red pulp (ref. 21, and unpublished observations). 
Splenic macrophage progenitors differ from bone malTOW macrophage progenitors in 
their expression of Ly-6C, suggesting that macrophages in the spleen and bone malTOW 
arise from different progenitors lO9 Clonable splenic macrophage progenitor cells have 
been reported to give rise to mature macrophage colonies which differ in antigen 
presentation capacity"0-113. Together these data are suggestive of the existence of 
different progenitors for functionally different mature macrophages. The spleen contains 
several mature mononuclear phagocyte populations, distinct both in phenotype and ana-
tomical localization. Several studies have addressed the origin of these distinct 
popUlations. Following splenic macrophage elimination by administration of chlodronate 
liposomes, these subsets were shown to differ significantly in repopulation kinetics, 
varying from one week for total recovery of red pulp macrophages to more than one 
month for recovery of marginal zone macrophages 1l4. Recently it was shown in 
macrophage-depleted radiation chimeras that all splenic macrophage populations can be 
bone malTow-derived 1l5. In addition, it was found that under steady state conditions 
subpopulations of mature splenic macrophages retain the capacity to proliferate and 
thus may contribute substantially to the maintenance of the splenic macrophage 
populations1l5,116. These data cOlTespond with previous findings" 7,118. For example, it 
has been shown that under steady state condit'ions 55% of all isolated splenic 
macrophages originate from blood-derived monocytes, while 45% is maintained by 
local proliferation l17• Currently 1\0 data are available that indicate a clear contribution 
of local splenic (pre)monocyte precursors to the maintenance of mature splenic macro-
phages. Still, a role for such cells cannot be excluded liS. 
Omentum: In the mouse precursors of the mononuclear phagocyte lineage have been 
reported to reside in the milky spots of the omentum I8,119,120. These precursors are 
thought to contribute to the maintenance of the peritoneal macrophage population"9.121. 
However, on the basis of the data available it is not clear whether these precursors are 
deposited in the milky spots early in ontogeny, or whether they are bone marrow 
(monocytic) derived122. 
Next to bone marrow, the spleen and omentum are the best studied for the presence 
of macrophage precursors. Little is known about these cells in other organs. In liver 
macrophage precursors have also been reportedJ23,124, but this was under experimental 
conditions that induced recruitment of these cells from the peripheral blood. Under 
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steady state conditions and after liver transplantation. DC could be grown from normal 
mouse liver125,126, However, although whole body perfusion was performed before 
harvesting the liver, it cannot formally be excluded that these cells arise from peripheral 
blood-derived cells that adhere to the liver vasculature, 
2 Development of mononuclear phagocytes in ontogeny 
Macrophage-like cells are among the first hematopoietic cells appearing in the mouse 
embryo. Using immunoelectron microscopy macrophages can be detected in the blood 
islands of the yolk sac at day 9 of gcstation l27,128. Because of their immature character-
istics they are named I1primitive macrophages,,127,128, By day 10 of gestation these 
primitive macrophages have acquired a more mature phenotype and arc named "fetal 
macrophages .. 127,128. It has been suggested that the primitive macrophagcs are not 
derived from monocytic cells but develop directly from local hematopoietic ce1l5127-I3O, 
This suggestion is based on the absence of promonocytic and monocytic cells in the 
mouse yolk sac at day 9 127,128,131-133, wllile cOinmitted hematopoietic precursors with ill 
vitro myeloid differentiation capacity have been detected in the yolk sac already at day 
7/8 of gestation 13I ,I34,135, Cells of the monocytic lineage start to appear in the yolk sac 
at day 10 of gestatiOll I27,J32,133_ 
Around day 10 of gestation, when the yolk sac is connected to the developing 
embryonic vascular system, primitive/fetal macrophages enter the vite11ine vessels, 
migrate through the blood to the fetal liver and colonize various embryonic 
tissuesI27-129. This is in contrast to adult macrophages which do not migrate through the 
blood. In addition, primitive/fetal macrophages have a high proliferative potential, 
reflected in the large proportion of cells in cycle l27,128,136, and therefore might be a self-
sustaining population. Once in the tissues they gradually obtain features similar to those 
of resident macrophages in adult animals 137,138 and may persist there after birth l3o,136. 
Thus, it has been suggested that primitive/fetal macrophages constitute a separate line 
of macrophage development in ontogeny, independent of the monocytic lineageI30,136. 
Recently several studies have addressed the origin of the adult hematopoietic system 
of the mouse. Definitive adult hematopoietic stem cells were shown to develop in the 
intraembryonic aorta-gonads-mesonepluos (AGM) region 139,140, analogous to what has 
previously been found in nonmammalian vertebrates14I . This is in contrast with the 
generally accepted idea that definitive hematopoiesis originates in the yolk sacI3l. 
Recently it was demonstrated by ill vitro organ cultures of the yolk sac, liver and AGM 
that the AGM region autonomously and exclusively generates the definitive hema-
topoietic stem cens which form the adult hematopoietic system 140, 
Monocytic cells, which are part of the adult hematopoietic system, appear in the 
yolk sac aner the blood circulation is establishedl27,132,133, This finding is suggestive of 
a seeding of the yolk sac by precursors from the AGM region, In accordance with this 
notion is the finding that in cultures of yolk sacs, isolated from the embryo before 
circulation, a reduced myeloid differentiation potential was found 142• However, 
confimlation of the AGM origin of yolk sac monocytic cells requires further 
experimentation. 
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In Fig. 2 a scheme of macrophage development in ontogeny is presented, summariz-
ing currently available data. Thus, macrophages are thought to develop along two 
distinct lines in ontogeny. The earliest detectable macrophages are the primitive 
macrophages in the yolk sac, which colonize embryonic tissues. Later in ontogeny the 
monocyte/macrophage lineage arises, presumably from the definitive hematopoietic 
stem cells generated in the AGM. 
YS PB tissues 
o-~ 0 0-------'-----+1 
i i 
progenitor 
AGM 
resident M0 
FL 
Figure 2. Development of mononuclear phagocylcs in ontogeny. Macrophagcs are thought to develop along 
two separate lineages in ontogeny. First to appear are the primitivc macrophages in thc yolk sac, probably 
arising from a local hematopoietic precursor with ill vitro mycloid differentiation capacity. Primitive 
macrophages mature into felal macrophages without passing through the stage of promonocyles and 
monocyles, and colonize the embryonic tissues (including felal liver). Once in the tissues they mature into 
cells resembling adult resident macrophages and are thought to persist after birth as a self-sustained 
population of cells. In fetal liver, these fetal macrophages may give rise to Kupffer cells (sec section 3). Later 
in ontogeny, cells of the monocytic/macrophage lineage appear in the embryo. These cells are part of the 
final adult hematopoietic system and arc presumably deriyed from the hematopoietic stem cells generated in 
the AGM. Once generated, cells of the definitive hematopoietic system spread through the embryo and finally 
colonize the bone marrow, the adult site of hematopoiesis. YS: yolk sac; AGM: aorta-gonads-mesonephros 
region; PB: peripheral blood; FL: fetal liver; BM: bone marrow; M¢I: macrophage; LTRC: long-term 
repopulating cell. In the AGM, FL, and BM shaded cells represent cells of the definitiYc hematopoietic 
system, ranging from hematopoietic stem cells to mature blood cells. 
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3 Origin of mononuclear phagocyte heterogeneity 
Based on differences in tissue localization, expression of surface molecules, and 
functional properties, macrophages can be divided into distinct subsets. As illustrated in 
Fig. 3, several mechanisms contributing to mature macrophage heterogeneity have been 
suggested. These are (i) the: generation of self-maintained, bone marrow independent 
populations early in ontogeny; (ii) induction of heterogeneity in response to local condi-
tions or stimuli encountered in peripheral tissues; and (iii) heterogeneity resulting from 
differences at the macrophage precursor level. In the following, experimental data 
supporting each of these mechanisms will be discussed shortly (for detailed reviews see 
ref, 6, 8, and 143), 
Self-maintained populatiolls generated ill ol/togeny 
As described in section 2, a separate population of fetal macrophages originates from 
primitive yolk sac macrophages before the appearance of cells of the monocytic 
lineage. These macrophages migrate early in ontogeny into various fetal tissues and are 
thought to persist after birth as resident macrophagesJ30.I36. For several adult resident 
macrophage populations a fetal origin has indeed been described, including Kupffer 
cells I29,I37, alveolar macrophagesl44.145 and microglia l46. Also for dendritic cells 
(Langerhans cells in the skin) a fetal macrophage origin has been suggested l47. 
Evidence that certain peripheral macrophage populations under steady state conditions 
may be self-sustained instead of dependent on monocyte influx, was obtained from 
studies in which bone marrow and peripheral blood precursors were depleted by the use 
of the bone-seeking isotope 89SrI6.17,148-151 and from experiments using bone marrow 
chimeras or parabiotic animals152.153. These studies showed that the number of Kupffer 
cells, alveolar macrophages and resident peritoneal macrophages is independent of 
monocyte influx, indicative of maintenance by local proliferation. In addition, it has 
been shown that Langerhans cells are a long-lived and slow-cycling cell population, 
capable of self-reproduction I54,155. However, several studies have reported also on a 
bone marrow origin of e.g. Kupffer cells and Langerhans cells66.67,156,157_ Therefore, a 
dual origin of resident macrophages has been suggested, in which both local 
proliferation of resident cells (possibly generated during ontogeny), and monocyte 
influx contribute to the maintenance of resident macrophage populations15,158,159. 
Inductioll of heterogeneity by local factors ill the peripheral/issues 
According to the concept of the mononuclear phagocyte system, the differences 
observed between macrophages from different organs, or from different anatomical sites 
within one organ, are the result of the exposure of cells to different tissue micro-
environments. Indeed it has been shown that tissues differ in their local concentrations 
of growth factors such as M_CSpI60,161 and GM_CSp162,163, Previously these growth 
factors were shown to contribute to phenotypic and functional heterogeneity of mature 
macrophages ill \'ilro21 ,164-166. In addition, recent studies in mice deficient for these 
growth factors have confirmed and extended the ill vitro data on the influence of M-
CSP and GM-CSP on the functional activity of macrophages l67, 
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Figllre 3. Hypothetical mechanisms contributing to mononuclear phagocyte heterogeneity. A. Self-maintained 
populations generated in ontogeny. In ontogeny resident macrophages may arise from fetal macrophages 
entering the tissues. In adult life such populations are self-maintained, independent of monocyte inllux. B. 
Induction of heterogeneity by local factors in peripheral tissues. Mature macrophage heterogeneity may arise 
at the level of monocytes entering the various tissue microcnvironments (differentiation), or at the level of 
macrophages responding to altering conditions in their microenvironment (activation). By definition, 
activation of macrophnges is a reversible process. Co Induction of heterogeneity at the precursor level. C.I. 
Separate precursor populations that give rise to different types of mature macrophages may be generated 
during mononuclear phagocyte development. Co2. Differences in function and phenotype associated with 
different maturation stnges may contribute to mononuclear phagocyte heterogeneity. 
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The osteopetrotic op/op mouse lacks the macrophage-specific growth factor M-CSF 
due to a spontaneous inactivating mutation in the M-CSF gene. As a result the number 
of macrophagcs and osteoclasts is severely reduced. However, not aU macrophage 
populations were affected by the mutation. It appeared that populations of tissue 
macrophages clearly differ in their M-CSF dependencyI68.17I. Three groups of 
macrophage populations could be discerned: (i) macrophage subsets that are totally M-
CSF-dependent (less than 5% of normal cell numbers found in op/op mouse), (ii) 
partially M-CSF-dependent macrophage populations (5-80% of normal cells), and (iii) 
M-CSF-independent populations (>80% of nom1al numbers still present)169. For 
example. peritoneal macrophages, osteoclasts and spleen methallophils are almost 
completely dependent on M-CSF, whereas e.g. Langerhans cells and dendritic cells of 
lymphoid organs are M-CSF_independentI69.170. It has been suggested that these 
differences in M-CSF dependency reflect functional differences, with M-CSF-dependent 
macrophages most likely playing a role in various tissue reactions, including responses 
to bacterial infection, tumor cell growth, and tissue remodeling I69,170. M-CSF-indepen-
dent macrophages, on the other hand, were hypothesized to be primarily involved in 
mounting an immune response l69,170, 
In contrast to the op/op mouse, general analysis of the GM-CSF knockout mouse 
showed no reduction in the basal numbers of granulocytes or monocytes/macro-
phagesl72,173, However, the function of alveolar macrophages was severely impaired, 
indicating an important, irreplaceable, role for OM-CSF in the regulation of alveolar 
macrophage fUl1ction l72,173. 
In addition to these colony-stimulating factors, other factors like IFN-~, IFN-y, 
TNF-a, LPS, IL-4, IL-13, IL-IO have been shown to contribute to macrophage 
diversity I43,174,175. Obviously, cell-cell interactions, as well as interactions with the 
extracellular matrix may also play a role in generating macrophage heterogeneity. As 
yet, the precise mechanisms involved in the tissue-specific generation of macrophage 
diversity are not clear. It is to be expected that analysis of mutant mice will contribute 
significantly to our understanding of these processes. 
Induction of heterogeneity at the precursor level 
Heterogeneity can find its origin at the macrophage precursor level in two ways. First, 
precursors can differ in functional capacities as a result of differences in maturation 
stages and in this way contribute to the functional heterogeneity among mononuclear 
phagocytes. Second, subpopulations of precursor cells may exist, which develop along 
intrinsically different gene programs into distinct subtypes of mature macrophages. 
Maturation of bone marrow-derived macrophages has been shown to be accompanied 
by changes in phenotype such as increasing levels of ~-galactosidaseI76, decreasing 
levels of myeloperoxidasel77 and increasing or decreasing levels of cell surface markers 
(178 and chapter 2 of this thesis). In addition, maturation stage-related functional 
changes have also been reported. Phagocytic capacity, cytotoxicity, chemotactic 
responses, the production of various molecules associated with inflammation have all 
been shown to be expressed maximally at specific stages of maturation179-185. 
Phenotypic heterogeneity resulting from differences in maturation stage was also found 
General introduction 25 
among freshly isolated human peripheral blood monocytes. Two monocyte subsets were 
identified on the basis of differential CD 14 and CD 16 expression, a CD 14+ 16+ and a 
less mature CD 14++ 16- subset (reviewed in 186). On the basis of differences in the 
expression of several other cell surface markers and in cytokine production. it has been 
suggested that these monocyte subsets differ in their functional capacities, with the 
CDI4+16+ cells being of a proinflammatory type186. 
The existence of separate precursor populations which give rise to different mature 
macrophage subsets has first been suggested by Bursuker and Goldman l87•188. They 
found that bone marrow precursors could be divided into two populations: one giving 
rise to mononuclear phagocyte colonies expressing high levels of S'-nucleotidase 
activity and one giving rise to colonies expressing low levels of this enzyme. As the 
level of enzyme expression in either of these populations could not be modulated, they 
suggested that the difference in enzyme expression reflected the existence of inherently 
different precursor subsets l88 . Since then, several studies have been pubHshed, 
supporting the existence of such macrophage precursor populations. These studies 
report on clonal differences of bone man-ow and spleen derived macrophages in antigen 
presentationIIO-1I3,I89.191, cytotoxicityl92, and cytokine productionl93 . In addition, im-
mortalized bone marrow macrophage precursor cell lines have been shown to differ in 
their capacities to differentiate into either non-phagocytic, phagocytic, or class II 
expressing mature macrophages, suggestive of the existence of precursors with 
divergent differentiation pathways l94. 
Blood monocytes form the link between macrophage precursors in the bone marrow 
and mature tissue macrophages. Thus, if heterogeneity originates already at the level of 
the bone marrow precursors, then such a heterogeneity should be reflected also at the 
level of blood monocytes. Indeed, monocyte subsets heterogeneous in phenotype and/or 
function have been detected in peripheral blood, e.g. a subset of monocytes expressing 
a proinflammatory phenotype, named P monocytes l95,196 and a CD64- subset with a 
high accessory and antiviral activity 197, As no obvious maturational differences were 
found so far that could be underlying the observed heterogeneity, these data support the 
concept of different precursor subsets. 
Previously it has been shown that macrophages derived ill vitro from precursors 
using either M-CSF or GM-CSF as a growth factor differ morphologically and 
functionally8,198.205. Thus, the local concentrations of growth factors such as M-CSF 
and GM-CSF are likely to have an effect on the developmental pathway followed by 
each individual macrophage precursor. It remains to be established, however, to what 
extent microenvironmental stimuli early in macrophage development contribute to the 
generation of mature macrophage diversity. It is possible that predetermined develop-
mental programs are fol1owed once they are acti vatcd by local stimuli. 
In summary, the currently available data indicate that heterogeneity of mature 
macrophages can originate also at the level of macrophage precursor cel1s in the bone 
man-ow and peripheral blood. However, the precise developmental stagc(s) at which 
heterogeneity is generated, the mechanisms involved in the generation of such heteroge-
neity, and the contribution of precursor heterogeneity to mature macrophage heteroge-
neity ill vivo, remain to be established. 
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4 Introduction to the experimental work 
As discussed in the previous sections, many questions still exist concerning the origin 
and development of the mononuclear phagocyte system. Further identification of the 
branch points of the mononuclear phagocyte system with other hematopoietic lineages 
and branch points between mononuclear phagocyte sublineages, may shed light on the 
processes involved in lineage commitment of progenitor cells. Such studies require the 
identification of mononuclear phagocytes at early stages of their development. To this 
end a panel of monoclonal antibodies has been generated in our laboratory against 
immortalized macrophage precursors from the bone marrow of the mouse178,19-\., 1\vo of 
these antibodies, ER-MPI2 and ER-MP20, each have been found to recognize cell 
surface molecules differentially expressed by bone marrow macrophage precursor cells. 
A third antibody, ER-MP58, appears to detect all M-CSF-responsive bone marrow 
progcni tors l78. It is not clear whether the observed heterogeneity in macrophage pre-
cursor phenotype reflects the existence of macrophage sublineages, or different stages 
of maturation along a linear differentiation pathway. The aim of the studies described in 
this thesis was therefore to (i) isolate bone marrow macrophage precursor subsets for 
analysis of their developmental potential, and Oi) to separate early myeloid-committed 
progenitor cells from hematopoietic progenitors with other or broader activities in order 
to facilitate studies on the processes involved in commitment to the myeloid/mono-
nuclear phagocyte lineage. 
In chapter 2 the expression of the ER-MPI2, ER-MP20, ER-MP58 markers and a 
selected panel of other currently available anti-mononuclear phagocyte markers was 
examined on macrophages developing in liquid bone malTOW cultures stimulated with 
M-CSF. Such cultures give insight into which stage(s) of macrophage development are 
recognized by the antibodies. In this chapter data on the differential recognition of 
mononuclear phagocytes obtained from the bone marrow cultures and other models of 
macrophage development described in the literature are reviewed to come to a classifi-
cation of anti-mononuclear phagocyte antibodies. In this classification, emphasis is on 
the interpretation of phenotypic characteristics in terms of macrophage developmental 
stages and functional capabilities. 
The experiments described in chapter 3 were undertaken to examine 0) whether the 
phenotypic heterogeneity detected among macrophage precursors by ER-MP12 and ER-
MP20 monoclonal antibodies"8 could be extended in two-color flow cytometry, and (ii) 
whether this phenotypic heterogeneity reflected different maturation stages or the 
existence of macrophage sublineages. 
In a parallel study on the ER-MPI2120 phenotype of hematopoietic stem and 
progenitor cells it was found that cells which have the capacity to confer hematopoietic 
reconstitution after intravenous transfer into irradiated recipient mice, reside in the ER-
MP12hi20- and ER_MPI2 fficd20- bone marrow subsets,06. To examine if progenitors of 
the T, B and myeloid lineages can be separated on the basis of differential ER-
MP12120 expression, the early ill vivo differentiation capacity of the ER-MPI2h;20- and 
ER_MP12med20- bone marrow subsets was determined after transfer into irradiated 
recipients (chapter 4). 
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The experiments described in chapter 5 were designed to answer the question 
whether myeloid-committed cells present in the ER-MPli';20· subset can be distin-
guished and purified from the other hematopoietic stem and progenitor cells in this 
subset (sec chapter 4). For this purpose, bone marrow cells were triple labeled with ER-
MPI2120 and ER-MP58, an antibody previously found to detect all M-CSF-responsive 
progenitors in mouse bone marrow178. Subsets differing in ER-MP58 expression were 
isolated from the ER-MPI2h;20· bone marrow population by cell sorting and tested ill 
vitro and ;11 vivo for their capacity to differentiate along the myeloid, B, T, and 
erythroid lineages. In addition, the expression of the ER-MP58 antigen on various 
hematopoietic stem cell subsets was investigated. 
As discussed in this introduction, dendritic cells (DC) are at least in part linked to 
the monocyte/macrophage lineage. In chapter 6 we questioned in which of the ER-
MPI2/20/58-defined bone marrow subsets OM-CSF-responsive DC progenitors reside. 
For this purpose, ER-MPI2/20/58 subsets were isolated by cell sorting and cultured in 
the presence of GM-CSF. After various periods of time, cultures were examined for the 
presence of DC-like cells by microscopic inspection of cellular morphology and 
immunocytochemical analysis of MHC class II expression. In addition, we asked till 
what ER-MPI2/20-defined stage of development DC-like cells can be derived from 
macrophage precursors. To this end, ER-MPI2120/58 bone marrow subsets containing 
different stages of macrophage maturation were cultured in the presence of M-CSF to 
induce further development along the monocyte/macrophage lineage. After four to five 
days of culture the stimulant was changed to OM-CSF and the capacity of the develop-
ing macrophage precursors to give rise to DC-like cells was assessed as described 
above. 
From the initial experiments described in chapter 3 we learned that upon double 
labeling of bone marrow with ER-MPI2 and ER-MP20 monoclonal antibodies 6 bone 
marrow subsets can be discerned with a remarkable hematopoietic lineage homogeneity. 
These data suggested that ER-MPI2120 analysis of bone marrow could provide a new, 
relatively simple, and objective method for differential analysis of mouse bone marrow 
composition. In chapter 7 we aimed at validating the use of this method in an 
experimental ill vivo model. To this end, changes in bone marrow cellular composition 
were monitored in a sublethal infection with Lister;a 1Il0llocytogelles. Data obtained 
from ER-MP12/20 bone marrow subset analysis were compared with data obtained 
from analysis of lineage marker expression and from conventional morphological 
analysis. The correlation between the different methods was assessed by linear regres-
sion analysis. 
In chapter 8, we have applied ER-MPI2/20 bone marrow subset analysis (validated 
in chapter 7) in a study on the effects of dietary fish oil supplementation in mice. Fish 
oil consumption has been shown to enhance the resistance to infections in various 
experimental animal models207 . Examination of the cellular composition of bone 
malTOW and the frequency of M-CSF-responsive macrophage precursors contributed to 
shed more light on the meehanism(s) behind the enhanced resistance induced by dietary 
fish oil. 
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Abstract 
In this review, we present and discuss a selected panel of antibody-defined markers 
expressed during different stages of mouse macrophage development. We distinguish four 
categories of markers, which are characteristic of: (1) macrophage precursors and immature 
macrophages (ER-MPI2, ER-MP20, ER-MP54, ER-MP5S); (2) mature macrophagcs in 
general (F4/S0, BMS, Mac-I, Mac-2, ER-BMDMI); (3) macrophage subsets (ER-HR3, 
ER-MP23, ER-TR9, Forssman antigen, MOMA-I, MOMA-2, Monts-4, SER-4), and (4) 
IFN-y-stimulated macrophages (H-2Ia, LFA-I, ICAM-I, 15S.2, MBR-2, TM-2, TM-4, and 
TM-5). It should be noted that many of the markers in this last category are inducible by 
other stimuli as well. The rigid classification of markers into four separate groups should 
be regarded as a digitalization of a continuum, thus inevitably implicating a simplification 
of the complex phenotypic changes that occur during mononuclear phagocyte development. 
Nevertheless, the current selection of antibodies against markers for different develop-
mental stages of macrophages constitutes an important tool for characterization of mouse 
macrophages which participate in various biological processes. 
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Introduction 
The cell surface of the mouse macrophage has been mapped extensively since the intro-
duction of hybridoma technology in the late seventies. An array of monoclonal antibodies 
elicited against different macrophage populations has been produced and characterized (see 
ref. I for an overview), Yet, defining discrete, functional stages in mouse macrophage 
development using antibodies against discriminating detemlinants appeared to be much 
more complicated than describing functionally distinct lymphocyte subtypes. 
The limited insight into the link between phenotype and function of different 
macrophage populations may be ascribed primarily to the complexity of the mononuclear 
phagocyte system (see recent reviews by us and others'·2). Different macrophages are 
involved in a wide variety of processes, such as (I) clearance of potentially harmful 
substances, (2) killing of microorganisms and tumor cells, (3) regulation of and partici-
pation in inflammatory and immune responses, and (4) regulation of hem at 0- and lympho-
poiesis. This functional diversity is clearly reflected in the phenotypic diversity of the 
various mononuclear phagocyte populations, although it is often difficult to interpret 
observed phenotypic differences. 
In this review, we will discuss a selected panel of markers, detected by monoclonal 
antibodies, useful for the phenotypic characterization of mouse macrophages. Emphasis 
will be on the interpretation of phenotypic characteristics - and on the limitations thereof 
- in terms of macrophage developmental stages and functional capabiJities. To that end, 
we will first attempt to define the different processes in macrophage development, as many 
slightly different definitions are being used in the field. 
We regard the phenotypic and functional changes that macrophages undergo during 
development as being caused by either maturation, differentiation, or activation of the cells 
(schematically depicted in Fig. I). Matl/ratioll is the process by which cells acquire 
features typical of cells in later stages of development, and lose aspects of earlier stages. 
Differentiatioll, in our view, is a specific type of maturational process by which diversity 
is generated. Both maturation and differentiation are, in principle, irreversible. In contrast, 
activation of macrophages is a reversible process by which ceIJs are stimulated to express 
particular functions or by which the accomplishment of certain existing functions is 
enhanced. These processes may occur concunently, that is, a cell might both mature and 
become activated as a response to a specific stimulus. 
In accordance with the different developmental processes, macrophage markers may 
be classified as (J) maturation markers, which are either positively or negatively correlated 
with the cell's maturation stage, (2) differentiation or subset markers, which are expressed 
differentially by cel1s of similar maturation stages, and (3) activation markers, whose 
expression can be induced or enhanced by particular external stimuli and is indicative of 
certain functional capabilities. Inevitably, the assignment of a particular marker to one of 
these categories depends significantly on the experimental models used to study 
maturation, differentiation and activation. 
In our previous work, we have adopted and developed three different models for the 
identification of macrophage maturation markers, recognized by newly prepared and exist-
ing monoclonal antibodies. The first model consists of a panel of macrophage cell lines, 
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Pigure J. Schematic representation of different facets of macrophage development. M: maturation; D: 
differentiation; A: activation; de-A: de-activation. 
which can be aligned in order of increasing maturity and represent stages ranging from 
CFU-GM to relatively mature exudate macrophages3. M-CSF-stimulated bone marrow cell 
cultures abrogated at different time points provides a second maturation modeI4,5. Thirdly, 
multiple macrophage precursor cell lines can be stimulated to develop into more mature 
stages by external stimuli, such as mouse post-endotoxin serum6. 
Models for the identification of macrophage differentiation or subset markers are not 
as clearly defined as the maturation models mentioned above. In the latter, homogenous 
popUlations of mature cel1s are generated from precursors, and diversification, which is by 
definition the hallmark of differentiation, is rarely observed. Yet, different macrophage 
subsets can be easily discerned ill situ by immunohistochemical analysis of complex organs 
such as the spleen 7. Here, phenotypically distinct macrophage subsets are found in different 
microanatomical locations. The developmental relationship between these subsets is 
unclear, but the cells do not show conclusive maturational differences that might explain 
their phenotypic heterogeneity. However, at some point in their development the distinct 
macrophage subsets share a common progenitor and thus represent the end-stages of a 
differentiation process. Therefore, to identify different subset markers we use immunohisto-
chemistry of macrophages in lymphoid and non-lymphoid organs as the main technique. 
Macrophage activation markers are, by definition, induced by specific external stimuli 
and the expression of these markers decreases again when the stimulus is removed. As a 
screening model, macrophage cell lines or primary bone marrow cultures are stimulated 
with lFN-y, which is known to mediate several functional changes in a broad spectrum of 
macrophages. For instance, IFN-y-stimulated macrophages show increased ability to present 
antigen to CD4+ T cells, as a consequence of increased MHC class II expression, and are 
primed for further stimulation to become tumoricidal8. However, stimulating macrophages 
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with IFN-y precludes the development of other functional stages. Thus, in general, 
activation markers are linked directly to the type of stimulus given, as wel1 as to the type 
of responding macrophage. 
In the following sections we will discuss a panel of macrophage markers, classified as 
either immature or mature markers, subset markers or activation markers according to the 
criteria mentioned above. Unfortunately, the discussion will show that very few of these 
markers, if any, arc fully specific for a single category. OUf experience is that the same 
holds true for other macrophage markers not included in the present selection. Yet, using 
combinations of multiple markers from the different categories for the phenotyping of 
mouse macrophages enables a plausible description of their developmental stage in tcnns 
of relative (im)maturity, belonging to a particular subset or being (un)stimulated. 
Materials and Methods 
BOlle marrow cultures 
Macrophage development was followed in liquid bone marrow cultures stimulated with M-
CSF, as described before6. Briefly, bone marrow was harvested from BALBlc mice (10-20 
weeks of age), which had been kept under clean, routine conditions in accordance with 
institutional guidelines for animal welfare. The cells obtained were cultured for varying 
periods of time in DMEM, supplemented with 10% fetal calf serum, 13% L-cell 
conditioned medium and antibiotics, and then phenotypically analyzed. 
Monoclonal antibodies 
The characteristics of and references for monoclonal antibodies described in this paper are 
summarized in Table 1. Hybridomas marked with HER_II were established in our own 
department; MinD, M3/38, MI/22.2S, MS1I14, YNII1.7 and MAIS8.2 producing 
hybridomas were obtained from the American Type Culture Collection (Rockville, MD); 
monoclonal antibodies andlor hybridomas designated BM8, F4/80, H3S.89, MOMA-I, 
MOMA-2, Monts-4, MIV 38, SER-4, TM-2, TM-4, and TM-S were kindly provided by 
the respective producers andlor BMA Biomedicals AG (Augst, Switzerland). For cellular 
staining, either undiluted hybridoma supernatants or optimally diluted purified antibody 
preparations were used. 
Immullofluorescence staining alld jiow cytometric analysis 
Staining of cells was perfonned using routine procedures, essentially as described before9. 
Cellular fluorescence as a measure of antibody binding was determined using a FACScan 
(Becton Dickinson, Sunnyvale, CA) with logarithmic amplification of FITC fluorescence 
signals. Results are expressed either as perccnt positive cells compared to ceUs stained with 
a control monoclonal antibody, or as molecules equivalent to soluble FITC (MESF). The 
lattcr values were obtained by interpolation of cel1ular fluorescence values compared to a 
standard curve prepared using microspheres of known fluorescence intensity (Flow 
Cytometry Standards, Research Triangle Park, NC). 
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Table 1 Monoclonal antibodies against markers of mouse macrophage development 
Antibody Antigen 
blllllaltire macrophage markers 
ER-MPI2 
ER-MP58 
ER-MP54 
ER-MP20 .) Ly-6C 
Mallire macrophage markers 
F4/80 a) 
BM8 
l\I1no .) 
M3/38 .) 
ER-DMDMI') 
Mac-la, 
CDllb, 
Ly-40 
Mac-2, 
CBP35 
COI3? 
Macrophage subsel markers 
ER-HR3 
ER-MP23 
ER-TR9 
M1I22.25 .) 
MOMA-l 
MOMA-2 
Monts-4 
SER-4 
Forssman Ag 
SER; sialo-
adhesin 
Macrophage aclimlioll nwrkers 
MS/l14 a) H-21a 
H35.89 .) LFA-la, 
CDlIa 
YNIIL7 .) ICAM-I, 
MALA-2, 
C054 
MA158.2 158.2 
MIV 38') MDR-2 
TM-2 
Tl\f-4 
TM-5 
Mol.mass (Wa) 
140 
90, 80-85, 
70-75 
14 
160 
125 
170 
32-35 
160 
76,67 
(non-red.) 
69,55 
(red.) 
38 
80-100 
170-185 
25-34 
180 
95 
45 
Antigen 
single -chain (glyco)protein 
glycoprotein, usually PI-linked 
single-chain glycoprotein 
CR3a, fibrinogen Rb), clotting factor X R, 
adhesion molecule 
galactose-specific lectin; IgE- and laminin-
binding protein 
aminopeptidase N 
two distinct single chain (glyco)proteins; 
high M, form secreted 
single chain (glyco-)protein 
involved in M9 neutral polysaccharide 
uptake 
glycosphingolipid hapten 
(glyco- )protein 
sialylaled glycoconjugate R 
homodimer; Ag-peptide binding for 
presentation 
C054 and lCAM-2 ligand 
COlI/COI8 ligand 
Reference 
9 
9 
9 
9 
75 
" 23 
34 
38 
39,40 
42 
44 
76 
50 
53 
54 
55 
77 
78 
79 
69 
71 
74 
D.I\I. Paulnock, 
personal comm. 
D.I\I. Paulnock, 
personal comm. 
a) Also other monoclonal antibodies with the same or similar reactivities have been reported; b) R ::: receptor. 
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Results and Discussion 
Table 1 shows a selection of monoclonal antibodies directed against markers of different 
mouse macrophage developmental stages, i.e. universal immature and mature macrophage 
markers, subset markers, and macrophage activation markers. As outlined above, the 
distinction between the different marker categories is not always absolute. In particular. 
the discrimination between universal mature macrophage markers and subset markers is 
more or less arbitrary, since no markers exist, to our knowledge, that are expressed by all 
macrophages, and arc relatively specific for these cells. In other words, all mature 
macrophage markers arc in fact subset markers. Yet, a distinction between the two 
categories is made on the basis of the widespread expression of universal mature markers 
by macrophages ill vitro as wen as ill vivo, and the more restricted occurrence of subset 
markers, 
Immature macrophage markers 
The panel of immature macrophage markers, ER-MPI2, -20, -54, and -58, has been 
generated against macrophage precursor hybrid cell lines and selected for recognition of 
markers expressed preferentially by immature stages of maturation using the ill vitro 
models9 , The decreasing expression of these markers upon maturation of macrophages is 
clearly illustrated by the decreasing percent of cells positive for these markers during M-
CSF- stimulated bone marrow culture (Fig. 2). Additional studies by ourselves and others 
have confirmed and extended the initial characterization of these markers 1o- 12, 
Using these markers for identification of macrophage precursor cells, it should be 
realized that, in the macrophage lineage, ER-MPI2, -20, -54 and -58 antigens are restricted 
to precursor stages, but these markers are also expressed by other cell types, In recent 
experiments, about 40% of freshly isolated bone marrow cells was repeatedly found 
positive for ER-MPI2, in contrast with 6-9% assessed earlier using less advanced 
technology (cf. ref. 13 and 9). This significant percent of bone marrow cells found positive 
for ER-MPI2 already indicates that other hematopoietic cells are recognized as well. ER-
MP 12 also detects pluri- and multipotent stem cells and prothymocytes in bone marrow 
as well as particular lymphoid cells in bone marrow and peripheral lymphoid organs l2- 15, 
Although the identity of the ER-MPI2 antigen has not yet been established, it bears 
similarity to CD34 with regard to high level expression by early hematopoietic cells. 
The antigen recognized by ER-MP20 has been identified definitively as Ly-6C 11 and 
is expressed by monocytes and granulocytes, as well as by a subpopulation of CD8+ T 
cells. Quantitative analysis of ER-MP20 antigen expression permits the identification of 
monocytes in bone marrow as these cells show the highest antigen levels12, Bone marrow 
macrophage colony-fonning cells (M-CFC) are either ER-MP20 negative or show an 
intermediate level. The fonner are the most immature: they produce the largest colonies 
and pass through an ER-MP20 positive stage upon maturation ill \litrol2 , Mature 
macrophages, however, are ER-MP20 negative. Therefore, ER-MP20 is a typical marker 
of intermediate stages of bone marrow-derived macrophage maturation, Surprisingly, in 
spleen all M-CFC are found in the ER-MP20h; fraction, whereas no M-CFC are present 
in the corresponding fraction in bone marrow 11 , Although the origin of this distinction is 
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Figure 2. Expression of immature macrophage markers in M·CSF-stimulatcd bone marrow culture. Cells were 
harvested al different time points from liquid bone marrow cultures and analyzed phenotypically using flow 
cytometry. The number of morphologically identifiable mononuclear phagocytes (Le. monoblasts, (pro)monocyles 
and macrophages) in these cultures increases from less than 10% at day 0 to 60-70% at day 4 and >98% at day 
7. Data represent the mean net percenl of marker-positive cells, compared to negative control values, as 
determined in at least two experiments; the standard deviations were less than 10%. 
not known, it is possible that environmental differences determine expression of the ER-
MP20 antigen by macrophage progenitors: the antigen is significantly induced or up-
regulatcd after interferon-y or interfcron-()'}~ stimulation (unpublished data and ref. 16). 
The inducibility of ER-MP20 antigen expression is strikingly maturation-stage-dependent, 
as it can be induced in immature cel1s, but not in mature macrophages. 
The ER-MP54 antigen was selected as a surface marker of macrophage precursor cel1 
lines, but appeared to be absent from the cell surface of normal bone marrow cells9. 
Instead, bone marrow cells express this marker only cytoplasmically. Specific experimental 
conditions, such as corticosteroid treatment ill vitro, may induce ER-MP54 surface 
expression on some non-transformed cells (unpublished). Immunohistological examination 
shows an ER-MP54 antigen distribution that is restricted to presumable myeloid cells: the 
majority of bone marrow cells and some clusters in the splenic red pulp (unpublished). 
ER-MP58 demonstrates a similar, relatively specific, staining of myeloid cells in 
sections of bone marrow and spleen (unpublished), Yet, this marker is present on the cell 
surface of the majority of normal bone marrow cells, including virtually all M-CSF-
responsive macrophage precursors9, Expression of ER-MP58 decreases significantly upon 
maturation of macrophages, However, reduced levels can still be demonstrated on bone 
marrow-derived macrophages ill vitro (Fig. 2) as we1l as on some macrophage cell lines 
with mature features. Thus, high level ER-MP58 expression is characteristic of precursor 
cells, although the marker may be retained by some macrophages in more mature stages. 
Taken together, the markers detected by ER-MPI2, -20, -54, and -58 are expressed 
selectively by immature cells of the macrophage lineage. However, other cell types may 
be positive for these markers as well, implicating that expression of one or more of these 
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antigens does not necessarily identify the cells under study as macrophage precursors. If, 
on the other hand, the macrophage identity of such cells has been established, then 
expression of ER-MPI2, -20, -54 andlor -58 antigens is highly suggestive of their im-
mature nature. 
Mature macrophage markers 
The panel of universal mature macrophage markers that we regularly use to demonstrate 
macrophage maturity includes F4/S0, BMS, Mac-I, Mac-2 and ER-BMDMI. Fig. 3 shows 
the expression of these markers during M-CSF-stimulated bone marrow culture. Despite 
the differences found in the percent of positive cells in freshly isolated bone marrow, all 
of these markers are expressed unifonnly by the mature macrophages obtained from day 
7 and beyond (Fig. 3a). Not only does the percentage of positive cells increase in these 
cultures as macrophages mature, the level of antibody binding per cell increases even more 
dramatically, indicating enhanced antigen expression by more mature cells (Fig. 3b). The 
differential staining of fresh bone marrow for the different markers clearly reflects the 
presence (e.g. Mac-I) or absence (e.g. ER-BMDMI) of these markers on other hemato-
poietic cell types, especially myeloid cells. 
The F4/80 antigen is perhaps the most universal and widely used macrophage marker 
with relative specificity for this cell type, Expression of this marker commences early 
during macrophage development, but after the M-CFC stage17. 11/ vitro, most if not all 
mature macrophages express the F4/80 antigen, but il1 vivo some macrophage populations 
do not show detectable F4/S0 antigen levels, especially those in lymphoid micro-
cnvironmcnts l8 . This lack of significant antigen exprcssion may be due to high local 
concentrations of lymphocyte-derived cytokincs, some of which have been shown to down-
regulate F4/80 antigen expression l9, F4/80 is a selective, but not an exclusive marker for 
macrophages, since freshly isolated eosinophils as well as endothelial-like cells in bone 
marrow stromal cultures bind the F4/S0 antibody2o,21. 
BMS is a macrophage marker that bears significant similarity to F4/S0". Although the 
apparent molecular masses of these antigens are different, 125 kDa for BMS vs. 160 kDa 
for F4/S0, the staining patterns obtained show a high degree of overlap. The original 
description of BMS showed expression of the antigen only by cells beyond the monocytic 
stage. In our hands, however, monocytes and myeloid precursors also specifica11y bind 
small, but detectable amounts of the BMS antibody as demonstrated by sensitive flow 
cytometry. 
The Mac-I (CDllb/CDIS) antigen was one of the first macrophage markers defined 
by monoclonal antibody23. Expression of Mac-I is detected on cells beyond the M-CFC 
stage in bone marrow and spleen ll ,24 and increases significantly with maturation of 
macrophages ill vitro5. Yet, Mac-l is undetectable on many "tissue-fixed" macrophages, 
but it is expressed at different levels by virtually all "free" macrophage populations25•26. 
In addition, granulocytes and NK cells express Mac-l as well as activated and memory 
CDS+ cytotoxic T cells and some unusual B-1 lymphoeytes23.27-29. Using blocking studies, 
it was found that anti-Mac-I monoclonal antibody recognized the a-chain of type 3 
complement receptor, a member of the integrin family30. This receptor is involved in 
adhesive processes with different ligands. First of all, CR3 mediates uptake of opsonized 
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Figure 3. Expression of universal mature macrophage markers in M-CSP-stimulated bone marrow culture. (a) 
Mean net percent of marker-positive cells at different time points during ill vitro macrophage development (cf. 
Icgcnds Fig. 2); (b) quantitative analysis of monoclonal antibody binding to developing macrophagcs. Data 
represent the mean net antibody binding to the marker-positive cells depicted in (a). 
microorganisms and particles by binding of iC3b and C3d (reviewed in 31), In addition, 
it was shown for macrophage - Listeria interactions, that CR3 not only functions as a 
receptor for internalization but also seems to trigger processes essential for killing of the 
bacterium32, Second, CR3 binds other molecules, such as fibrinogen and clotting factor X, 
mostly through an Arg-Gly-Asp containing sequence in the ligand3', Third, CR3 is 
critically involved in the recruitment of myelomonocytic cel1s in response to various 
inflammatory stimuli, probably by binding to ICAM-l (CD54) molecules on the inflamed 
endothelium (reviewed in 33), 
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Mac-2 was originally presented as a macrophage subpopulation-specific marker34. 
However, expression of this antigen closely cOITelates with macrophage maturation in all 
ill vitro models (Fig. 3; ref. 3, 5, 6). It is induced in precursor cells at a relatively late 
stage, just preceding the ability of cells to become adherent. Cloning and sequencing of 
the Mac-2 gene showed that it does not contain a classic signal peptide Of transmembrane 
domain, indicating that it is mainly an intracellular protcin35 . This is confirmed by the 
finding that the percent of Mac-2 positive spleen cells increases from about 20% to more 
than 70% upon permeabilization of the cell membrane]6. The latter finding also implies 
that many cell types other than macrophages also express the Mac-2 antigen. Mac-2 has 
been identified as a galactose-specific lectin. Cell surface expression may thus be explained 
by binding of secreted molecules to surface-bound glycan moieties, since binding is 
abolished by incubation of ceUs in the presence of competing suga~7. 
The ER-BMDM 1 antigen is, from the universal mature markers described here, induced 
last on developing macrophages (Fig. 3). Bone marrow cells as well as blood monocytes 
are essentially ER-BMDMI negative, and expression is observed uniformly on all mature 
cells in the various models38 . III vivo, however, only specific macrophage subpopulations 
are detected by this antibody, including about one third of the resident peritoneal and 
alveolar macrophages. Certain inflammatory macrophages, such as thioglycollate-elicited 
cells, express high levels of this marker. Furthermore, populations belonging to the 
dendritic leukocyte lineage are mostly ER-BMDMI positive. The biochemical characteris-
tics of the antigen - a molecular mass of 160 kDa and demonstrated aminopeptidase N 
activity - suggest that this marker is the mouse homologue of human CDl3 38. 
Macrophage subset markers 
As outlined before, the distinction between universal mature macrophage markers and 
subset markers is more or less arbitrary. Our criterion for classification is that subset 
markers are not universally expressed by all mature macrophages in the ill vitro maturation 
models, in contrast to the universal mature markers. Also, subset markers show a restricted 
distribution ill vivo (see below). The subset markers that we use (ER-HR3, ER-MP23, ER-
TR9, Forssman antigen, MOMA-I, MOMA-2, Monts-4, and SER-4) are typical of different 
macrophage subsets in tissue sections of various organs, and all, except Forssman antigen, 
show a high degree of specificity for mononuclear phagocytes. 
The macrophage subset marker ER-HR3 is expressed by a specific subpopulation of 
mouse macrophages, located especially in hematopoietic organs: bone marrow and splenic 
red pUlp39,4o. The number of ER-HR3 positive macrophages in the red pulp constitutes only 
a subset of all (F4/80 positive) red pulp macrophages, yet includes the so-called central 
macrophages of the erythropoietic islands. Induction of extramedullary hematopoiesis in 
the liver by phenylhydrazine treatment of mice is accompanied by the appearance of ER-
HR3 positive central macrophages. This observation supports the notion that the ER-HR3 
positive macrophage subset is functionally involved with erythropoietic activity40. Yet, 
other subsets which are not apparently involved with hematopoietic activity, such as those 
located in the lymph node paracortex and the ileal lamina propria, also express the ER-
HR3 antigen41 . 
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ER-MP23 is a marker particularly expressed by connective tissue macrophages, or 
histiocytes42 . Interestingly, macrophages in many, but not all, connective tissues located 
ncar epithelia express high levels of this antigen: e.g. dermal macrophages and macro-
phages in the reticular connective tissue of the submandibular gland are strongly ER-MP23 
positive, but those in the intestinal lamina propria are generally ER-MP23 negative. In 
addition to a location in connective tissue, ER-MP23 positive cells may also occur sparsely 
in lymphoid tissues. Furthermore, ER-MP23 positive non-lymphoid cells, being either 
macrophages or dendritic leukocytes, are among the first cells to infiltrate the pancreatic 
islets of the pre-diabetic NOD mouse43 . III vitro studies of ER-MP23 expression among 
different macrophages populations and derived cell1ines have indicated that macrophages 
are either strongly positive for this marker, or negative/dull. This ER-MP23 phenotype of 
ill vitro maintained cells is surprisingly stable~ in our hands, an ER_MP23-/dull cell ]ine 
could not be converted by a variety of stimulants into an ER-MP23hi cell line and vice 
versa42. This led us to conclude that ER-MP23 might be a subset marker characteristic of 
a distinct lineage of macrophage development. 
ER-TR9 antigen expression is characteristic of splenic marginal zone macrophages and 
macrophages located in the medullary and trabecular sinuses of lymph nodes",45. These 
highly phagocytic populations are unique in their ability to retain and ingest neutral 
polysaccharides, such as Fico]] and dextran. Interestingly, ill vivo administration of the ER-
TR9 antibody abolished endocytosis of these polysaccharides, but did not influence the 
ability to ingest latex or carbon particles46. The ER-TR9 monoclonal antibody probably 
does not recognize the binding site of the neutral polysaccharide receptor, since injection 
of polysaccharides prior to administration of the antibody did not diminish binding of the 
latter. 
The Forssman glycolipid antigen (Fo) is expressed by a subset of stromal macrophages 
mainly associated with early hemo-lymphopoietic development: macrophages in bone 
marrow stroma, splenic red pulp, and thymic cortex47,4S. Furthermore, medullary macro-
phages in inguinal and axial lymph nodes, but not in mesenteric lymph nodes, express Fo. 
This marker is less specific for mononuclear phagocytes than the other subset markers 
from the present selection; in adult tissues also reticular cells in various organs and thymic 
epithelial cells are Fo+, whereas developing mesenchymal cells express Fo transiently. Fo 
expression is inducible by IL-4 or IL-6 in a small percent of macrophages in a specific 
stage of development49. 
The antigen recognized by MOMA-J is expressed by a macrophage subset typified by 
the metallophilic macrophages at the white pulp side of the marginal sinus in the spleen, 
and capsular and medullary sinus macrophages in peripheral lymph nodes50. 111ese 
populations are characterized by a high level of nonspecific esterase activity, which, linked 
to their strategic location, is suggestive of a degrading and detoxifying functionSI . Injection 
of the MOMA-I monoclonal antibody into neonatal mice led to a significant reduction of 
the presence of MOMA-I positive cells, and concomitantly, to impaired humoral immune 
responses against thymus-dependent (TD) and thymus-independent type 2 (TI-2) antigens52. 
This suggests a role for the marginal mctallophilic macrophages in the presentation of 
these antigens, although in the neonate a subpopulation of cells located in the red pulp also 
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shows MOMA-l expression and may thus be involved in the immune responses against 
TD and TI-2 antigens. 
The MOMA-2 monoclonal antibody is especially useful for the identification of 
macrophages in lymphoid tissues53 . Most, if not all, macrophages in lymphoid micro-
environments show high level expression of this marker. The antigen is located primarily 
in the cytoplasm, but it can also be demonstrated on the cell surface. The expression of 
the MOMA-2 antigen shows a high degree of similarity with the expression of acid 
phosphatase. including the localization of both markers to a cytoplasmic region of dendritic 
leukocytes. MOMA-2 is expressed early during the development of mononuclear 
phagocytes, since a significant fraction of bone marrow cens as well as all blood mono-
cytes are positive. 
Immunohistological examination of the expression of the Monts-4 antigen suggests that 
this marker is expressed by both MOMA-l and MOMA-2 positive subsets". Yet, many 
macrophage populations do not express Monts-4, including most splenic red pulp macro-
phages. Expression of the antigen decreases quickly upon culture of isolated Monts-4+ 
macrophages, suggesting the necessity of continuous stimulation for Monts-4 expression. 
In agreement with this, we have never observed significant Monts-4 antigen expression by 
ill vitro maintained macrophages, including transformed as well as growth factor-dependent 
cen lines and bone marrow-derived macrophagcs. 
The macrophage subset marker SER, identified by monoclonal antibody SER-4, has 
been characterized most extensively in relation to the function of the antigen and the 
antigen-expressing macrophages in hematopoiesis55. Initially identified as a receptor for 
sheep erythrocytes, SER is now also known as sialoadhesin. a receptor for sialylated 
glycoconjugates Deeuring on developing hematopoietic cells. Antibodies against SER arc 
able to block interaction between sialylated compounds and SER. Interestingly, ligand 
binding to SER does not induce phagocytosis, suggesting that SER's primary function is 
to maintain physical contact between cells and/or mediate signal transduction. The receptor 
is expressed by stromal macrophages at hematopoietic sites. such as resident bone marrow 
macrophages and a subset of splenic red pulp macrophages. but also by macrophagcs in 
lymphoid microenvironments, such as splenic marginal metal10phils and lymph node 
subcapsular and medullary maerophages. Here, SER is thought to be involved in the 
intcraction between stromal macrophages and activated T cells and plasmablasts56. 
Macrophage activation markers 
A fourth catcgory of macrophage markers comprises antigens induced by activating agents. 
Induced expression of such activation markers is accompanied by. and in the ideal situation 
indicative of, specific functional acquisitions. Generic activation markers, however, do not 
exist, as the phenotypic and functional response of a macrophage depends greatly on the 
nature of both the stimulus and the responding cell. Yet, IFN-y is a major stimulator of 
multiple macrophage functions, and was therefore chosen as a "model activating agent" to 
identify macrophage activation markers. As the following discussion will show, many of 
the present activation markers are also induced by other agents. 
Expression of MHC class II antigens, in the mouse H-2Ia, is induced in most 
maerophages by IFN-y, as well as by a number of other stimuli including IL-4, GM-CSF 
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and IL-3 57-60. On the other hand, IFN-alp and M-CSF have been shown to counteract the 
IFN-y- or OM-CSF-mediated induction of la expressions9•6J • Colony-forming macrophage 
precursors do not express Ia antigens24, but expression is induced during ill vitro 
development in about 15-30% of the cells (unpublished observation; ref. 62). This apparent 
heterogeneity is not c1onal1y detennined, however63. Expression of Ia molecules is a 
prerequisite for macrophages to present antigen to CD4+ T helper cells, but not a "prooft 
of their ability to do so; productive stimulation of Th cells requires appropriate co-
stimulatory signals in addition to la-bound antigenic peptides". 
LFA-I (CD II a/COIS) belongs to the integrin family and shares its p-chain type with 
Mac-I and p150/95 (COllb and COlic, rcsp.). Expression of LFA-I is already found on 
immature cells, as part of bone marrow M-CFC is LFA-l+ 24, Yet, among more mature 
cells, LFA-l can be considered a marker of primed and activated stages and its expression 
can be induced by several stimulants including IFN-y, LPS, JL-4 and IL_3 60•6S • Various 
macrophage populations, however, are refractory with respect to induction of LFA-I 65. As 
an integrin, LFA-l is critical1y involved in many cel1ular interactions and is a ligand for 
ICAM-I, ICAM-2 and possibly others. Howcver, to be functional, the LFA-I molecule 
needs to be activated to reach a high-affinity state66. Therefore, expression of LFA-l is a 
sign of potential, but not necessarily actual, involvement in LFA-I - ICAM-interactions. 
The major ligand of LFA-I, ICAM-I (C054), may also be considered a macrophage 
activation marker. Expression of this member of the immunoglobulin superfamily is 
induced by a variety of inflammatory cytokines, including IFN-y, IL-I and TNF_a67 
ICAM-l shows a widespread cellular and tissue distribution, including vascular endo-
thelium, lymphocytes, monocytes, macrophages and dendritic leukocytes68• This suggests 
that the ICAM-I - LFA-I interaction is probably regulated at the level of activation of the 
LFA-I molecule. 
The antigen 15S.2 is another IFN-y-inducible marker for macrophages in both mature 
and immature stages of development69.7o. In addition, expression of 158.2 can be induced 
by LPS, but not by IFN-alP, muramyl dipeptide or bestatin. The initial characterization 
of this marker suggested a link between enhanced 158.2 expression and tU1110ricidai and/or 
bactericidal activity of macrophages. In our hands, however, IFN-yalso induces high level 
expression of this marker in macrophage precursor cel1s without inducing concomitant 
cytotoxic activities (unpublished results). 15S.2 is weakly expressed by resident macro-
phages, but can be demonstrated at significant levels on exudate macrophages as well as 
exudate granulocytes. 
MBR-2 is one of a cluster of antigenic detenninants on the same or closely associated 
molecules7i . Initially, this marker was defined on a sUbpopulation of B cells, but its 
presence on macrophages and erythrocytes was also recognized72. In contrast to the 
activation markers described above, MBR-2 is induced by IFN-y only on macrophages in 
more mature stages of development (unpublished). Expression of MBR-2 is not fully 
dependent on induction by IPN-y, however, since macrophages maturing ill vitro show 
increasing expression of MBR-2 in the absence ofIFN-y stimulation73. Resident peritoneal 
macrophages also express significant levels of MBR-2. The immunohistochemical profile 
of anti-MBR monoclonal antibodies is characterized particularly by reactivity with capillary 
endothelia. 
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The TM-2, TM-4, and TM-5 antibodies were raised against IFN-y-stimulated RAW264 
macrophage tumor cells in order to obtain markers for intermediate stages in the 
tumoricidal activation pathway (ref. 74; D.M. Paulnock, personal communication). As such, 
these antigens are expressed by stimulated RAW264 cells, but not by IFN-y-stimulated 
WEHI-3 cel1s that cannot be induced to express tumoricidal activity. Likewise, resident 
peritoneal macrophages, which cannot be induced to kill tumor cells, fail to express these 
antigens after stimulation. Induction of TM-2, -4 and -5 expression by responsive ceHs is 
relatively specific for IFN-yexposure, since IFN-(JJ~, TNF-a, LPS, IL-4 and GM-CSF are 
ineffective in this respect. Analysis ofTM-antigen profiles of different exudate macrophage 
populations revealed a more complex pattern, suggesting that TM-4 and -5 antigens are 
associated with an inflammatory phenotype, willIe induction of TM-2 occurs during the 
later stages of activation to tumoricidal activity. 
Concluding remarks 
The available monoclonal antibodies against mouse mononuclear phagocyte markers, of 
which the current panel is only a selection, pennit us to identify different stages in the 
development of these cells. Using multiple markers from each category, we feel confident 
in determining from the cellular phenotype whether macrophages are immature, mature, 
belong to a specific subset, or arc more or less stimulated. This classification is still rather 
crude, and definitely needs further refinement. This, however, can only be achieved when 
more insight is obtained into the developmental relationships between the various members 
of the mononuclear phagocyte system and the phenotypic hallmarks that identify the 
different stages. Considering the "rudimentary" classification, caution should be exercised 
in drawing conclusions from results obtained with single markers, since many experimental 
conditions unexpectedly induce or suppress the expression of particular antigens. Such an 
"aberrant" phenotype is likely to have functional significance. This, however, remains 
elusive until the function of the irregularly up- or down-modulated antigen has been 
clarified. Unfortunately, many markers described in this overview still lack a functional 
designation, thus leaving us with "good guesses" in relating the cellular phenotype to a 
specific cellular function. A major effort of the forthcoming years, therefore, will be to 
transform these "good guesses" into "solid evidence" by elucidating the functions of the 
various macrophage markers and translating these in terms of cellular capabilities. 
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Abstract 
The characterization of early branch points in the differentiation of leukocytes requires 
identification of precursor cells in the bone marrow. Recently, we produced two mono-
clonal antibodies, ER-MPI2 and ER-MP20, which in two-color flow cytometric analysis 
divide the murine bone marrow into six defined subsets. Here we show, using fluores-
cence-activated cell sorting followed by macrophage colony-stimulating factor-stimulated 
culture in soft agar, that precursors of the mononuclear phagocyte system reside only 
within the ER-MPI2hi20-, ER-MPI2+20+, and ER-MP12-20hi bone marrow subsets. 
Together these subsets comprise 15% of nucleated bone marrow cells. Furthermore, we 
provide evidence that the macrophage precursors present in these subsets represent 
successive stages in a maturation sequence where the most immature ER-MP12hi20- cells 
develop via the ER-MPI2+20+ stage into ER:-MPI2-20hi monocytes. 
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Introduction 
Macrophages form a heterogeneous population of cells which play essential roles in a wide 
variety of biological processes (for reviews see I and 2). As yet, it is not clear whether 
their extensive diversity is generated solely at the level of the monocytes entering the 
tissue microenvironments, or also at the level of the macrophage precursors in the bone 
marrow. Studies on the early stages of macrophage development have been seriollsly 
hampered by the limited characterization and low frequency of macrophage precursors in 
the bone marrow. To approach this problem, we previously produced a panel of mono-
clonal antibodies using immortalized macrophage precursors as immunogcns3. Two of 
these monoclonal antibodies, ER-MPI2 and ER-MP20, were shown to detect phenotypic 
heterogeneity among bone manow macrophage precursors3, In the present study we aimed 
at identifying distinct macrophage precursor subsets in mouse bone marrow using ER-
MPI2 and ER-MP20 monoclonal antibodies in two-color flowcytometric analysis and cell 
sorting. Bone marrow subsets sorted on the basis of their differential expression of ER-
MP12 and ER-MP20 antigens were examined on cellular composition. macrophage 
colony/cluster forming capacity, cell surface expression of the macrophage maturation-
related marker Mac-I, and expression ofER-MPI2 and ER-MP20 antigens during macro-
phage maturation ill vitro. In this report we show that three phenotypically distinct subsets 
of M-CSF-responsive bone marrow macrophage precursors can be identified. Moreover, 
our data indicate that these three macrophage precursor subsets reflect successive, 
phenotypically defined, stages of ill vivo macrophage development. 
Materials and Methods 
Mice 
Female C57BLl6-Ly-5.I-Pep3b mice (breeding pairs kindly provided by Dr. I.L. Weissman, 
Stanford University, Stanford, CAl between 6 and 20 weeks old were used in all 
experiments. Animals were kept under clean routine laboratory conditions with free access 
to food and water. 
Antibodies and conjugates 
The monoclonal antibodies used in this study were MI170 (anti-Mae-I)4, ER-BMDMI 
(anti-aminopeptidase N)5, ER-MPI2 3, and ER-MP20 (anti-Ly-6C)3.14. Antibodies were 
applied as hybridoma culture supernatants or as purified monoclonal antibodies conjugated 
to FITC (fluorescein isothiocyanate, isomer I, Sigma Chemical Co., St. Louis, MO) or 
biotin (N-hydroxysuecinimidobiotin, Boehringer Mannheim GMBH, FRG) by standard 
procedures. 
R-Phycoerythrin-eonjugated streptavidin (SAV-PE; Caltag Laboratories, San Francisco, 
CAl, Tri-Color-conjugated streptavidin (SAV-TC; Caltag Laboratories), FITC-conjugated 
rabbit-anti-rat IgG F(ab)', fragments (RaRa-FITC; Cappel, Organon Teknika, Tumhout, 
Belgium), and R-phycoerythrin-eonjugated goat-ant i-rat IgG (mouse adsorbed; GaRa-PE; 
Caltag Laboratories), were used as second stage fluorescent reagents. 
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Preparation of cell sllspensions 
Bone marrow cel1 suspensions were prepared as described previously6. Briefly, femora and 
tibiae were ground, using a mortar, in Dutton's Balanced Salt Solution (Gibco, Breda, The 
Netherlands) supplemented with 5% fetal calf serum, 60 ~g1ml penicillin and 100 ~g/ml 
streptomycin (DBBS-FCS-PS). 111e cell suspension was aspirated through a 22-gauge 
needle and filtered over a nylon sieve (mesh size 100 ~m; Polymon PES, Kabel, 
Amsterdam, The Netherlands) to remove connective tissue, bone fragments, and clumps 
of cells. 
Cultured bone malTOW cells were isolated from Teflon bags (sec below) and washed 
with DBBS-FCS-PS prior to immunofluorescence labeling. 
Immullofluorescence labeling, flow cytometric analysis and cell sorting 
For phenotypic analyses, I x 106 - 5 x 106 freshly isolated bone malTOW cells/well or 
5xlO4 cultured cells/well were aliquotted into 96-microwell plates (round-bottom, Nunc, 
Denmark) and labeled with the appropriate antibodies in phosphate-buffered saline 
supplemented with 0.5% bovine serum albumin and 20mM NaN3 (PBS-BSA-NaN3). All 
incubations were perfOJmed on ice for 30 min and were followed by three washes with 
PBS-BSA-NaN3. For single-color analysis, cells were incubated first with hybridoma 
supernatant, washed and then incubated with RaRa-FITC, supplemented with 2% normal 
mouse serum (NMS) to avoid nonspecific binding. For two-color analysis, cel1s were 
incubated first with biotinylated monoclonal antibody, followed by FLTC-Iabeled 
monoclonal antibody and SAV-PE simultaneously. For tbree-color analysis, cells were 
incubated first with hybridoma supernatant followed by GaRa-PE. After two washes, cells 
were washed in the presence of 3% normal rat serum to block free binding sites on GaRa-
PE. Subsequently, cells were incubated with biotinylated monoclonal antibody followed 
by FITC-labeled monoclonal antibody and SAV-TC simultaneously. Percentages of 
positive cells obtained from three-color analysis were compared with those obtained from 
single stainings and were found to be identical (data not shown). Culture supernatant of 
the non-producing Y3 myeloma followed by RaRa-FITC (one-color analysis) or GaRa-PE 
(three-color analysis) was used as negative control, since, in our hands, control values 
obtained with Y3 supernatant are identical to those obtained with rat isotype control 
monoclonal antibodies (unpublished data). Phenotypic analyses were performed with a 
FACScan cytofluorimeter (Becton Dickinson, Snnnyvale, CAl. 
For cell sorting experiments, 2xl08 bone marrow cells were incubated for 30 min with 
2 ml DBSS-FCS-PS containing biotinylated ER-MPI2, washed with a large volume of 
DBSS-FCS-PS and subsequently incubated (30 min) with 2 ml optimally diluted ER-
MP20-FITC and SAV-PE simultaneously. After two washes, the cells were resuspended 
in PBS supplemented with BSA (0.5% w/v), D-glucose (0.45% w/v; Merck, Amsterdam, 
The Netherlands), penicillin (60 ~g/ml) and streptomycin (100 ~g1ml) to a final 
concentration of 3xl06 cells/ml. Before sorting, the cell suspension was filtered over a 30 
~m sieve (Polymon PES) to avoid clogging of the nozzle. All sorts were perfolTlled using 
a FACS Vantage cell sorter (Becton Dickinson). After sorting, viable cells were counted 
using a Btirker hemocytometer. The purity of the sorted cell populations was detennined 
by FACScan analysis and nornlally exceeded 95%, unless stated otherwise. 
58 Chapter 3 
M-CSF-stimulated bOlZe lJIanvw culture 
The medium used for M-CSF-stimulated bone marrow culture (either in soft agar or in 
Teflon culture bags, see below) was a-modified DMEM (Gibco) supplemented with 20% 
L-cell conditioned medium (LCM) as a source of M-CSF, 20% FCS (heat inactivated; 
Hyclone Laboratories, UT), glutamine (2mM), penicillin (60 ~g/ml), streptomycin (100 
~g/ml), p-mercaptoethanol (10-4 M) and sodiumselenite (10-7 M). LCM was prepared as 
previously described7. The same LCM and FCS batches were used throughout the study. 
To assess the frequency of macrophage precursors within the sorted subsets the 
macrophage coiolly'- and cluster-fonning capacity of the sorted cells was determined in M-
CSF-stimulated culture in soft agar. Cloning was performed as described by Wijffels et al.8 
with minor modifications. Briefly, a 6% agar stock (Bacto-Agar, Difeo Laboratories, 
Detroit, MI) was diluted with warm (42°C) culture medium. Cells were plated in 0.5 ml 
0.3% agar-medium on top of a layer of 0.3 ml 0.5% agar-medium in 24 well plates 
(Costar, Cambridge, MA, USA). Per sorted bone marrow subset two different cell 
concentrations were plated in six wells/concentration: 1000 and 250 cells/well for the ER-
MPI2""d20-, ER-MPI2-2o-, ER-MPI2-20m«' subsets and unlabeled, unseparated bone 
marrow, and 250 and 100 cells/well for the ER-MPI2hi20-, ER-MPI2+20+, and ER-
MPI2-2ifi subsets. After 12 to 14 days of culture (37°C, 7% CO,), the number of macro-
phage colonies (<: 50 cells) and clusters « 50 cells) generated from each subset was 
assessed by examining the plates using an inverted Jight microscope at low magnification. 
LCM as a source of M-CSF specifically stimulates macrophage development, as only 
macrophage progeny could be detected using morphological and immunohistological 
analysis (data not shown). 
For phenotypic analysis of ill vitro matured mononuclear phagocytes. sorted ceHs were 
cultured in Teflon culture bags in M-CSF-containing medium9. Depending on the duration 
of culture. the initial cell number was adjusted to ensure optimal growth and viability. 
Thus, 2x 10' cells were seeded in a volume of 2 ml medium for phenotypic analysis at day 
2 of culture, and 10' cells, also in a volume of 2 ml, for analysis after 5 and 7 days of 
culture. 
Morphological analysis 
Differential morphological analysis of sortcd bone marrow subsets was performcd on May-
Grtinwald-Giemsa stained cytospin preparations. Per subset five hundred cells were ana-
lyzed. 
Results 
ER-MP 12 alld ER-MP20 /IIolloc/ollal alltibodies recogllize /llOIphologically distillct bOlle 
marrow subsets 
Using the anti-macrophage precursor monoclonal antibodies ER-MPI2 and ER-MP20, six 
phenotypically distinct subsets can be detected in the bone marrolV of the mouse6. 1\vo 
subsets express the ER-MPI2 antigen but not the ER-MP20 antigen: an ER-MPI2""d20-
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% of cells in window: 
1. 1.7 4. 32.5 
2. 21.9 5. 31.0 
3. 8.4 6. 4.6 
ER-MP20 
Figllre 1. T\'.:o-color FACScan analysis of nucleated bone marrow cells labeled with ER-MPI2 and ER-MP20 
monoclonal antibodies. Percentages are the mean of eight experiments. 
and an ER-MP12h;20- subset (Fig. I). Similarly, two subsets exclusively express the ER-
MP20 antigen: an ER_MP12-20m,d and an ER-MPI2-20h; subset. Of the remaining two 
subsets, one expresses both ER-MP12 and ER-MP20 antigens, i.e. ER-MP12+20+ (for this 
subset no distinction was made in levels of antigen expression), and one lacks both 
antigens, i.e. ER-MP12-20-. In this study we determined the cellular composition of the 
Table 1 Morphological analysis of bone marrow subsets sorted on the basis ofER-MP58 expression 
BM subset Myeloid Erythroid Lymphoid Meg. Undiff. 
blasts 
Imm. Band + Monocytes Erythro- Polychr. + 
prog. segm. blasts noml.blasts 
ER_MPI2h120- 4" 0 18 3 25 0 49 
ER_MPI2rr><J20- 0 0 0 87 10 
ER-MPI2+20+ 20 7 7 14 3 4 0 4S 
ER-MPIZ-lO- 0 0 0 15 7. 0 0 9 
ER-MPI2-2r 4 91 2 0 0 0 0 3 
ER-MPI2-2<fi 19 0 74 0 0 0 • 
The sorted bone marrow subsets were spun onto microscopic slides and stained with May-Griinwald-Giemsa. Per subset 500 
nucleated cells were examined. a) Data represent the percentage of <:ells present in the ER-MPI2I20 subsets. FACScan analysis 
of the sorted bone marrow subsets revealed that the purity of the sorted fractions varied between 87% for the ER-MPI2+10+ 
subset and >95% for the other subsets. In each subset the prevailing cell t)'pC is in bold. lnun. prog.: inunature myeloid 
progenitors; band + segm.: band form and segmented gmnulocytes; polychr. + nom}. blasts: polychromatophilic erythrobla5ts and 
nonnoblasts; meg.: megakaryocytic cells; undiff. blasts: morphologically undifferentiated blasts. 
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Figure 2. May-GriinwaldiGicmsa stained cytocentrifuge preparations of bone marrow subsets sorted on the basis 
of ER-MPI2 and ER-MP20 expression. (a) ER_MPI2hl20- bone marrow subset; (b) ER-MPI2med20- subset; (c) 
ER-MP12+20 f subset; (d) ER-MP12-20- subset; (e) ER-MPI2-2<YIk.'<f subset; <0 ER-MPI2-2ifi subset. 
Magnification x 580. 
six ER-MP12120 bone marrow subsets. Therefore each subset was sorted, stained with 
May-Grtinwald/Giemsa and differentially counted (Table I and Fig. 2). The smallest 
subset, ER-MPI2ru 2o-, consistcd predominantly of blast cells: morphologically undifferen-
tiated blasts as well as recognizable blasts of the myeloid, erythroid and lymphoid lineages. 
The ER-MPI2m,d20- subset was remarkably homogenous with predominantly mature 
lymphoid cells and a few undifferentiated blasts. 111e ER-MPI2+20+ subset contained a 
large proportion of morphologically undifferentiated blasts, together with recognizable 
prccursors of the myeloid, erythroid and lymphoid lineages. The ER-MPIT20- subset 
consistcd almost exclusively of erythroid cells, erythroblasts as well as more mature cells. 
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The ER-MPI2-20""d subset was highly enriched for granulocytes. Finally, the ER-
MP 12-20"i subset contained mainly monocytes and a few immature myeloid cells and 
undifferentiated blasts. Thus, on the basis of ER-MPI2 and ER-MP20 antigen expression, 
mouse bone marrow can be separated into six morphologically distinct subsets with a 
relatively high cell type homogeneity. 
M-CSF-respol/sive macrophage preCl/rsors have the ER-MP J21d21r. ER-MP 12+20+, or ER-
MPlr2d,i phel/of)'pe 
The morphological analysis of the sorted subsets showed that putative macrophage 
precursors, i.e. morphologically undifferentiated blasts, immature myeloid cells and 
monocytes, are mainly present in the ER_MPI2hi20-, ER_MPI2m,d20-, ER-MP I 2+20+, and 
ER-MP12~20hi subsets. To verify the presence of macrophage precursors in one or more 
of these subsets, and their absence from the other ER-MPI2120 subsets, all six bone 
marrow subsets were isolated by cell sorting and cloned in soft-agar in the presence of the 
macrophage-specific growth factor M-CSF. Only from the ER-MPI2hi20-, ER-MP I 2+20+, 
and ER-MPI T20hi subsets could macrophage colonies and clusters be grown (Table 2). 
No macrophage colonies or clusters were obtained from the other three subsets. 
In the ER-MPI2hi 20- subset one out of eight plated cells gave rise to primarily large 
macrophage colonies in response to M-CSF (Table 2), while in the ER-MPI2+20+ subset 
one out of nine plated cells gave rise to primarily clusters and small colonies. In the ER-
MP12-20hi bone marrow subset, which consists predominantly of monocytes (cf. Table I), 
an average of one out of two plated cells fonned a smal1 cluster of usually less than 5 
Table 2 Presence of M-CSF-responsive macrophage precursors in bone marrow subsets sorted on 
the basis of ER-MP12 and ER-MP20 antigen expression 
BM subset No. of colonies! No. of clusters! Mean frequency Mean no. of macro-
103 plated cellsa ) Hf plated cells of macrophage phage precursors! 
precursors within 10' NBMC \M.CFC/ 
subset M-c1ustFC)b 
ER-MP12hi20- 108 ± 9 12 ± I 1:8 20 (18/2) 
ER-MPI2+20+ 22 ± 8 94 ± 10 1:9 91 (17n4) 
ER-MPlno'" o±o 409 ± 95 1:2 188 (0/188) 
Unfractionated 4 ± I 13 ± 3 1:59 170 (36/1 34) 
BMc) 
Macrophage colonies and clusters were determined after 12-14 days of M-CSF-stimulated culture in soft-agar. 
Colonies contain ~ 50 cells; clusters < 50 cells. No macrophage colonies or clusters were obtained from ER-
MPI21Th.-d20-, ER-MP12-20-, and ER-MP12-20mcJ bone marrow subsets. a)Data are the mean ± SO of three 
experiments. For each subset, two different concentrations of sorted cells were plated. Per concentration the 
number of colonies and clusters per 103 cells was calculated. The numbers shown in the table are the means of 
those calculated numbers. The numbers were corrected for the impurity of the sorted subsets; this was possible 
since contaminating cells were only from the subsets from which no macrophage colonies or clusters could be 
obtained. The means of the relative sizes of the bone marrow subsets in these three expcrjments were used to 
calculate the absolute numbers of macrophage precursor~\, and were 1.7% for the ER-MPI2hi20- subset, 7.9% for 
the ER-MP12+20+ subset and 4.6% for the ER-MPI2£v·1 subset. b) NBMC: nucleated bone marrow cells; M-
CFC: macrophage colony-forming cell; M-clustFC: macrophage cluster-fonning cell. c) 8M: bone marrow. 
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cells, and occasionally a cluster of 15-20 cells. Taking into account the relative sizes of 
the sorted subsets in bone marrow, these data indicate that macrophage colony-fOlming 
cells reside in approximately equal numbers in both the ER-MPIZh;ZO- and ER-MPIZ+ZO+ 
subsets. Macrophage cluster-fonning cells are mainly present in the ER-MPIZ+ZO+ and ER-
MP12-Z0h; bone marrow subsets. Together, our data show that (i) M-CSF-responsive 
macrophage precursors reside in the ER-MPIZh;ZO-, ER-MPIZ+ZO+, and ER-MPIZ-Zo'; 
subsets, and (ii) the proliferative potential of the M-CSF-responsive cells, as indicated by 
the sizes of the colonies or clusters fomlcd, decreases with a concomitant increase in ER-
MPZO and decrease in ER-MPIZ antigen expression. 
The ER-MP 12"'20-, ER-MP 12+20+ alld ER-MP n-2dd bOlle malTa\\' sllbsets differellliall), 
express the Mac-J antigen 
The differences in cellular composition and proliferative potential of the ER-MPIZhiZO-, 
ER-MPI Z+ZO+, and ER-MPIZ-ZOh; bone marrow subsets suggested a difference in matura-
tion stage between the macrophage precursors present in those subsets. To investigate this, 
we examined the expression of the macrophage maturation-related marker Mac-tW,11 
within the three subsets. As shown in Fig. 3, all ER-MPIZhiZO- cells were Mac-I 
negative/dull. In contrast, 40 ± 5% (11=3) of the ER-MPIZ+ZO+ bone marrow cells clearly 
expressed the Mac-l antigen. This percentage correlates closely with the total content of 
myeloid cells in this subset as determined by the morphological analysis (Table I). Finally, 
virtually all ER-MPI2-20hi cells were Mac-I-positive. This observation was in accordance 
with the morphological data which showed that this subset almost exclusively contains 
monocytes and some immature myeloid precursors, which are all Mac-I-positivelO,J2. Thus, 
the increase in the proportion of Mac-l positive cells and level of antigen expression 
observed from the ER-MPIZh;ZO- to the ER-MPIZ-Zo"; subset supports an increase in 
maturity of the macrophage precursors present in those subsets. 
ER.MP12~i20- TBM 
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Figllre 3. Cell surface expression of Muc-I antigen by ER.MPI2hi2o-, ER·MP12+20+-, and ER-MPI2""2cfU 
nucleated bone marrow cells. Cells were triple-labeled as described in materirus and methods with MlnO (Mac-
I), ER-MP12 and ER-MP20 monoclonru antibodies. Mac-I expression within the ER-MPI2!20 subsets was 
determined by flow cytometric analysis. The staining profile of total bone marrow (TBM) is also given. The 
dotted lines represent negative control values. Results arc from one representative experiment out of three. 
Jdelltijicat;oll of macrophage precursor subsets 
B 
log ~UOfesceocaintffi:;.;tl 
EA·BMDMl 
" 
;,; 
log f,lJO<escenca if1~ef1sitJ 
EA'BMDMl 
63 
day7 
Figure 4. Phenotypic development of ER-MPI2hi20- bone marrow cells cultured in the presence of M-CSF. ER-
MP12hi20- bone marrow cells were sorted and cultured in the presence of M-CSF·containing conditioned medium. 
At day 2, 5, and 7 of culture the cells were collected and the expression of ER-MPI2 and ER-MP20 antigens 
was detemlined in two-color now cytometric analysis (A). Negative control limits arc shown in each dot plot 
(vertical and horizontal lines). In addition, the expression of the macrophage maturation marker ER-BMDM I was 
determined in one· color analysis (B). Negative controls (dotted lines) are shown in each histogram. Results arc 
from one representative experiment out of two. 
/. + ER-MP 12 "2rr lIIacrophage precursors successively express the ER-MP 12 20+ alld ER-
MP lr2d" phellotype durillg M-CSF-stilllulated lIIaturatioll ill vitro 
So far, the data obtained in this study suggest that the three macrophage precursor subsets 
represent successive stages in a linear maturation pathway, implying that the progeny of 
the putatively least mature subset, i.e. ER_MPI2hi20-, should pass through the other two 
phenotypes upon macrophage maturation. To test this hypothesis directly, we sorted ER-
MP12hi20- bone marrow cells and cultured the isolated cells in M-CSF-containing 
conditioned medium. After varying periods of culture the level ofER-MPI2 and ER-MP20 
antigen expression was determined. As a marker for mature macrophages, the expression 
of the ER-BMDMI antigen was also examined. This latter antigen is expressed at 
increasing levels upon maturation from the monocytic stage onwardss. 
At day 2 of M-CSF-stimulated culture of ER_MPI2hi20- cells, about one third of the 
developing cells expressed both the ER-MPI2 and the ER-MP20 antigens (Fig. 4A), 
suggesting that many, if not all, mononuclear phagocytes indeed pass through the ER-
MP12+20+ stage upon ill vitro maturation. The remaining ER-MPI2+20- cells probably 
represented M-CSF-unresponsive cells from other hematopoietic lineages still present at 
this time of culture. At day 5 of culture, the cells had completely lost ER-MPI2 antigen 
expression (Fig. 4A). Yet, 50-59% (1I~2) of the cells expressed the ER-MP20 antigen at 
a high level, similar to that of ER-MP12-20hi monocytes in freshly isolated bone marrow 
(cf. Fig. I). The ER-MP20 negative cells present after 5 days of culture represented 
mononuclear phagocytes beyond the monocytic stage of development as (i) at this day of 
culture 26-34% of the cells expressed the mature macrophage marker ER-BMDMI (Fig. 
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4B) and (ii) the ER-MP20 negative cells showed a high level of autofluorescence (Fig. 4A, 
day 5 and 7) which is characteristic of more mature mononuclear phagocytes (ref. II and 
unpublished observations), Upon final maturation into mature macrophages (day 7) the 
expression of the ER-MP20 antigen was lost (Fig. 4A) and the large majority of the cells 
(66-75%) had become ER-BMDMI positive (Fig. 4B). 
In summary, these findings show that ER-MP12ni20- macrophage precursors succes-
sively express the ER-MP 12+20+ and ER_MPIT20hi phenotypes during M-CSF-stimulated 
maturation ill vitro. Under these conditions ER-MPI2-20- cells represent the final stage 
of macrophage development. The latter cells, however, are mature macrophages and do not 
represent the ER-MPI2-20- subset found in normal mouse bone marrow. 
Discussion 
In the present study we focused on the identification of different subpopulations of 
macrophage precursors in the bone marrow of the mouse. To this end, the reactivity of the 
anti-macrophage precursor monoclonal antibodies ER-MPI2 and ER-MP20 with bone 
marrow macrophage precursors was assessed in two-color flow cytometry. At least six 
phenotypically distinct bone marrow subsets can be discerned using these monoclonal 
antibodies. However, only three of these subsets, i.e. ER-MPI2hi20-, ER-MPI2+20+, and 
ER-MPI 2-20hi , gave rise to macrophage progeny after M-CSF-stimulated culture. Together 
these subsets comprise about 15% of nucleated bone marrow cells. 
All data presented in this study support the notion that these precursors reflect different, 
successive stages of macrophage development in the murine bone marrow. The first 
indication for the existence of a maturational difference came from morphological analysis 
of the sorted subsets. The differential counts showed that potential macrophage precursor 
cell types, i.e. morphologically undifferentiated blasts, immature myeloid cells, and 
monocytes, were not evenly distributed among the ER-MPli'i20-, ER-MPI2+20+, and ER-
MPIT20hi subsets. Morphologically undifferentiated blasts were concentrated in the ER-
MP12hi20- and ER-MPI2+20+ subsets, immature myeloid cells in the ER-MPI2+20+ and 
ER-MPI 2-20hi subsets, whereas monocytes were concentrated in the ER-MPI 2-20hi subset, 
thus suggesting differences in maturation stage among these subsets. A second indication 
was obtained from the differences in macrophage colony/cluster-forming capacities of the 
subsets. ER-MPI2hi20- cells formed the largest colonies and therefore are presumably the 
most immature cells. ER-MPI2+20+ and ER-MPI2-20hi cells formed predominantly large 
and small clusters, respectively, and thus, most likely represent subsequent stages. In the 
third place. the expression of the Mac-l antigen, which is expressed relatively latc during 
macrophage maturation JO,II, follows the proposed maturation sequence of the precursor 
subsets. The Mac-I antigen is not expressed in the ER_MPI2hi 20- subset, while about half 
of the ER-MP I 2+20+ subset and all cells in the ER-MP12-20hi subset are Mac-I positive. 
Finally. the most direct indication for the existence of a maturation sequence came from 
the phenotypic development of the, putatively youngest, ER-MPI 2hi20- precursors during 
M-CSF-stimulated culture. We found that the developing cells successively passed through 
ER-MP I 2+20+ and ER-MP12-20hi stages before final maturation into mature macrophages. 
Thus, the morphological data, the cionogenic data, the expression of Mac-I , and the pheno-
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typic development during culture all indicate that the three phenotypically distinct M-CSF-
responsive bone marrow macrophage precursor subsets most likely represent successive 
stages along a maturation pathway in the order ER-MPI2"'20- ~ ER-MP12+20+ ~ ER-
MPlr2o";. 
Interestingly, macrophage colonies could be generated from both the ER-MPI2h;20- and 
ER-MP12+20+ bone marrow subsets. Expressed in absolute numbers, about half of all bone 
marrow macrophage colony-forming cells resided in the ER-MPI2h;20- subset and the 
other half in the ER-MP12+20+ subset. MacVinie reported for C57BI!6J mice an M-CFC 
frequency in bone marrow of approximately twice the frequency of OM-CFC13. TIlus, of 
all macrophage colonies formed in their study, about two thirds was derived from an M-
CFC and one third from a OM-CFC. Combining these data with our observations on ER-
MP 12/20 expression by macrophage colony-forming cells, we speculate that the ER-
MP12hi20- macrophage precursors, which fonn the largest colonies, represent the more 
immature OM-CFC and part of the M-CFC, while the colony-fomling macrophage 
precursors in the ER-MPI2+20+ subset might represent the majority of the M-CFC. 
Our data showed that the earliest M-CFC in the bone marrow are ER-MPli';20-. 
Recently splenic M-CFC were found to express the ER-MP20 antigen at a high level and 
thus differ from bone marrow M-CFC, which are ER-MP20- or ER_MP20d;m 14. It is 
unlikely that this difference in ER-MP20 expression reflects a maturational difference since 
the splenic ER-MP20h; cells are, like the bone marrow ER-MP20- and ER_MP20d;m cells, 
able to form large macrophage colonies in culture. Therefore, it will be interesting to study 
the ER-MPI2 antigen expression of splenic M-CFC, as, in bone marrow, this is clearly 
related to colony forming capacity. 
Both the differential counts and the macrophage precursor frequencies (cf. Tables I and 
2) of the ER-MPI2h;20- and ER-MP\2+20+ subsets indicate that these fractions do not 
solely contain precursors of the macrophage lineage. Morphological analysis of the subsets 
showed that precursors of the erythroid, lymphoid and granulocytic lineages are present 
in these subsets. In accordance with this observation, we recently reported that ER-
MPI2h;20- bone marrow cells gave rise to both myeloid cells as well as T and B cells 
upon intravenous (Lv.) transfer into irradiated recipients J5 • Thus, although the ER-
MPI2h;20- and ER-MPI2+20+ bone marrow subsets are both highly enriched for macro-
phage precursors, additional cell surface markers are required to separate early macrophage 
precursors from other hematopoietic progenitors. 
A remarkable finding was that no macrophage colonies or clusters could be grown from 
ER_MPI2mod20- bone marrow cells in M-CSF-stimulated culture, although we recently 
reported that ER_MP12med20- bone marrow cells, upon Lv. transfer into irradiated 
recipients, were capable of both myeloid, and T and B cell repopulation IS. This apparent 
contradiction can be explained by the presence of more immature progenitors and 
multipotent stem cells within the ER-MPI2""d20- subset l6. Such cells do not yet respond 
in culture to M-CSF alone. III vivo, however, the cells most likely meet the appropriate 
microenvironments and will eventually become sensitive to M-CSF and fOim mature 
macrophage progeny. 
To our knowledge, ER-MPI2 and ER-MP20 are the first set of monoclonal antibodies 
described which positively identify discrete, successive macrophage precursor stages in the 
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bone marrow of the mouse. Furthennore, as the ER~MP12hi20~ bone marrow subset was 
found to contain macrophage precursors as well as precursors of other lineages, it may be 
possible, using additional markers, to identify early branch points in hematopoiesis. 
We would like to thank Mr. J. Brandenburg and Ms. E. mil Bodegolll for animal care; Mr. T.M. mil Os for 
preparation oflhe figures; and Dr. R.E. Ploemacher for his col/f;llflOl/S support. This s/Ildy was supported by The 
Netherlallds Organization for Scientific Research (NWO), gnlll! 901-05-253. 
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Abstract 
Previously. we showed that six distinct subsets of bone marrow cells can by identified 
using the monoclonal antibodies ER-MPI2 and ER-MP20 in two-color immuno-
fluorescence analysis. Upon illfrafhymic transfer into sublethally ilTadiated mice, thymus-
repopulating ability was restricted to ER-MP20- bone marrow cells expressing either high 
or intermediate levels of the ER-MPI2 antigen (1-2% and -30% of bone marrow nucleated 
cells, respectively). TI,e highest frequency of thymus-repopulating cells was found in the 
minor subset of ER_MPI2hi20- bone marrow cells. In the present study we demonstrate 
that upon intravenolls transfer, thymus-homing and -repopulating bone marrow cells are 
exclusively confined to the ER-MPI2hi20- and ER_MPI2mcd20- bone marrow sub-
populations, the highest frequency being detected among ER_MPI2hi20- bone marrow 
cells. Analysis of the peripheral blood leukocytes of reconstituted mice showed that not 
only prothymocytes but also progenitor cells of the B cell lineage as well as the myeloid 
lineage were present within both subsets. Three-color flow cytometric analysis revealed 
that ER-MPIz!"20- bone marrow cells in particular were phenotypically heterogeneous 
with respect to the expression of the cell surface markers TIly-l, Sca-l , CD44, B220, and 
c-kit. Taken together our data demonstrate that ER-MPI2 positively identifies bone marrow 
cells with the ability to home to and repopulate the thymus. TIle phenotypic heterogeneity 
displayed by the ER_MPI2hi20- bone marrow subset, containing the highest frequency of 
thymus-homing and -repopulating cells, provides a basis for further separation of 
prothymocyte activity from other hematopoietic activities in the bone marrow of the 
mouse. 
68 Chapter 4 
Introduction 
The thymus is the major site for T cell development. In this organ, complex and poorly 
understood selection processes, likely directed by an intricate network of heterogeneous 
stromal cell populations, shape the TCR specificity repertoire of the maturing thymo-
cytcs l -6, 11le mature, selected thymocytes descend from a minute population of intrathymic 
precursor cclls l ,7,8 which undergo extensive proliferation and differentiation in the sub-
capsular zone of the thymic cortex. In adult life this intra thymic pool of T cell precursors 
is maintained by bone marrow-derived progenitor cells (prothymocytes)9.11 which seed the 
thymus continuously at a low rate12, 
So far, the characterization of prothymocytes is being hampered by a low frequency 
of these cel1s in the bone marrow, the absence of distinguishing morphological features 
and, above all, the paucity of monoclonal antibodies detecting cell surface antigens specific 
for T cell progenitors. Hence, the phenotype of thymus-repopulating cells is still poorly 
characterized. It is not clear as yet whether these progenitor cells are either multipalent 
stem cells, lymphoid lineage-restricted progenitor cells or progenitor cells exclusively 
committed to the T cell lineage. 
In the previous paperl3, we showed that six distinct subpopulations of bone marrow 
cells could be identified using the recently developed monoclonal antibodies ER-MPI2 and 
ER~MP20 14 in two~color immunofluorescence analysis. As assessed by illtrathYl1lic trans-
fer thymus-repopulating ability appeared to be restricted to ER-MPI2hi20- and ER-
MPI2medZO- bone marrow cells. The highest frequency of thymus-repopulating cells was 
found in the subpopulation of ER-MP1 2hiZO- bone marrow cells. 
In the present study we transferred the six bone marrow subpopulations isolated on the 
basis of different levels of ER-MPI2 and ER-MP20 antigen expression illll'aVellolls/y into 
sublethally ilTadiated Ly-S!Thy-l con genic mice in order to determine whether the ER-
MP12hi20- and ER_MPI2med20- subsets have the capacity to home to the thymus ill vivo 
and thus contain the genuine prothymocytes. Our data indicate that bone marrow cells 
which express the ER-MPI2 antigen but not the ER-MP20 antigen indeed meet these 
physiological criteria of prothymocytes. The highest frequency of thymus-repopulating cells 
was detected in the ER-MPI2hi20- bone marrow subpopulation. Furthennore, phenotypic 
analysis of peripheral blood leukocytes of reconstituted mice revealed that not only 
thymus-repopulating cells but also progenitor cells of the B cell lineage and the myeloid 
lineage were present among ER-MPI2hi20- and ER_MPI2med20- bone marrow cells. 
Finally, three-color flow cytometric analysis revealed that ER-MPI2hi20- bone marrow 
cells particularly were heterogeneous with respect to the expression of the cell surface 
antigens Thy-I, Sca-I, CD44, B220 and c-kit, indicating that this subpopulation can be 
further divided into smaller subsets. This phenotypic heterogeneity provides a basis for 
further attempts to separate prothymocytes from progenitor cells of other hematopoietic 
lillCages. 
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Materials and Methods 
Mice 
C57BLl6-Ly-5.1-Pep3b (Thy-1.2, Ly-5.1) mice (kindly provided by Dr I. L. Weissman, 
Stanford University, Stanford, CAl, C57BLlKa Bl-l (Thy-l.l, Ly-5.2), CBAlRij x 
CS7BLlKa [BCBA(Fl)]. BALB/c, B 1O.D2/n, BALB.k, and SJLlJ mice were cesarean 
dcrived, fostcr reared, raised and maintained under clean conventional conditions with free 
access to food and water (acidified to pH 2.8) in the mouse facilities of the Department 
of Immunology. 
MOJloclonal antibodies and fluorescent reagents 
The monoclonal antibodies used in the present study are listed in table 1. ACK2 (anti-c-kit) 
and A20-1.7 (anti-Ly5.1) were kindly provided by Dr S.-I. Nishikawa, Kumamoto 
University Medical School, Kumamoto, Japan and Dr S. Kimura, Sloan-Kettering Cancer 
Center, New York, NY, respectively. Monoclonal antibodies were used either (partially) 
purified, conjugated to biotin or FITC (Sigma, St. Louis, MO) by standard procedures or 
as culture supernatant. In some instances anti-Thy-1.2 monoclonal antibody conjugated to 
5(6)-carboxyftuorescein-N-hydroxysuccinimide ester (FLUOS, Boehringer Mannheim, 
Gennany) according to the manufacturer's procedure was used. Goat anti-rat Ig absorbed 
with mouse Ig and conjugated to phycoerythrin (GaRa-PE) (Caltag Laboratories, San 
Franscisco, CAl, rabbit anti-rat(Fab)'2 fragments coupled to FITC (RaRa-FITC) (Cappel, 
Organon Teknika, Turnhout, Belgium), streptavidin-phycoerythrin (SAV-PE) (Caltag 
Laboratories), and streptavidin-Tri-Color (SAV-TC) (Caltag Laboratories) were used as 
second stage fluorescent reagents. 
Table 1 Monoclonal antibodies 
Monoclonal antibody Antigen Reference 
ER-MPI2 ER-MPI2 14 
ER-MP20 ER-MP20 14 
59-AD2.2 Thy-I 15 
H129.19 C04 16 
53·6.72 C08 15 
KTJ cm 17 
RA36B2 8220 18 
RB68C5 Gr-l 19 
MlnO Mac~l 20 
IM7.8.1 C044 21 
ACK2 c-kil 22 
EI3 16t-7 Sca-l 23 
30HI2 Thy-1.2 15 
A20-1.7 Ly-5.t Dr. S. Kimura 
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Preparation of cell suspensions 
Suspensions of bone marrow cens and thymuses were prepared as described13 using 
Dutton's balanced salt solution (Gibco, Breda, The Netherlands) supplemented with S% 
FCS (DBSS-FCS). Peripheral blood was obtained by heart puncture and collected in tubes 
containing heparin-coated glass beads. Erythrocytes were depleted by hypotonic lysis using 
a 17 mM Tris buffer (pH 7.2) supplemented with 0.144 M ammonium chloride (4 volumes 
buffer per I volume blood). After 10 min at 4°C, the cells were washed 3 times with PBS. 
Imlllunojluorescence staining 
Two-color immunofluorescence stammg using conjugated monoclonal antibodies was 
performed as described beforen PBS supplemented with 0.5% BSA and 20 mM NaN3 
(PBS-BSA-NaN3) was used for washing as well as diluting the reagents to optimal 
concentrations. When fluorescein-conjugated second stage anti-rat Ig were used in two- or 
three-color stainings the ceHs were first incubated with hybridoma culture supernatant, 
washed and subsequently incubated with RaRa-FITC (two-color stainings) or GaRa-PE 
(three-color stainings) supplemented with 2% normal mouse serum to avoid nonspecific 
binding. After two washes the cells were incubated and washed in the presence of 2% 
normal rat serum to block any free anti-rat Ig binding sites of the conjugate. Next the cells 
were incubated with biotin-conjugated monoclonal antibody, washed and finally incubated 
with SAV-PE (two-color stainings) or SAV-TC and FITC-conjugated monoclonal antibody 
(three-color stainings). For cell sorting experiments bone marrow cens were stained as 
previously described l3 . 
Flow cyfomefric alia lysis and cell sorting 
Cell surface fluorescence was analyzed using a FACScan flow cytometer (Becton 
Dickinson, Mountain View, CAl. Erythrocytes and dead cells were excluded from analysis 
by electronic gating on the basis of light scatter characteristics. Cell sorting was performed 
using a FACS 440 (Becton Dickinson) as described prcviouslyl3. 
Cell trails fer alld alia lysis of repoplliatioll 
CS7BIIKa BI-I recipient mice (aged IO-IS weeks) were exposed to 7.S Gy (unless 
otherwise stated) of y-inadiation using two opposing 137Cs sources (Ganunacel1 40 
irradiator, Atomic Energy of Canada Ltd, Ottawa, Canada) at a dose rate of 1.01 Gy/min. 
Two hours after irradiation different numbers of un separated or sorted congenic bone 
marrow cells were injected i. v. into mice via their tail veins. Three weeks after i. v. transfer 
the recipient mice were killed. Thymocytes were stained with directly conjugated anti-Thy-
1.2 monoclonal antibody to detect donor-derived thymocytes. In one experiment recipient 
mice were irradiated at 8.0 Gy and reconstituted; after 4 weeks they were killed and their 
peripheral blood was analyzed for the presence of donor-derived T and B lymphocytes and 
myeloid cells. Peripheral blood leukocytes were dually labeled with either anti-B220 (B 
cells), anti-CD3 (T cells), or anti-Mac-I (myeloid cells) (followed by RaRa-FITC as a 
second stage reagent) and donor-specific biotinylated anti-Ly-S.I followed by SAV-PE. 
Cell surface fluorescence was analyzed on a FACScan flow cytometer (Becton Dickinson). 
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Cell suspensions with ~ I % donor-derived cells in thymus or peripheral blood were scored 
as positive for donor-type repopulation. 
Results 
Thymus-homing alld -repopulating ability of bone marrow sltbpopulatiolls sorted Oil the 
basis of a differelll expression of the ER-MP12 and ER-MP20 allligens 
In the accompanying paperl3 we showed that bone marrow cells could be separated into 
six subpopulations on the basis of difference in ER-MPI2 and ER-MP20 antigen 
expression. Using the intratilymic transfer assay thymus-repopulating ability appeared to 
be exclusively confined to ER-MPI2hi20- and ER_MPI2med20- bone marrow cells, with 
the highest frequency of thymus-repopulating cells being found in the fomler subset 
(constituting 1-2% of total nucleated bone marrow cells). 
In the present study we assessed the thymus-homing ability of the six bone marrow 
subpopulations after illtravenolls transfer in order to investigate whether functional 
prothymocyte activity is confined to the ER-MPI2hi20- and ER_12med20- subsets or maybe 
one of these. The six bone marrow subpopulations, each characterized by a different 
expression of the ER-MPI2 and ER-MP20 antigens, were isolated by ftuorescence-
activated cell sorting and transferred i. v. into sublethally irradiated Ly-5rrhy-1 congenic 
mice. Twenty-one days after cell transfer the thymuses of the recipient mice were analyzed 
for the presence of donor-derived (i.e. Thy-1.2+) thymocytes (Table 2). As a control the 
thymus-repopulating ability of unseparatcd bone marrow cells was detennined. 
In nine out of 39 mice (23%) reconstituted with total bone marrow cells donor-derived 
thymocytes were detected after i.v. injection of 25,000 cells. In recipient mice injected Lv. 
with 25,000 separated bone marrow cells thymus-homing and -repopulating cells appeared 
to be restricted to the ER-MPI2hi20- and ER_MPI2",ed20- subpopulations. In experiments 
3 and 4, thymus-repopulating cells were only detected in the bone marrow subpopulation 
with a high level of ER-MPI2 antigen expression, while in the second experiment, only 
a very low percentage (3.5% ± 1.6%) of donor-derived thymocytes was detected in eight 
out of 15 mice reconstituted with ER_MPI2med20- bone marrow cells. Re-analysis of the 
sorted bone marrow fractions revealed the same degree of purity (>96%) for the ER-
MP12med20- subset in each experiment (data not shown), indicating that the differences 
between the individual experiments cannot be explained by the presence of contaminating 
ER_MPI2hi20- cells. 
Results were more clear-cut when only 5000 cells were injected Lv. Under these 
conditions thymus-repopulating ability was exclusively confined to ER-MPI2hi20- bone 
marrow cells (Table 2). These data demonstrate that: (i) bone marrow cells expressing the 
ER-MPI2 antigen but not the ER-MP20 antigen are able to home to and repopulate the 
thymus of sublethally irradiated mice after i.v. transfer; (ii) the ER-MPI2hi20- bone 
marrow subset contains the highest frequency of thymus-homing and -repopulating bone 
marrow cells. 
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Table 2 Thymus-homing and -repopulating ability of sorted bone marrow cell subpopulations 
Cell source % ofBM Number Exp. Positive % Donor-derived 
ccllsa) of cells number mice/total thymocytesc) 
transfered miceb) 
total BM 25 x 103 9/39 29.6 ± 7.8 
5 x 103 0110 
ER-MPI2moo20- 30.7 ± 4.9 25 x 103 4/10 45.3 ± 6.1 
2 8115 3.5 ± 1.6 
3 019 
4 0114 
5 x 103 3 0110 
4 0110 
ER-MPI2h;20- 2.1 ± 0.4 25 x 103 I 517 24.0 ± 10.2 
2 515 44.5 ± 15.7 
3 516 36.2 ± 11.6 
5 x 103 3 4/6 25.4 ± 11.5 
4 10115 33.2 ± 8.3 
ER-MPI2+20+ 9.2 ± 3.1 25 x 103 119 2.4 
ER-MPI2-20moo 26.8 ± 6.6 25 x 103 0118 
ER-MPI2'20h; 4.8 ± 1.7 25 x 103 0114 
ER-MPI2-20- 28.6 ± 5.6 25 x 103 0114 
C57BL/Ka 81-1 (Ly-S.2, Thy-l.l) recipient mice were irradiated 7.5 Oy and injected i.v. with donor cells of 
C57BLl6-Ly-5.J-Pep3b (Ly-5.1, Thy-1.2) mice. Thymus reconstitution was analyzed 21 days after cell transfer. 
a) The relative distribution of the subpopulalion among nucleated bone marrow cells (mean percentage ± SEM 
of 14 experiments). b) Thymus suspensions with ~ I % donor-derived Ihymocytes were scored as positive. c) The 
mean percentage of donor-derived (Thy-1.2+) cells ± SEM was calculated from four to 10 mice. 
Mult;-lilleage reCollstUut;oll potellti'al of ER-MP 12lii2(T alld ER-MP 12med20- bone marrow 
cells 
To assess the developmental potential of ER-MP12hi20- and ER_MPI2mcd20- bone marrow 
cells more extensively we Lv. transferred sorted ER_MPI2hi20- or ER_MPI2med20- bone 
marrow cells, or unseparated bone marrow ceBs into 8 Gy irradiated Ly-Sffhy-l congenic 
recipient mice. Four weeks later peripheral blood nucleated cells were analyzed for the 
presence of donor-derived (Le. Ly-5.1+) cells. In each sample the percentage of T 
lymphocytes (CD3+ cells), B lymphocytes (B220+ cells), and myeloid (Mac-I+) cells of 
donor origin was detennined. These results arc shown in Table 3. Donor-derived cells were 
detected in all recipient mice. The average percentage of Ly-5.1 + peripheral blood 
nucleated cells appeared to be maximal after i.v. transfer of ER-MP12h120- bone marrow 
cells (e.g. 31.0% versus 13.5% after transfer of 5000 ER_MPI2med20- cells). The highest 
percentage of donor-derived T lymphocytes in peripheral blood was detected after transfer 
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of ER-MPI2hi20· bone marrow cells (e.g. 6.2% versus 1.4% after transfer of 5000 ER-
MP 12med20· cells). 
At this time point (i.e. 28 days after i.v. transfer) the percentage of donor-derived 
peripheral T cells was still low. Yet high p~rcentages of donor-derived (Thy-1.2+) 
thYlllocytes were detected aner transfer ofER-MPI2hi20· cells as well as ER_MPI2med20· 
cells (Table 3). The considerable percentage of donor-derived thymocytes in mice 
reconstituted with 5000 ER_MPI2med20· cells is in sharp contrast with the absence of 
donor-derived thymocytes at 21 days after transfer of these cells (Table 2). This apparent 
discrepancy may be explained by the presence of multipotent hematopoietic stem cells 
within the ER_MPI2med20· subset. These cells most likely need additional maturational 
events in the bone marrow and may therefore need morc time to mature into thymocytes 
(i.e. 28 days instead of 21 days). 
Donor-derived cells belonging to the B cell lineage and myeloid lineage were also 
found after i.v. transfer of either subset (Table 3). The highest percentage of both donor-
derived B lymphocytes and myeloid cells was found after transfer of ER-MPI2hi20· bone 
marrow cells. Taken together our results show that both ER_MPI2hi20· and ER-
MP12med20- bone marrow subsets contain not only prothymocytes but also progenitor cells 
capable of differentiating into B lymphocytes and myeloid cells. 
Cell sUlface phenotype of ER-MP1211i2rr and ER-MP12",ed2rr bone 1II00TOII' cells 
The cell surface phenotype of both bone marrow subsets was examined using three-color 
immunofluorescence analysis in order to investigate to what extent ER-MP12hi20- and ER-
MP12med20- bone marrow ce11s arc phenotypically heterogeneous and resemble previously 
described bone marrow subpopulations enriched for hematopoietic stem cells and pro-
genitor activity24-26. The staining profiles of ER-MPI2hi20· and ER_MPI2mcd20· bone 
marrow subpopulations with a panel of monoclonal antibodies against different cell surface 
antigens is shown in Fig. IA and B respectively. For comparison the profiles of ungated 
nucleated bone marrow cells are shown (Fig. I C). 
We analyzed the expression of the mature lineage markers Gr-I, Mac-I, CD4, CD8 and 
BnO by ER_MPI2hi20· and ER_MPI2med20· bone marrow cells in order to compare the 
current progenitor fractions with those isolated by others using depletion of bone marrow 
cells for the mentioned mature markers24,25,27,28. Compared to un separated bone marrow 
cells (Fig. IC) both ER-MPI i"20· and ER-MPI 2med20· bone marrow subpopulations were 
depleted of cells that strongly expressed Gr-I and Mac-I (Fig. IA and B, respectively). 
Lymphoid cells expressing high levels of CD4 and CD8, most likely mature T lympho-
cytes, were only detected in the ER_MP12med20· subset (Fig. 1B). In both sUbpopulations 
cells were detected which stained dimly for CD4. In this context it is noteworthy that low 
levels of CD4 were recently detected on pluripotent stem cells29,30 and on the earliest 
subset of thymocytes detectable7•8. About 90% of the ER_MPI2med20· bone marrow cells 
expressed B220 (Fig. IB), suggesting that the majority of the cells in the ER_MPI2med20· 
bone marrow subset belong to the B cell lineage. In contrast, ER_MPI2hi20· cells differed 
strikingly from the ER_MPI2med20· subset in that about 50% lacked the expression of 
BnO (Fig. IA). Analysis of the forward light scatter against the fiuorescence distribution 
(Fig. 2A) revealed that the B220· cells in the ER_MPI2hi20· subset were mainly blast-like 
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Table 3 Thymus and peripheral blood chimerism after Lv. reconstitution with sorted ER_MP12hi20-
and ER_MP12med20- bone marrow subpopulations 
Cell source Cell number (IIr) % donor-derived thymo- % donor-derived 
cytes (Thy_1.2+)bl cells (Ly-5.1 +)dl 
10 x 103 (7) 89.5 ± 1.9 66.5 ± 6.4 
5 x 103 (7) 39.9 ± 12.0 31.0 ± 8.0 
ER_MPI2moo20- 25 x 103 (9) 72.3 ± 6.4 51.5 ± 6.8 
10 x IOJ (6) 61.8 ± 10.3 34.7 ± 10.5 
5xI03 (4) 24.9 ± 13.8 13.5 ± 4.8 
total BM 25 x 103 (6) 49.9 ± 15.7 23.1 ± 6.8 
10 x IOJ (2) 35.9 6.7 
C57BUKa BI-I (Ly-S.2, Thy-I.!) recipient mice were irradiated 8.0 Oy and reconstituted i.v. with donor cells 
of C57BU6-Ly-5.I-Pep3b (Ly-5.1, Thy-I.2) mice. Thymus and peripheral blood chimerism was analyzed 28 days 
after cell transfer. a) 11: Number of mice analyzed. tI) The average percentage ± SEM of donor-derived thymo-
cells. Interestingly the ER-MPI2hi20- bone marrow cells expressing the highest level of 
B220 antigen appeared to be large blast-like cells while ER-MPI2hi20- cells with an 
intermediate level of B220 expression showed a scatter profile characteristic for lymphoid 
cells (Fig. 2A). 
Both subsets contained cells that expressed low levels of Thy-l as well as cells lacking 
detectable levels of this cell surface marker (Fig. IA and B). Low levels of the Thy-l 
antigen have been detected on bone marrow cells with thymus-repopulating ability and 
other hematopoietic progenitors and stem cells24 ,31-33, A small percentage of ER-
MP12hi20- bone marrow cells (2.5-7%) expressed high levels of the Thy-l antigen 
(Fig. I A). Analysis of the forward light scatter against the fluorescence distribution 
revealed that the majority of the Thy_Ihi ER-MPI2hi20- cells were large blast-like cells 
(Fig. 2B), suggesting that these cells are probably not T lymphocytes. In contrast, the 
majority of the Thy_I hi cells in the ER-MPI2m,d20- bone marrow subset (Fig. IB) 
appeared to be small lymphoid cells (data not shown), most likely representing mature T 
cells. 
It has been shown previously that thymus-repopulating ability is exclusively confined 
to bone marrow cells expressing Sca-l (Ly_6A1E)25. Our data demonstrate that about 30% 
of both ER-MPI2hi20- and ER-MP 12m,d20- bone marrow cells expressed Sca-l (Fig. IA 
and B, respectively) compared to about 10% of un gated bone marrow cells (Fig. I C). The 
only other cells in bone marrow that expressed this cell surface marker were found in the 
ER-MPI2+20+ subset (data not shown). Thus, in accordance with the thymus-repopulating 
activity the expression of Sca-I appeared to be restricted to bone marrow cells expressing 
the ER-MPI2 antigen. 
ER-MPI2hi20- cells differed markedly from ER-MPI2m,d20- cells in the expression 
of e-kit, the receptor for stem cell factor'4.35, which has been reported on hematopoietic 
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Table 3 Thymus and peripheral blood chimerism after i. v. reconstitution with sorted ER·MP12hi20-
and ER-MPI2med20- bone marrow subpopulations (continued) 
Peripheral blood 
% T cells (CD3+) of donor 
origin (LY_5.!+)d) 
16.4 ± 3.3 
6.2 ± 1.8 
5.9 ± 0.8 
5.3 ± 1.7 
1.4 ± 0.4 
4.1 ± 1.6 
1.2 
% B cells (B220+) of donor 
origin (Ly-5.! +)d l 
84.9 ± 3.0 
76.5 ± 3.3 
74.4 ± 3.2 
52.7 ± 9.2 
42.5 ± 2.6 
48.6 ± 9.4 
23.0 
% myeloid cells (Mac-I +) of 
donor origin (Ly-5.1 +)dl 
83.6 ± 8.3 
44.0 ± 15.3 
74.1 ± 6.4 
55.9 ± 13.7 
23.0 ± 12.3 
33.5 ± 10.4 
8.6 
cytes (Thy-I.2+). c) The average percentage ± SEM of donor-derived (Ly-5.1 +) peripheral blood nucleated cells. 
d) The average percentnge ± SEM of either peripheral blood T cells (CD3+), B cells (B220+), and myeloid cells 
(Mac-l+) which were of donor origin (LY-5.l+). 
stem cel1s and progenitor cells26,36,37, Two percent of the cells in ungatcd bone marrow 
and in the ER_MPI2fficd20- subpopulation expressed high levels of c-kit (Fig. IC and B, 
respectively). In contrast, 35-40% of the ER-MP12h;20- cells, mainly blast-like cclls (data 
not shown), expressed this cell surface marker at high levels (Fig. IA), suggesting a high 
frequency of progenitor cells in this latter sub population. 
CD44 is differentially expressed by most hematopoietic cells38. Multipotent stem cells 
and progenitor cells, including thymus-repopulating cells, express intermediate levels of 
this surface rnarkc12 1.25,38 while the earliest intrathymic T cell precursors express high 
levels7 Our results show that all ER-MPI2,"ed20- bone marrow cells expressed intermed-
iate levels of this antigen (Fig. IB). Analysis of the ER-MP12h;20- sUbpopulation revealed 
cells expressing intelmediate levels as well as high levels (marc than 50%) of CD44 (Fig. 
IA). 
Taken together our data demonstrate that: (i) selection against ER-MP20 and for ER-
MPI2 antigen expression results in the depletion of bone mmTOW cells expressing high 
levels of the myeloid lineage differentiation markers Gr-I and Mac-I; (ii) both ER-
MPl2hi20- and ER_MP12fficd20- cells are heterogcneous with respect to the expression of 
several cell surface markers; (iii) ER-MP12hi2o- cells are phenotypically more hetero-
geneous than ER_MPI2fficd20- bone marrow cells. 
E.'pressioll of ER-MP12 alld ER-MP20 alltigens by dijferellf mouse straills 
The potential usefulness of the ER-MPI2 and ER-MP20 antigens for the enrichment of 
bone marrow cells with thymus-repopulating ability depends, partly, upon the exprcssion 
of these cell surface markers by a wide variety of mouse strains. Therefore we examined 
the expression of the ER-MPI2 and ER-MP20 antigens by bone marrow cells from mice 
of different haplotypes (Table 4). Our results show that both antigens are at least expressed 
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Figure I. Cell surface phenotype of ER.MP12bi20- (A), ER·MPI2med20- (B) and unseparated bone marrow cells 
(C). Bone marrow cells were stained with monoclonal antibodies specific for either of the indicated antigens 
(second stage reagent: GuRa-PE), FITC-conjugated ER-MP20, and biotinylated ER-MPI2 (followed by SAV-TC). 
Control: isotype-matched control monoclonal antibody (lgG2a or IgG2b). Life gates were set on either ER-
MP12hi20- (A) or ER_MPI2med20- cells (8) and the expression of the indicated markers was analyzed. 
Histograms in panel A, B and C were generated from 4000, 10000, and 14000 events respectively. The results 
of one representative experiment arc shown. 
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Figure 2. Forward scatter versus log fluorescence distribution ofER-MP12hi20- bone marrow cells stained with 
8220 (A) and Thy-l (D). Bone marrow cells were stained as described in Methods (three-color staining). Life 
gates were sct on ER_MPI2hi20- cells and the expression of the third marker was analyzed. I: blast-like cells 
expressing high levels of either B220 (A) or Thy-l (8). 2: lymphoid cells expressing 8220. Dot plots were 
generated from 8000 events and arc the result of one representative experiment. 
by mice of H_2b, H_2b/q, H_2d, H_2k, and H-2' haplotypes. The distribution of cells among 
the bone marrow subsets characterized by different expression of the ER-MPI2 and 
ER-MP20 antigens varied only slightly between the different mouse strains. Most 
importantly, approximately the same percentage (\.3-\. 7% of total nucleated bone marrow 
cells) of ER-MPI2h;20- bone marrow cells were detected in all tested strains. 
Table 4 Relative distribution of bone marrow subsets characterized by distinct patterns of ER~MP12 
and ER-MP20 antigen expression in various mouse strains 
Mouse stmin H·2 IT20- a) 12med20- 12bi20- IT20med tno" 12+20+ 
C57BU6·Ly-5.t b 26.6 26.8 1.7 29.5 5.2 10.2 
C57BUKu BL~ I b 22.6 20.5 1.6 42.2 7.1 5.8 
BCBA(FI) b/q 29.7 t6.2 1.3 40.7 5.7 6.4 
BALB/e d 22.4 30.9 1.5 36.2 4.5 4.5 
BALB.k k 28.5 21.5 1.3 40.6 4.0 4.4 
SJLIJ 26.9 32.7 1.5 27.5 5.5 6.2 
Bone marrow cells were simultaneously stained with ER~MP 12 and ER-MP20. The percentages of nucleated bone 
marrow cells among the six different subpopulations were determined by FACScan analysis. a)ER-MPI2'"2o- etc. 
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Discussion 
In the previous paperl3 we showed that by using the monoclonal antibodies ER-MPI2 and 
ER-MP20 in two-color immunofluorescence analysis six distinct subpopulations of bone 
marrow cells could be identified. Upon intra thymic transfer into sublethally irTadiated 
recipient mice we found that thymus-repopulating ability was exclusively confined to bone 
marrow cells that expressed either high or intemlcdiate levels of the surface antigen 
ER-MPI2 but lacked the expression of the surface marker ER-MP20. The highest 
frequency of thymus-repopulating cells was found in the minor subset of ER-MPI zl"20-
bone marrow cells (\-2% of total nucleated bone marrow cells). However, by means of 
intrathymic transfer the ability of the injected cells to home to the thymus, which is a 
prerequisite for prothymocytes, could not be assessed. 
In the present study we transferred the six bone marrow subpopulations i.v. into 
sublethally irradiated mice in order to investigate whether thymus-homing and 
-repopulating cells (i.e. prothymocytes) are contained within the ER-MPI2hi20- and 
ER-MPI2""d20- bone marrow sUbpopulations. Our results demonstrate that prothymoeyte 
activity (assayed 21 days after i.v. transfer) is indeed restricted to the ER_MPI2hi20- and 
ER_MPI2med20- subset of bone marrow cells. The highest frequency of thymus-homing 
and -repopulating cells was detected in the ER_MPI2hi20- subpopulation. 
Analysis of the peripheral blood leukocytes of mice reconstituted 28 days earlier with 
either ER-MPI2hi20- or ER-MPI2,"cd20- cells revealed the presence of donor-derived T 
lymphocytes, B lymphocytes and myeloid cells, indicating that not only thymus-
repopulating cells, but also progenitor cells of the B cell lineage as well as the myeloid 
lineage were present in both sUbpopulations. 
At this later time point of analysis (i.e. 28 days) high percentages of donor-derived 
thymocytes were found after i.v. transfer of either 5000 ER_MPI2hi20- or 5000 ER-
MP12med20- cells, whereas at 21 days donor-derived thymocytes were only detected in 
mice reconstituted with the ER-MPI 2hi20- subset. This apparent discrepancy is most likely 
explained by the presence of multipotent stem cells within the ER_MPI2med20- subset39 
which need to undergo additional maturational events in the bone marrow before acquiring 
the ability to home to the thymus. These cells therefore need more time to mature into 
thymocytes, resulting in the detection of donor-derived thymocytes at a later time point 
(i.e. 28 days after i.v. transfer). In contrast the thymus-repopulating cells in the 
ER-MPI2hi20- subpopulation probably already have acquired the ability to home to the 
thymus, and therefore will give rise to progeny at an earlier time point (i.e. 21 day after 
i.v. transfer). 
Our results demonstrate that although the ER-MPI2hi20- subset of bone marrow cells 
contains a high frequency prothymocytes the separation of the pro-T cell activity from 
other hematopoietic activities will depend upon the use of additional cell surface markers. 
Cell surface phenotyping revealed that both ER-MPI2hi20- and ER_MPI2med20- bone 
IllaITOW cel1s were heterogeneous with respect to the expression of several cell surface 
markers. Both subpopulations lacked cells expressing high levels of Gr-I and Mac-I, 
indicating that ER-MP20 is extremely suitable for depleting at least mature myeloid cells 
in the enrichment procedure of hematopoietic progenitor cells. As the Mac-t antigen has 
been detected on a subset of thymus-repopulating cells24•25 ,40 it remains to be tested 
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whether Mac-l lo cells, constituting a small percentage of both ER-MPI2hi2o- and ER-
MP12med20- cells, are capable of differentiating into the T cell lineage, Cells expressing 
high levels of CD4 were depleted of the ER_MPI2hi20- subset, indicating that mature T 
lymphocytes (at least CD4+CDS- cells) are excluded by selecting for high levels of ER-
MPI2 antigen expression, In contrast mature T lymphocytes were detected among ER-
MPI2"1<d20- cells. Cells expressing low levels of CD4 were found in both subsets. Recent 
reports have shown that both hematopoietic stem cells and the earliest detectable 
thymocytes express CD4 at a low leveI7.8.29.3o. Therefore the use of anti-CD4 monoclonal 
antibody in bone malTOW purging protocols should be avoided because this may lead to 
the depletion rather than the enrichment of progenitors and stem cells. 
Almost all of the ER_MP12med20- bone marrow cells expressed B220. These cells 
therefore most probably belong to the B cell lineage. In contrast, half of the ER-MPI2hi20-
bone marrow cells were B220-. Surprisingly the ER-MP 12hi20- cells expressing high levels 
of B220 appeared to be blast-like cells. Further research is required to detennine whether 
this B220hi sUbpopulation of ER-MPI2hi20- bone marrow cells is restricted to B cell 
lineage development. On the other hand the presence of thymus-repopulating cells in this 
B220hi subset may not be excluded, because at least some T cell progenitor activity has 
been detected in a subset of the Thy-lloSca-l + bone marrow cells expressing B220 and 
Mac_1 40, 
The majority of ER-MPI2hi20- and ER_MPI2med20- cells are Thy-l-, while both 
subsets contain cells expressing low levels of Thy-I. Progenitor cells, including thymus-
repopulating cells, and hematopoietic stem cells have been found to express low levels of 
Thy-l 24.25.28. However, it has recently been shown that only in Thy-l.l genotype mouse 
strains was the stem cell activity restricted to Thy_Ilo bone marrow cells while in mouse 
strains expressing the Thy-1.2 allele (i.e. the common fOln) of the Thy-l locus, found in 
mice used in this study) this activity was detected in both Thy-l- and Thy_llo subsets41 . 
Although the thymus-repopulating ability of the Thy-I.T and Thy-I.io cells was not 
assessed in that study41 a low level of Thy-l expression is maybe not a valid criterion for 
the isolation of prothymocytes from the bone marrow of Thy-1.2 genotype mice. 
Interestingly, some ER-MPI2hi20- bone marrow cells expressed high levels of Thy-1.2. 
These cells are most likely immature, because they have a blast-like appearance in the 
scatter profile. As about 50% of the natural killer cells express Thy-l 42 the presence of 
these cells within the Thy_lhi subset of ER-MP12hi20- cells may not be excluded. 
Cells expressing the Sca-I antigen were present in both subsets, It has been shown 
previously that Sca-l is expressed by thymus-repopulating cells and other hematopoietic 
progenitors and stem cel1s25 ,28,40, 111is cell surface marker however is not an ideal marker 
for the isolation of thymus-repopulating cells, because Sca-l is constitutively expressed 
only by bone marrow cells of Ly_6b haplotype mice43 , In contrast our data show that the 
ER-MPI2 and ER-MP20 antigens are expressed on a broad range of mouse strains with 
only slight differences in the size of the six bone marrow subpopulations. 
Cells expressing high levels of the proto-oncogene c-kit were markedly enriched among 
ER-MPI2hi20- bone marrow cells. This cell surface marker has been detected on 
hematopoietic stem cells and progenitor cells26,36-38, also including the earliest intrathymic 
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precursor cells44 Therefore separation of the ER_MPI2hi20- bone marrow cells on the 
basis of c-kit expression may lead to the further purification of prothymocytes. 
ER-MPI2hi20- cells expressed either high or intermediate levels of CD44 while all ER-
MP12med20- bone marrow cells expressed this cell surface marker at an intelmediate level. 
An intennediate level of CD44 has been detected on pluripotent stem cells and 
Thy-lloLin-Sca-l + bone marrow cells25,38 while the carliest intrathymic T ccll precursors 
express high levels of CD44 7,8. In this context separation of ER-MPI2hi20- bone marrow 
cells on the basis of high levels of CD44 expression may lead to a further enrichment of 
thymus-repopulating cells. 
Finally, cell surface markers such as Fall-3, which distinguishes pluripotent stem cells 
from B cell progenitors45 , or the heterogeneity of different stem cell and progenitor subsets 
for rhodamine 123 retention and wheat geml agglutinin affini ty39,46,47 may prove to be 
useful for the separation of the pro-T cell activity from other hematopoietic activities in 
the ER-MPI2hi20- subset. 
In summary our data demonstrate that progenitor cells with the capacity to home to and 
repopulate the thymus are confined to the ER-MPI2hi20- and ER_MPI2med20- subsets of 
bone marrow cells. The highest frequency of thymus-homing and -repopulating bone 
marrow cells was found among ER-MP12hi20- cells which heterogeneously expressed the 
cell surface markers Thy-I, Sca- I. CD44, B220, and c-kit. This phenotypic heterogeneity 
provides a basis for the further purification of thymus-homing and -repopulating ceHs from 
the ER-MPI2hi20- subpopulation. 
We thank Mr J. Bralldenburg and Ms E. Will Bodegom for allimal care and Mr T.M. Will Os Jor the preparatioll 
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Abstract 
Studies on the early events in the differentiation of the non-specific immune system require 
the identification and iso1ation of myeloid-committed progenitor cells. Using the mono-
clonal antibodies ER-MPI2 and ER-MP20, generated against immortalized macrophage 
precursors, we have shown previously that the earliest macrophage colony-stimulating 
factor (M-CSF)-responsive cells in the bone marrow have the ER_MPI2hi2W phenotype. 
In addition, we found that the ER-MPI2hi20· subset (comprising about 2% of total 
nucleated marrow) contains progenitor cells of all hematopoietic lineages. Aiming at the 
identification and purification of the myeloid progenitor cells within the ER-MPI2hi20· 
subset, we used ER-MP58, a marker expressed at high level by all M-CSF-responsive bone 
marrow progenitors. With this marker the ER-MPI 2hi20· cell popUlation could be divided 
into three subfractions: one with absent or low level ER-MP58 expression, one with 
intClmediate and one with high ER-MP58 expression. These subfractions were isolated by 
fluorescence-activated cell sorting and tested ill vitro and ill vivo for their differentiation 
capacities. In addition, the expression of ER-MP58 on stem cell subsets was examined in 
the cobblestone area-fonning cell (CAFC) assay. Our data indicate that in the ER-
MP12hi20· sUbpopulation myeloid-committed progenitors are characterized by high-level 
expression of the ER-MP58 antigen, whereas cells with other or broader differentiation 
capacities have an ER-MP58 negative/low or intermediate phenotype. These myeloid-
committed progenitors have no significant repopulating ability ill vivo, in contrast to the 
ER-MP58 intemlCdiate cells. Primitive CAFC-28/35, corresponding to cells providing long-
term hematopoietic engraftment ill vivo, also did not express the ER-MP58 antigen at a 
high level. Thus, cells committed to the myeloid lineage can be separated from progenitor 
cells with other differentiation capacities by means of multiparameter cell sorting using 
ER-MP58 in combination with ER-MPI2 and ER-MP20. 
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Introduction 
Primitive hematopoietic stem cells differentiate into various lineage-committed progenitor 
cells. At present, it is largely unknown what the crucial events are in lineage commitment 
of hematopoietic stem cel1s. The study of the mechanisms involved in lineage commitment 
requires the identification of lineage-specific markers which pennit the isolation of 
different subsets of committed progenitor cells. 
The currently available cell separation protocols combine multiple cell characteristics 
to obtain bone mmTOW cell populations that are highly enriched in hematopoietic stem cell 
activity!-4. Although ptimitive hematopoietic stem cells can be separated from more com-
mitted progenitor cells in this way, the different classes of committed progenitor cells are 
stiH difficult to dissectS, Using density separation and counterflow centrifugal clutriation, 
a highly enriched population of granulocyte/macrophage colony-forming cells (OM-CFC) 
has been isolated from the bone marrow of cyclophosphamide-treated mice6,7. Isolation of 
committed progenitors on the basis of cell surface antigen expression. however, has the 
advantage that infOlmation on phenotypic changes associated with commitment may 
provide insight into molecules and, ultimately, the mechanisms crucial in lineage 
commitment, 
In our search for cell surface markers that allow the identification of myeloid-
committed progenitors, we previously generated a series of monoclonal antibodies which 
recognize cell surface antigens expressed by mouse hematopoietic progenitor cells8,9, Using 
two of these monoclonal antibodies, ER-MPI2 and ER-MP20, we identified in mouse bone 
marrow three successive maturation stages of cells of the macrophage lineagelO, TIle bone 
marrow subset containing the earliest macrophage colony-stimulating factor (M-CSF)-
responsive progenitor cells, i.e. the ER-MPI2hi20- (about 2% of nucleated bone marrow 
cells), was found to contain also cells with thymus-repopulating ability, cells with capacity 
to reconstitute al1 hematopoietic lineages in sublethally irradiated mice II, as well as 
primitive hematopoietic stem cel1s 12, 
In the present study, we searched for novel cell surface markers which distinguish the 
myeloid-committed progenitor cells present in this ER-MPI2hi20- bone marrow subset 
from primitive hematopoietic stem cells and cells committed to other lineages, To this 
purpose, we employed the ER-MP58 monoclonal antibody, which was previously found 
to detect all M-CSF-responsive progenitors in total mouse bone marrow8• The ER-
MP12hi20- population was fractionated on the basis of ER-MP58 expression using 
multiparameter flow cytometry, The resulting three subfractions were then tested ill vitro 
for their content of macrophage colony-forming units (CFU-M), granulocyte/macrophage 
colony-forming units (CFU-OM), and CFU-pre-B, and ill vivo for their potential to 
repopulate the thymus and to confer peripheral blood reconstitution of the myeloid, B 
lymphoid, and erythroid lineages. In addition, the expression of ER-MP58 on the various 
stem cell subsets was examined ill vitro in the cobblestone area-forming cell (CAFC) 
assay. Our data indicate that early, ER-MPI 2hi20-, myeloid-committed cells can be 
separated from other hematopoietic stem and progenitor cells on the basis of their high 
level ER-MP58 expression. 
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Materials and methods 
Mice 
C57BL6/Ly5.l-Pep3b (Thy-1.2, Ly-5.1; breeding pairs originally provided by Dr J.L. 
Weissman, Stanford University, Stanford, CAl, C57BLlKa Bl-I (Thy-I.!, Ly-5.2) and 
CBNRij x C57BLlKa [BCBA(FI)] mice were kept under specific pathogen free conditions 
with free access to food and water in the mouse facilities of our department. 
Monoclonal autibodies allti conjugates 
The monoclonal antibodies used in this study were ER-MPI2 8, ER-MP20 (anti-Ly6C)8.I3, 
ER-MP58 8, A20-1.7 (anti-Ly-5.1; kindly provided by Dr S. Kimura, Sloan-Kettering 
Cancer Center, New York, NY), 30HI2 (anti-Thy-1.2)14, RA3 6B2 (anti-B220)15, KT3 
(anti-CD3)16, and MlnO (anti-Mac-l)l7. Antibodies were used either as undiluted 
hybridoma culture supernatants (ER-MP58 and MlnO), or purified and conjugated to N-
hydroxysuccinimidobiotin (Boehringer Mannheim, Mannheim, FRO; ER-MPI2 and A20-
1.7), fluorescein isothiocyanate isomer I (FITC, Sigma, St.Louis, MO; ER-MP20, RA3 
6B2 and KT3), or 5(6)-carboxy-fluorescein-N-hydroxysuccinimide ester (FLUOS, 
Boehringer Mannheim; 30H 12). 
FITC-conjugated rabbit anti-rat IgO F(ab)'2 fragments (Cappel, Organon Teknika, 
Turnhout, Belgium), R-phycoerythrin-conjugatcd goat-anti-rat IgG (mouse-adsorbed; Caltag 
Laboratories, San Francisco, CAl, Tri-Color-conjugated streptavidin (Caltag Laboratories) 
and R-phycoerythrin-conjugated streptavidin (CaJtag Laboratories) were used as second-
stage reagents. 
Cell suspensions 
Bone malTOW een suspensions were prepared in PBS supplemented with 5% heat-
inactivated fetal calf serum, 60 l1g1ml penicillin and 100 I1g/ml streptomycin as described 
previouslyW Thymus suspensions were made in PBS supplemented with 0.5% bovine 
serum albumin (BSA) and 20mM NaN3 by gently pressing thymic lobes through a 100-l1m 
nylon sieve (Polymon PES, Kabel, Amsterdam, The Netherlands). 
Immunofluorescent staining alld cell sorting 
For cell sorting experiments, 2 x 108 bone marrow cells were labeled as describedw, using 
PBS supplemented with 5% heat-inactivated fetal calf serum, 60 l1g1ml penicillin and 100 
I1g/ml streptomycin as washing buffer. A FACS Vantage (Becton Dickinson, Sunnyvale, 
CAl was used for all cell sorting experiments. After sorting, the purity of the sorted cell 
populations exceeded 95%, unless stated otherwise. Viable cells were counted using a 
BUrker hemocytometer. 
Immunofluorescent labeling for phenotypic analysis was perfOlTIled as described 10,11, 
with the only modification that cells were incubated ill each step for 10 min at room 
temperature (in the presence of NaN3 to avoid antibody internalization) instead of 30 
minutes on ice. In our hands, this modification does not influence staining levels or 
profiles (data not shown). All phenotypic analyses were performed with a FACScan 
cytofluorimeter (Becton Dickinson). 
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Conditioned media 
Conditioned medium of L929 and CJ8/GMIO.l cells was used as a source of M-CSF and 
recombinant GM-CSF, respectively. The CJ8/GMIO.I celliinels was kindly provided by 
Drs. S.Green and J.Karo, Cambridge, GB. Conditioned media were prepared as 
described l9 . 
Enumeration of c%lly-fonning units ill culwre 
CFU-MICFU-GM cllltllre 
The frequency of M-CSF- and GM-CSF-responsive cells in bone maITOW (subsets) was 
assessed in soft-agar cultures. The medium used in these cultures was Iscovc's modified 
Dulbecco's medium (IMDM) with G1utamax-I (Gibco BRL) supplemented with 20% FCS 
(heat-inactivated), penicillin (final concentration 60 Ilglml), streptomycin (100 Ilglml), ~­
mercaptoethanol (IO-4M; ~-ME; Mcrck) and 20% of M-CSF-containing conditioned 
medium or 10% of GM-CSF-containing conditioned medium (which was previously 
assessed to be an optimal concentration for colony formation). The colony assay was 
performed as described ID• After 12-14 days of culture, the number of colonies (2 SO cells) 
was determined by examining the plates using a phase contrast microscope. 
CFU-pre-B cllltllre 
Pre-B cell colonies were grown as described by Lee et a1.20 with some modifications. 
Briefly, a single cell suspension of total or fractionated bone marrow was cultured in 
IMDM with Glutamax-I (Gibco) supplementcd with 60 Ilglml penicillin, 100 Ilg/ml 
streptomycin, IO-4M ~-ME, 1% BSA, 15% FCS, 1.2% (w/v) methy1cellulose (Methocel 
MC, Fluka Chemie, Buchs, Switzerland) and 20 ng/ml mouse IL-7 (R&D Systems, 
Abingdon, UK). IL-7 was shown to induce specifically the formation of pre-B cell colonies 
from fresh bone marrow20. After 6 days of culture at 37"C, 5% CO2 in air, the number of 
colonies (2 50 cells) was counted. 
Cell transfer and analysis of repoplliation 
For analysis of subset differentiation capacity ill vivo, sorted bone marrow cells of 
CS7BL6/Ly5.I-Pep3b mice were injected intravenously into sublethally (7.S Gy) irradiated 
congenic CS7BLlKa BI-J mice (II weeks old), as described by Slieker et aLII. Recipient 
mice were killed I, 2, and 3 weeks after transfer and thymus (week 3) and peripheral 
blood (all time points) were isolated and analyzed for donor-type repopulation by FACS 
analysis ll . Donor-derived reconstitution of the erythroid lineage was analyzed (week 3) by 
detennining the hematocrit using a hematocrit centrifuge. 
Cobblestone al'ea:forllling cell (CAFC) assay 
For frequency analysis of hematopoietic stem cell subsets, sorted bone marrow cells were 
cultured in the limiting dilution-type long-term bone marrow culture as previously 
developed and described by Ploemacher et al. and van der Loo et aI.21 -24• Cultures were 
examined for 5 weeks at weekly intervals for the presence of cobblestone areas 
(hematopoietic clones) using an inverted phase-contrast microscope. 
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Results 
ER-MP58 detects alllllOlplwlogically recogllizable lIIyeloid progellitor cells illlllOllse bOlle 
marrow 
Previously, we found that ER-MP58 is expressed by all M-CSF-responsive cells in mouse 
bone marrow', making this marker of potential interest for the purification of myeloid-
committed cells from the ER-MPIZhiZO- bone marrow subset. Therefore, we analyzed the 
reactivity pattern of ER-MP58 on normal bone marrow cells_ Upon staining of bone 
marrow cells with ER~MP58, we sortcd the bonc marrow into two fractions: one 
characterized by a high ER-MP58 expression (ER-MP58hi; 39 ± 4% of nucleated bone 
man·ow; 11=15; Fig. IA) and one with absent to low level ER-MP58 expression (ER-
MP58-11o), and analyzed their cellular composition on May-Grlinwald/Giemsa-stained 
cytocentrifuge preparations (Table I). The ER-MP58hi bone mallOW fraction appeared to 
be highly enriched for all stages of myeloid cells. The ER_MP58-l1o bone marrow fraction, 
on the other hand, contained virtually no myeloid cells: in this fraction almost all erythroid 
and lymphoid cells were found. Both bone marrow fractions contained blast cells without 
morphological lineage characteristics, with a majority in the ER_MP58-no subset. Thus, 
ER-MP58 distinctively recognizes all stages of myeloid development in the bone marrow. 
These data support the selection of ER-MP58 to purify further myeloid-committed 
progenitors from the ER-MPIZhiZO- bone marrow subset. 
Early M-CSF- or GM-CSF-respollsive cells e.'press the ER-MP58 alltigell predolllillalltly 
at a high level 
To examine ER-MP58 expression on M-CSF- and OM-CSF-responsive cells present in the 
ER-MPIZhiZO- bone marrow subset, bone marrow was triple-labeled with ER-MPIZ, ER-
MP20 and ER-MP58 monoclonal antibodies. Flow cytometric analysis revealed that within 
the ER-MPIZhiZO- bone man·ow fraction, three subfractions could be identified on the 
basis of their ER-MP58 expression (Fig. IC): Z5±8% of the ER-MPIZhiZO- cells had a ER-
Table 1 Morphological analysis of bone marrow subsets sorted on the basis of ER~MP58 expression 
BM subset Myeloid Erythroid Lymphoid Undiff. 
blasts 
Imm. Band + Monocytes Erythro- Polychr. + 
prog. segm. blasts normoblasts 
ER_MP58-1lo 0 3 0 30 27 t8 22 
ER_MP58hi t7 58 t2 2 0 5 6 
For differential cell counts, bone marrow cells were sorted on their level of ER-MP58 antigen expression, spun 
onto microscopic slides and stained with May-GriinwaldlGlemsa. For each fraction 100 cells were counted. Data 
represent the percentage of cells present in the ER-MP58 subsets. No megakaryocytes were found in these 
samples. hnm. prog.: immature myeloid progenitors; band + segm.: band form and segmented granulocytes; 
polychr.: polychromatophilic erythroblasts; undiff. blasts: morphologically undifferentiated blasts. 
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Figllre 1. Cell surface expression of ER-MP58 antigen 
by (A) total nucleated bone marrow cells and by (C) ER-
MP12hi2(J and (D) ER-MP12+2() nucleated bone 
D marrow ceIls (2.4 ± 0.3% (11=9) and 31 ± 7% (11:::10) of 
total nucleated bone marrow, respectively; see (B». Cells 
were triple-labeled with ER-MP58, ER-MPI2 and ER-
MP20 monoclonal antibodies and expression on total 
bone marrow and within the ER_MPI2hi20· and ER-
MPI2+20· subsets was dclennined using a FACS 
Vantage flowcytometer. The negative control is shown as 
a dotted linc. Windows as used for cell sorting arc 
shown. 
MPS8hi phenotype (11=8), 35±3% expressed the ER-MP58 antigen at an intermediate level 
(ER_MP58med) and 40±8% showed no or low level expression of the antigen (ER-
MP58-flo), To examine which of these subfractions contained myeloid progenitor cells, all 
three ER-MP58 subfractions of the ER-MPI2hi20- population were isolated by cell sorting 
and cloned in soft-agar in the presence of the myeloid growth factors M-CSF or GM-CSF. 
Both in M-CSF- and GM-CSF-stimulated cultures, colonies could be grown primarily from 
the ER_MPI2',i20-58hi and, to some extent, from the ER_MPI2hi20-S8m,d subfraction, but 
not from ER-MPI2hi20-58-110 bone marrow cells (Table 2), On the basis of their recovery, 
it was calculated that the large majority of the M-CFC (82-86%) and the majority of the 
GM-CFC (52-66%) reside within the ER_MPI2hi20-58hi bone marrow popUlation, 
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BOlle marrow cells with pre-B cell colol1yjormillg capacity primarily express the ER-MP58 
antigen at all intermediate level 
To test for the presence of cells with the capacity to differentiate along the B cell lineage, 
the ER-MPI2hi20- bone marrow cells were sorted on the basis of their differential ER-
MP58 expression and tested ill vitro in the CFU-pre-B assay. The large majority (87 ± 
10%, 11=3) of the pre-B cell colonies were generated from the ER_MP58med subfraction, 
while only 13 ± 10% originated from the ER-MP58hi subfraction (Table 3). No CFU-pre-
B were found in the ER_MP58-no subfraction. Although the numbers of CFU-pre-B 
differed considerably in the three experiments, the relative distribution over the ER-MP58 
subfractions was consistent. 
Hematopoietic progenitor cells with early reconstitution potential ill vivo express ER-MP58 
at all intermediate level 
To extend the ill vitro results mentioned above, we assessed the early myeloid, B lymphoid 
and erythroid developmental potential of the three ER-MPI2hi20- subfractions ill vivo. For 
this purpose, we transferred the sorted subsets intravenously (Lv.) into 7.5-Gy sublethally 
ilTadiated congenic recipient mice for analysis of repopulation at day 7, 14 and 21 after 
transfer. The repopulating ability of the ER_MPI2hi20-58-/lo subset was tested at day 21 
only, as the data obtained ill vitro from the colony assays (section 3.2 and 3.3) as well as 
data on ER-MP58 expression by primitive hematopoietic stem cells (section 3.6) indicated 
that this subset contains more primitive hematopoietic stem cells, not likely to give 
progeny ill vivo after 1 or 2 weeks. For analysis of repopulation, nucleated peripheral blood 
cells were analyzed for the presence of donor-derived (Ly-5.1+) cells. In addition, the 
percentage of myeloid (Mac-l +) and B (B220+) cells of donor origin was determined 
(peripheral T cell reconstitution cannot yet be determined at these time points; 25 and 
unpublished observations). Seven days after transfer, donor-derived repopulation was stil1 
low for all subsets tested (Table 4). Few myeloid cells, but no B cells of donor origin 
could be detected at this time point. At day 14, a substantial percentage of donor-derived 
cells was found only in mice injected with the ER_MPI2hi20-58med subset (46.6% 
compared to an average of 3.7% after transfer of equal numbers of ER_MPI2hi20-58hi 
bone marrow ce11s). Similar results were obtained at day 21 after transfer: only the mice 
reconstituted with the ER_MPI2hi20-58med subfraction showed substantial donor-derived 
repopulation (40% compared to 9% and 3% found after transfer of equal numbers of ER-
MPI2hi20-58-no and ER_MPI2hi20-58hi cells, respectively). Consequently, at these time 
points donor-derived cells belonging to the myeloid or B cell lineages were found 
particularly after i.v. transfer of ER_MPI2hi20-58mcd cells, and much less after transfer of 
the ER_MP58-no and ER_MP58hi subfractions. To analyze the capacity of the ER-MP58 
subfractions to repopulate the erythroid lineage, the hematocrit of donor-reconstituted mice 
was determined and compared with the hematocrit of non-reconstituted, endogenously 
repopulated mice (Table 4). Erythroid repopulation exceeding endogenous repopulation was 
only found in mice reconstituted with the ER_MPI2hi20-58med sub fraction. Together, these 
data indicate that cells with the capacity to repopulate the myeloid, B lymphoid and 
erythroid lineages ill vivo as early as 2-3 weeks after i.v. transfer reside essentially all in 
the ER_MP58med subfraction of the ER_MPI2hi20- bone marrow subset. 
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Table 2 Presence of M-CSF- and GM.CSF-responsive precursors in ER-MP12hi20- bone marrow 
subfractions sorted on the basis of ER-MP58 expression 
M-CSF-stimulated culture 
BM fraction No. of colonies per % recovery relative 
10' plated cells distribution 
Exp. II II II 
ER-MPI2h'20- all 427 256 100 100 
ER-MPI2h'20- 58-110 -,) _b) 
ER-MPI2"20- 58m'" 250 250 21 40 14% 18% 
ER-MPI2"20- 58" 1600 2000 127 179 86% 82% 
Colonies were determined after 12-14 days of M-CSF- or GM-CSF-stimulated culture. Data are from two 
experiments. The recovery and relative distribution of the CFU-M/-GM in the three ER-MP58 subfractiolls was 
calculated using their frequencies of 34.0 and 22.9% for ER_MP5Shi (experiment I and II, respectively); 36.6 and 
Bone marrow cells with thymus-repopulating ability have the ER-MP5s-110 and ER-
MP58111ed phenotype 
To analyze Ihe capacity of the ER-MP58 subfractions 10 repopulale Ihe T cell lineage, we 
detennined Ihe thymus-repopulaling ability of Ihe ER-MPI2hi2o- 58-no, 58med and 58tli 
subsets in the experiments described in the previous section. At 21 days after transfer, 
thymuses were analyzed for donor-derived (Thy-1.2+) repopulation (Table 5). Cells with 
Ihymus-repopulating ability appeared 10 be restricted to Ihe ER_MP58-no and ER_MP58m,d 
subfractions. No donor-derived thymus-repopulation was observed in mice injected with 
ER-MPI2"'20-58"i cells. Comparing Ihe experiments in which 5000 cells per mouse were 
injected, the highest frequency of Ihymus-repopulating cells was found in Ihe ER-
MPI2"i20-58med subfraclion (53% of all mice reconsliluled versus 23% of all mice given 
ER-MPI2"'ZO-58-no cells). 
Primitive hematopoietic stem cells are ER-MP58 negative/low 
We also investigated the expression of the ER-MP58 antigen on various hematopoietic 
stem cell subsets in vitro. For this purpose, the stem ceH content of bone malTOW fractions 
sorted on Ihe basis of differenlial ER-MP58 expression was delennined using Ihe CAFC 
assay, a limiting dilution-type long-telm bone marrow culture. Previously we demonstrated 
that bone marrow stem ceUs represent a heterogeneous population of cells residing in both 
the ER-MPI2"'20- and ER_MPl2med20- bone marrow subsets t2• Hence we chose 10 
combine Ihese Iwo bone man-ow subsets (further denoled as ER-MPI2+20-) and usc Ihe 
combined popUlation as the starting-population for cell sorting on the basis of differentiai 
ER-MP58 expression. The expression of the ER-MP58 anligen wilhin Ihis ER-MPI2+20-
subset is shown in Fig. ID. An average of 6 ± 3% (n=7) of Ihe ER-MPI2+20- cells 
expressed Ihe ER-MP58 antigen al a high level (ER-MP58"'). The olher 94 ± 3% was 
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Table 2 Presence of M-CSF- and OM-eSF-responsive precursors in ER_MPI2hi20- bone marrow 
subfractions sorted on the basis of ER-MP58 expression (continued) 
OM-eSF-stimulated culture 
BM fraction No. of colonies per % recovery relative 
10' plated cells distribution 
Exp. II II II 
ER-MPl2hi20- all 283 300 100 100 
ER-MP12hi20- 58-110 -,j 3 0.4 0.3% 
ER-MP12hi20- 58moo 375 417 48 57 34% 48% 
ER-MPI2h'20- 58h' 767 800 92 61 66% 52% 
40.7% for ER_MPSSffiCi.I (exp. I and II, respectively) and 29.4 and 36.6% for ER_MP5S--llo (exp. I and II. 
respectively). a) Less than I in 7500 plated cells; b) less than I in 6000 plated cells; c) less than I in 2100 
plated cells. 
characterized by absent or low level ER-MP58 expression (denoted ER_MP58-nO). These 
two subfractions were sorted and tested in the CAFC assay. Primitive CAFC, which give 
rise to cobblestone areas at day 28/35 of culture, were exclusively found in the ER-
MP58-flo fraction (Fig. 2A). These primitive CAFC-d28/35 have been shown to correspond 
with cells with long-term repopulating ability (LTRA) ill viv021-24, Less primitive CAFe, 
i.e. stem cells giving rise to cobblestone areas at day 7110 of culture were enriched in the 
Table 3 Presence of CFU-pre-B in ER_MP12hi 20- bone marrow subfractions sorted on the basis of 
ER-MP58 expression 
BM fraction No. of colonies per % recovery relative distribution 
105 plated cells 
Exp. II III II JII II JII 
ER_MP12h'20- all 250 10 50 100 100 100 
ER-MPl2hi20- 58-110 -,j _b) _b) 
ER-MPl2hi20- 58moo 1350 67 150 198 273 105 94% 92% 76% 
ER-MPl2hi20- 58hi 100 10 80 14 23 33 6% 8% 24% 
Colonies (>50 cells) were determined after 6 days of IL-7-stimulated culture. Data are from tlm.."'e independent 
experiments with 2 dishes per group. Variability in CFU-pre-B assay has also been reported by others32.3-1. 
Recovery and relative distribution of CFU-pre-B was calculated as described in legend of Table 2. In the third 
experiment 20.8% of the ER_MPI2hi20- cells were ER-MP58h\ and 34.9% ER_MP58med• a) Less than one in 
3000 plated cells; b) Less than one in 10-1 plated cells. 
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Table 4 Early peripheral blood repopulation in (he myeloid, B, and erythroid lineages after Lv. 
reconstitution with sorted ER_MPI2hi20- bone marrow subfractions 
BM subfraction Days after Lv. 
transfer 
7') 
14') 
21 d) 
7 
14 
21 
7 
14 
21 
7 
14 
21 
none (irradiation control)h) 21 
No. of cells 
injected 
20000 
20000 
10000 
_0 
5000 
20000 
20000 
5000 
20000 
20000 
5000 
% donor-derived 
cells:!) 
1.6 ± 0.7 
28.9 ± 11.0 
75.6 ± 14.5 
8.8 ± 3.4 
1.0 ± 0.6 
46.6 ± 11.3 
39.9 ± 7.2 
1.7 ± 1.3 
3.7 ± 3.3 
2.9 ± 2.9') 
C57BUKaBl-I (Ly-S.2. Thy-l.1) recipient mice were sublethally irradiated (7.5 Gy) and injected i.v. with bone 
marrow cells of C57BLl6-Ly-S.I-Pep3b (Ly-5.1, Thy-1.2) mice. Injected cell numbers were chosen on the basis 
of earlier transfer experiments involving the total ER-MPIZhI20· bone marrow subset (II and unpublished data). 
Peripheral blood chimerism was analyzed 7, 14 and 21 days after celliransfer. a) Data are the means ± SD. 
b) Results are from two experiments with 13 to J7 mice analyzed in total per group, except for tht! irradiation 
ER_MP58hi subset. For such CAFC a high correlation wiIh CFU-S-7112 has been 
reporled21 -24. These CAFC-d7110 were also present in the ER_MP58-flo subset. Considering 
the frequencies of the ER-MP58 subfractions within the ER-MPI2+20- bone marrow 
population, our data show that about half of the less primitive CAFC were recovered from 
this ER-MP58-flo subfraclion (Fig. 2B). In conclusion, all primitive hematopoietic stem 
cells as well as part of the more mature stem cells do not, or only at a low level, express 
the ER-MP58 antigen. 
Discussion 
In this study we searched for cell surface markers allowing the separation of myeloid-
committed cells from other hematopoietic progenitor cells in mouse bone marrow. 
Previously we generated a panel of monoclonal antibodies against immortalized 
macrophage progenitor cells from mouse bone marrow (reviewed in 9). With two of these 
monoclonal antibodies, ER-MPI2 and ER-MP20, we previously identified a bone marrow 
popUlation (ER-MPI2hi20-; about 2% of nucleated bone marrow) containing various 
classes of hematopoietic progenitor cells, including the earliest M-CSF-responsive 
cells JO•12 Here we report that early myeloid-committed cells can be separated from other 
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Table 4 Early peripheral blood repopulation in the myeloid, B, and erythroid lineages after Lv. 
reconstitution with sorted ER_MPI2hi20- bone marrow subfractions (continued) 
% myeloid cells (Mac-I+) 
of donor original 
2.7 ± 0.6 
44.6 ± 14.1 
75.6 ± 14.5 
37.9 ± 28.4 
3.6 ± 2.4 
69.6 ± 13.8 
73.6 ± 15.8 
1.7 ± 0.4 
8.0 ± 7.1 
11.4 ± 10.3 
% B cells (B220+) of donor 
original 
ND') 
64.3 ± 15.1 
52.7 ± 10.8 
19.7 ± 7.4 
ND 
67.3 ± 3.0 
54.8 ± 9.2 
ND 
2.2 ± 1.2 
6.8 ± 4.7 
erythroid repopulation 
(hematocrit)b) 
40 ± 3 
10 ± 8 
41 ± 3 
14 ± 6 
14 ± 9 
control group (11=3). Data are the means ± SD, c) Results are from 3 mice analyzed per group. d) Results are 
from one experiment out of two with similar results, with 7 or 8 mice analyzed per group. c) ND: donor B cells 
were not detectable at this time point. 0 Not tested. g) Percentages are based on 5 donor-repopulated mice out 
of7 injected; in the other groups all recipient mice \vere repopulated. h) These mice were used to determine the 
endogenous erythroid repopulation. 
Table 5 Thymus-repopulating ability of ER_MPI2hi20- bone marrow subfractions sorted on the 
basis of ER-MP58 expression 
BM fraction No. of cells No. of positive mice! % donor-derived 
injected total No. of micea) thymocytesb) 
ER-MPI2hi20- all 10000 10114 47 ± 10 
ER-MPI2hi20- 58-110 5000 3/13 44 ± 15 
10000 113 42 
ER_MP12hi20- 58moo 5000 9117 40 ± 11 
ER_MPI2hi20- 58hi 5000 0/13 
10000 0/4 
C57BUKaBI-1 (Ly-5.2, Thy-LJ) recipient mice were sublethally irradiated (7.S Oy) and injected Lv. with bone 
marrow cells ofCS7BU6.Ly-S.l-Pep30 (Ly-S.I, Thy-I.2) mice. Thymus reconstitution was analyzed 21 days after 
cell transfer. Results arc pooled data from two experiments with similar results. a) Thymus suspensions with ~ 
I % donor-derived thymocytes were scored as positive. oj Data are the mean ± SEM. 
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Figure 2. CAFe frequency and recovery in hone marrow subsets sorted on the basis of ER+MP58, ER-MP12 and 
ER·MP20 expression. In (A) the frequency of CAFe in the ER-MPI2+20-SS--/lo and ER_MP12+20-SShi 
subfractions is expressed as percentage of the CAFe frequency in the tolal ER-MPI2+20- starting-population. 
In (8) the recovery of CAFe is shown. (0) ER·MPI2-t20- (starting-population), (.8) ER-MP12+2o-5S--llo, (0) 
ER-MP12+20-SShi bone lllarIOW subsets. Data represent the mean of two experiments. 
hematopoietic progenitor and stem cells residing in the ER-MP12hi20- bone malTOW 
population on the basis of their high level ER-MP58 expression. This conclusion is based 
on functional data obtained ill vitro and ill vivo. M-CSF- and GM-CSF-responsivc cells 
were predominantly found in the subpopulation of ER-MP12hi20- cells with a high level 
ER-MP58 expression (at average 84% and 59% of all recovered M-CFC and GM-CFC, 
respectively). On the basis of this high ER-MP58 expression, these myeloid precursors 
could be separated from the large majority of cells with the capacity to develop along the 
B cell lineage (ER_MP58mcd), along the T cell lineage (ER_MP58-no or ER_MP58mcd), and 
along the erythroid lineage (ER_MP58med). Primitive hematopoietic stem cells (CAFC-
d28/35) were not found among cells with high level ER-MP58 expression. 
For cells with myeloid differentiation potential, our data indicate that ER-
MP12hi20-58med cells are less mature than ER_MP12hi20-58hi cells. This is suggested by 
the different distribution of MCFC versus GM-CFC in the ER-MP58hi and ER_MP58mcd 
subfractions (see Table 2). Furthermore, our finding that differentiation capacities for all 
hematopoietic lineages were contained in the ER-
MP58med sUbpopulation suggests the presence of multi potent stem cells within this fraction. 
An indication that such multipotent cells indeed were present in the ER_MP58med 
subpopulation was obtained from the CAFC data: part of the less primitive CAFC-d711 0, 
correlating with CFU-S-d 12 22 i.e. multipotent stem cells with short-tenn repopulating 
ability ill vivo, are characterized by a negativellow to intermediate ER-MP58 expression. 
A seemingly contradictory finding was that the ER_MP12hi20-58hi subset did not give 
rise to substantial donor-derived myeloid repopulation upon transfer into irradiated 
recipients, while the majority ofER-MP12hi20- myeloid-committed cells (M-CFC and GM-
CFC) are present in this particular subpopulation. However, this finding is in accordance 
with a recent report showing that committed progenitors do not contribute to early 
hematopoietic reconstitution of irradiated recipients26. In earlier studies the role of 
committed progenitors in repopulation ill vivo had already been questioned by Harrison et 
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Figure 3. Schematic representation of ER-MP58 antigen expression during bone marrow hematopoiesis as 
detemlined in the present study. For clarity, the overlap between the hematopoietic subsets is not taken into 
account. X: progenitors conmliUed to other than myeloid lineages and/or multi-potent progenitor/stem cells. 
al. and Uchida et al., as these autors demonstrated that multiline age precursors, and Thy-
1.1IoLin-Sca-l + hematopoietic stem cells are capable of early hematopoietic repopu-
lation27,28. It has been suggested that committed progenitors cannot contribute significantly 
to lineage reconstitution28 because they are limited in the number of cell divisions they can 
underg029. Alternatively, committed progenitors may be less efficient than stem cells in 
homing to the bone marrow upon Lv. transfer, and thus lack the appropriate micro-
environment to produce mature blood cells28 . In summary, our data on repopulation ill vivo 
show that the ER_MPI2hi20-5Shi myeloid-committed progenitor population is not 
contaminatcd by multipotent stem cells. 
The ER-MPI2hi20-5S-1I0 subset gave only limited repopulation of the myeloid, Band 
T cell lineage ill vivo, and no CFU-C (unpublished data), CFU-M, CFU-GM, or CFU-pre-
B activity ill vitro. This subset probably contains morc primitive hematopoietic stem cells 
that ill vitro need additional growth factors, while ill vivo a time-period exceeding 3 weeks 
is required to allow substantial peripheral repopulation. This possibility is supported by our 
finding that the most primitive stem cells in the ER-MPI2+20- subset are found in the ER-
MP5S-1I0 subfraction. 
To our knowledge, ER-MP5S is the only marker at present which differentiates between 
early myeloid-committed cells and other hematopoietic progenitor and stem cells in mouse 
bone marrow. Recently, Trevisan and Iscove5 reported phenotypic similarity of progenitor 
cells detected in a variety of short-tern! assays (CFU-multi, CFU-E/Meg, CFU-G/M, as 
well as short-term repopulation ill vivo) for the expression of H-2K, CD45, AA4.1, HSA, 
CD71 and the lineage markers B220, Mac-I, Gr-l and CDS. Tins indicates that none of 
these markers allows for separation of myeloid-committed progenitor cells from other 
hematopoietic activities. In addition to the markers mentioned above, the macrophage 
marker F4/S0 cannot be used for identification of myeloid-committed progenitor cells 
either, as bone marrow M-CFC do not express this antigen30. Recently, Antica et al.31 
reported that Linihy-IloHSA+Sca-2+ progenitor cells have the capacity to differentiate 
into the Band T and myeloid lineages. Thus, Sca-2 does not discriminate between early 
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myeloid and lymphoid progenitors either. So far, ER-MP58 seems to be the earliest 
expressed marker useful for identification and purification ofmycloid~committed cells from 
mouse bone marrow. 
The molecular identity of the ER-MP58 antigen is as yet unknown. Clearly, ER-MP58 
is distinct from commonly used myeloid markers as Mac-I, F4/80 and Or-I. The finding 
that high level ER-MP58 expression coincides with myeloid commitment might refiect a 
role for the ER-MP58 antigen in myeloid differentiation. However, support for this notion 
awaits the characterization of the ER-MP58 antigen. 
In Fig. 3, a schematic representation of ER-MP58 antigen expression during hemato-
poietic differentiation in bone marrow is shown, summarizing the presently available data. 
While ER-MP58 is not or only faintly expressed on primitive hematopoietic stem cells, it 
is transiently expressed at an intcnnediate level during differentiation and maturation into 
the erythroid and lymphoid lineages. More mature erythroid and lymphoid cells are again 
characterized by a negative to low expression of this marker. In contrast, commitment to 
the myeloid lineage coincides with upregulation of ER-MP58 expression. with a continued 
high level of ER-MP58 on the most mature stages of myeloid development in bone 
marrow. Upon further maturation of monocytes into tissue macrophages, expression of ER-
MP58 is downregulated again8•9. 
We would like to thallk Tar mil OJ fl.lr preparation of the figllres alld loop Brandenburg for animal care. This 
Jtudy was slIpported by The Netherlands Orglllliwtionfi1r Scientific Re.wlrch (NWO). grallt 90/-05-253. 
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Abstract 
The lineage relationship of dendritic cells (DC) with other hematopoietic cell types has been 
extensively studied. So far, evidence in support of three distinct DC lineages has been reported. 
These are a myeloid, a lymphoid and a separate DC lineage. Previously we have generated two 
monoclonal antibodies, ER-MPI2 and ER-MP20, which in two-color flow cytometry identify 
different maturation stages of M~CSF-responsive myeloid precursors. In the present study we 
examined in which of the ER-MP12120 bone marrow subsets OM-eSP-responsive DC 
precursors are present. For this purpose, ER-MP12120 bone marrow subsets were isolated using 
a cell sorter and cultured for 14 days in the presence of rGM-CSF. In these cultures DC 
development was assessed on the basis of morphology and MHC class II expression. At day 
3 of culture, DC-like cells were exclusively f.resent among the cells growing from the ER-
MPI2+20+ (myeloid blasts) and ER-MPI2-20 ' (monocytes) bone marrow subsets. From day 
6 onwards, DC-like cells were also found among cells grown from the ER-MP12hi20- subset 
(consisting of early blast cells). No DC-like cells could be grown from the ER_MPI2m,d20-, 
ER-MPI2-20-, and ER_MPI2-20med bone marrow subsets, which consist of lymphoid, erythroid 
and granUlocytic cells, respectively. Thus, DC precursors reside in the same ER-MP12120-
defined bone marrow subsets as macrophage precursors and are not found in the subsets 
containing the morphologically identifiable precursors for the other hematopoietic lineages. In 
addition, the difference in time of appearance in culture between DC grown from the ER-
MP12hi20- versus the ER-MP12+20+ and ER_MPI2-20hi bone marrow subsets suggests that DC 
precursors from the ER_MP12hi20- subset are more immature than those from the other two 
bone marrow subsets. Tlus is similar to the difference in maturation stage we previously 
reported for the ER-MP 12!20-defined macrophage precursors. To approach the question whether 
DC share precursors with macrophages all along this ER-MPI2/20-defined pathway, bone 
Illarrow subsets were first cultured for four or five days in the presence of M-CSF to induce 
development along the macrophage lineage. Subsequently the capacity of these M-CSF-derived 
cells to generate DC-like cells was tested in GM-CSF-stimulated cultures. We found that cells 
with the capacity to differentiate into DC-like cells are still present in the day 4 to 5 M-CSF-
stimulated cultures. So far, the data obtained from these cultures support a common ER-
MPI2!20-defined developmental pathway for DC and macrophage precursors. In addition, our 
data suggest that macrophages and DC-like cells are derived from a common precursor 
population till at least the monocytic bone marrow stage. 
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Introduction 
Dendritic cells (DC) are bone marrow-derived cells that have the unique capacity to initiate 
a primary immune response by efficient antigen presentation to naive T cells I , The 
dendritic cell system is widely distributed throughout the body and comprises Langerhans 
cells in the skin, veiled cells in the lymph, interdigitating cells in the lymphoid organs and 
interstitial DC in the connective tissue of non-lymphoid organs2 , Many studies have 
addressed the lineage relationships of DC with other hematopoietic lineages, Three possible 
origins for DC have been suggested, which may exist next to each other. First, a 
considerable amount of experimental data supports a myeloid origin of DC (reviewed by 
Peters et a1. 3, Lutz et a1 4 , Thomas and Lipsky\ DC have been generated ill vitro from 
different stages of myeloid development, ranging from early common progenitors for DC, 
granulocytes and macrophages in bone marrow to monocytes in peripheral blood3,6-10, In 
these experiments, the generation of DC from precursors was dependent on the presence 
of GM-CSF in the cultures. Second, several studies report on a lineage relationship 
between DC and lymphoid cells, Common progenitor populations for DC and lymphoid 
cells have been identified in bone marrow and thymusll - 16. In these studies, no direct 
evidence was given for the existence of a common muItipotent progenitor cell for T, DC, 
NK and B cells in either the thymic or bone marrow progenitor populations, due to a lack 
of suitable clonal assays, So far, only a common multi potent BINKlDC progenitor could 
be demonstrated 14. Yet, a recent study on mouse thymic DC precursors strongly suggests 
the existence of a common precursor of DC and T cells, next to myeloid-related DC, with 
CD8u as a marker of the lymphoid-related DC lineage", Apart from the reported lineage 
relations with the myeloid and lymphoid lineages, a third possibility is that DC originate 
from a separate progenitor. In GM-CSF- and TNF-a-stimulated human bone marrow 
cultures, progenitor cells distinct from CFU-OM have been detected that give rise to pure 
DC colonies in culture (CFU-DC)17, The DC generated in such colonies resembled 
epidennal DC17 . In addition, a separate precursor giving rise to Birbeck granule-positive 
DC has been detected in liquid cultures of human bone marrow and cord blood9,IS, 
Together, these data are suggestive of the existence of a separate DC precursor for epi-
dermal Langerhans cells I8,19. 
In our studies on the early differentiation of the mononuclear phagocyte system in the 
mouse, we have previously generated two monoclonal antibodies, ER-MPI2 and ER-
MP2020, which in two-color flow cytometry identify different maturation stages ofM-CSF-
responsive macrophage precursors. We showed that the most immature ER_MP12hi20-
macrophage precursors develop via the ER-MPI2+20+ stage into ER-MPIT20h; mono-
cytes21 . Thus, in mouse bone marrow, development along the macrophage pathway is 
characterized by upregulation of ER-MP20 followed by dOlVnregulation of ER-MPI2 
antigen expression. The ER-MP12+20+ bone marrow subset consists mainly of myeloid 
precursors (about 80% of the cells express Or-I, unpublished observation), while the ER-
MPI2-20h; subset consists ofmonocytes22 , The early ER-MPI2h;20- progenitor popUlation, 
however, was found to contain also cells with B, T, and erythroid differentiation capacities 
as well as hematopoietic stem cells23,24, Using a third cell surface marker, ER-MP58, we 
recently described that based on a high expression of ER-MP58 myeloid-committed cells 
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can be separated from all other hematopoietic capacities present in the ER-MPI2h;20-
subset (ER_MP58-no or ER-MP58n"d)". 
In the present study we questioned in which of the ER-MPI2120/58-defined bone 
marrow subsets GM-CSF-responsive DC progenitors reside. For this purpose, bone marrow 
was fractionated by cell sorting on the basis of differential ER-MP 12120/58 antigen 
expression and the subsets were cultured in the presence of GM-CSF. After various periods 
of time, cultures were examined for the presence of DC-like cells by microscopic 
inspection of cellular morphology and immunocytochemical analysis of MHC class II 
expression. In addition, we asked till what ER-MPI2120-defined stage of development, 
DC-like cells can be derived from macrophage progenitors. To tltis end, sorted bone 
marrow subsets were cultured in the presence of M-CSF to induce development along the 
macrophage lineage. After four to five days of culture the stimulant was changed to GM-
CSF and the capacity of the ill vitro generated macrophage precursor cel1s to give rise to 
DC-like cells was determined. Our data support a similar ER-MPI2120/58-defined 
maturation pathway for DC and macrophage precursors in mouse bone marrow. In 
addition, our data are suggestive of a common progenitor of macrophages and DC till at 
least after the bone marrow monocytic stage. 
Materials and Methods 
Mice 
Female C57BL6ILy-5.1-Pep3b mice between II and 13 weeks of age were used in this 
study. Animals were specific pathogen free, and were kept with free access to food and 
water. 
Monoclonal antibodies alld conjugates 
In this study the following monoclonal antibodies were used: ER-MPI2 (anti_CD31)20.25, 
ER-MP20 (anti_Ly_6C)20.26, ER-MP58 20,,,; M5/l14 (anti-MHC class II)27. Antibodies were 
used either as undiluted culture supernatants (M5/114) or purified and conjugated to FITC 
(fluorescein isothiocyanate, isomer I, Sigma Chemical Co., St. Louis, MO; ER-MP20) or 
biotin (N-hydroxysuccinintidobiotin, Boehringer Mannheim GmbH, Mannheim, FRG; ER-
MPI2). As second stage fluorescent reagents were used R-Phycoerythrin-conjugated or Tri-
Color-conjugated streptavidin (SAV-PE and SAV-TC, respectively; Caltag Laboratories, 
San Francisco, CAl, and R-phycoerythrin-conjugated goat-anti-rat IgG (mouse-absorbed; 
GaRa-PE; Caltag Laboratories). 
Cell suspensions 
Single cel1 suspensions of bone marrow, isolated from femora and tibiae, were prepared 
as described previously21.22. Cultured bone marrow cells were isolated from teflon culture 
bags (adherent as well as non-adherent cells) or from culture dishes or plates (non-adherent 
cells). Cells were washed in phosphate-buffered saline (PBS) supplemented with 5% fetal 
calf serum (FCS; heat inactivated), 60 "glml penicillin, and 100 "g/ml streptomycin when 
sterile suspensions were required. Prior to phenotypic analyses, cultured cel1s were washed 
102 Chapter 6 
with PBS supplemented with 0.5% (v/v) bovine serum albumin (BSA, Organon Teknika, 
Boxtel, The Netherlands) and 20mM sodium azide. 
Cell sorting and flow cytometric analysis 
For cell sorting, bone marrow cells were labeled with two (ER-MPI2 and ER-MP20) or 
three (ER-MPI2, ER-MP20, and ER-MP58) monoclonal antibodies as described pre-
viously21,22, Prior to cell sorting. cell suspensions were filtered over a 30 11m sieve 
(Polymon PES, Kabel, Amsterdam, The Netherlands) to avoid clogging of the nozzle. A 
FACS Vantage equipped with Lysis II software was used for cell sorting (Becton 
Dickinson, Sunnyvale, CAl. After sorting, the purity of the cell suspensions was checked 
by fe-running sorted samples. Purity exceeded 95%, unless stated otherwise. Suspensions 
were kept at 4°C throughout the staining and sorting procedure. Sorted ce1ls were counted 
in a Blirker hemocytometer. 
For flow cytometric analysis, samples of cultured cells (~ 2 x 104 cells) were pi petted 
into 96-microwell plates (round bottom, Nunc, Denmark) and labeled with antibodies as 
described before21 . Samples were analyzed on a FACScan flow cytometer using Cell Quest 
analysis software (Becton Dickinson). 
111l1ll111l0cytochemistl), all poly-L-lysille-coated slides 
For immunocytochemical analysis, aliquots of cultured cells were placed at 37"C, 7% CO2 
in air for one hour to adhere to poly-L-lysine coated microwell slides (Nutacon, Schiphol-
Oost, The Netherlands). Next, cell preparations were gently washed once with PBS (37"C), 
fixed in 1% paraformaldehyde in PBS for 10 minutes at RT, and washed twice with PBS 
and once with PBS supplemented with 0.5% BSA. Cells were incubated with primary 
monoclonal antibody, followed by rabbit anti-rat IgG conjugated to horseradish peroxidase 
(HRP; Jackson ImmunoResearch Laboratories, Inc., Pennsylvania, USA)(both incubations 
30 minutes, RT). Diaminobenzidine (DAB, Sigma, St.Louis, MO, USA) was used as 
substrate for the HRP. Between incubations, ce11 preparations were washed in PBS 
supplemented with 0.5% (v/v) Tween-20. After the DAB reaction was completed (3-5 
minutes, RT), the cell preparations were dehydrated and coverslipped using Entallan 
(Merck, Dannstadt, Germany). Antibody reactivity was detennined under a light 
microscope. Culture supernatant of the Y3 myeloma followed by the second stage antibody 
was used as negative control. 
Growth factars 
Conditioned medium of LADMAC cells28 was used as a source of mouse M-CSF. 
Conditioned medium was prepared as described elsewhere'9. Recombinant mouse GM-CSF 
(rGM-CSF) was a kind gift of Dr. R. Coffman (DNAX Research Institute of Molecular 
and Cellular Biology, Palo Alto, CAl. 
rGM-CSF- alld M-CSF-stillllllated bOlle IIUI/TOW clIltllres 
Dendritic cells were generated by culturing total bone marrow or isolated subsets in 100 
mm petri dishes or 24 well plates (Nunc) in DMEM supplemented with 5% FCS (heat 
inactivated; 0.22flm filtered), 60 flg/ml penicillin, 100 flg/ml streptomycin, and 20 ng/ml 
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rGM-CSF. Cells were cultured at 37" C, 7% CO, for various periods of time, up to 14 
days. 
Bone marrow-derived macrophages were generated by culturing total bone marrow or 
isolated subsets in Teflon culture bags30 in IMDM (with glutamax I; Gibco) supplemented 
with 20% FCS (heat inactivated; 0.22 11m filtered), 15% LADMAC-conditioned medium 
as a source of M-CSF, lOAM p-mercaptoethanol, 60 l1g1ml penicillin, 100 l1g1ml strepto-
mycin. Cells were cultured for 4 or 5 days at 37"C, 7% CO,. 
Results and Discussion 
DC precursors reside within the same ER-MP12120 bone marrow subsets as precursors 
of the lIIaclVphage Iilleage 
To examine in which ER-MPI2/20-defined bone marrow subset(s) DC precursors reside, 
bone marrow was labeled with ER-MPI2 and ER-MP20 monoclonal antibodies (Fig. I) 
and fractionated into 6 subsets using a cell sorter. 11le sorted subsets were cultured with 
GM-CSF in 24-well plates. After 3, 6, 10 and 14 days of culture, the development of DC-
like cells was evaluated by examining the plates under an inverted light microscope (Table 
I). At all time points tested, developing macrophages (from round non-adherent precursors 
to spindle shaped or round adherent cells) were the predominant cell type present. At day 
3 of culture, DC-like cells (non-adherent round cells with cytoplasmic processes/veils) 
were observed only in the cultures of the ER-MPI2+20+ and ER-MP12-2o"i bone marrow 
subsets. At day 6, few DC-like cells started to appear among cells grown from the ER-
MP12hi20- subset. By days 10 and 14, DC-like cells were clearly visible in cultures de-
% of cells in window 
1 2.1 4 5.7 
2 36.8 5 23.0 
3 28.6 6 3.7 
ER-MP20 
Figure 1. Dot plot ofER-MP12/20-labeled nucleated bone marrow cells. Upon double labeling of bone marrow 
cells with these monoclonal antibodies, six distinct subsets can be discerned. Gates used for cell sorting are 
shown. Percentages are the mean of five experiments. 
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Table 1 DC-like cells generated from ER-MP12120 bone marrow subsets 
BM subset Overall cell DC·like cells % of MHC Ir-+ cells with DC 
growth') visible in cultureb) morphology (immunocytochemistry) 
day 3 day 6 day 10 day 14 day 6 day 10 day 14 
Exp. II II II 
ER-MPI2hl2o- + ± + + 6 ND') 15 9 13 NO 
ER-MPI2mN20' 
ER·MPIZ--2o-
ER-MP12+20+ + + + + + 20 43 16 NO 18 NO 
ER-MP1Z-20""-..t 
ER-l-.fP12-20"i + + + + + 23 26 40 33 ND ND 
TBM + + + + + 19 NO 23 NO 28 NO 
3) During entire culture. bl Results are for both experiment I and II, as they were identica1. c)ND: not enough 
cells present on the poly-L-Iysine coaled slides to dctcnrune percentage MHC II positive cells. 
rived from this subset. No DC nor other cell types could be grown from the ER-
MPI2""dZO-, ER-MPI2-20- and ER-MPI2-20m,d subsets. These bonemalTow subsets 
consist of morphologically identifiable cells of the lymphoid, erythroid and granulocytic 
lineage, respectivc1y21.24, 
At days 6, 10, and 14, cultures were also examined for the presence of DC-like cells 
by assessing MHC class II expression in immunocytochemistry. Cells with high level 
MHC class II expression and typical DC morphology were scored as DC-like cells (see 
Fig. 2). At day 6, the frequency of DC in the ER-MP12hI20- culture was lower than that 
in the ER-MPI2+20+ and ER-MPI2-Z0hl cultures (an average of 6% versus 33% and 25%, 
respectively), analogous with the results from visual examination of the cultures. At days 
10 and 14, the frequency of DC-like cells in the ER-MPl2hi20~ subset had doubled (from 
6% to 12 and 13%, respectively), but was still lower than that in the ER-MPI2+20+ (16 
and 18%) and ER-MP12~20hi (at average 37% at day 10) subsets. 
Our results show that OM-CSF-responsive DC precursors reside in the same ER-
MPl2/20-defined bone marrow subsets as M-CSF-responsive macrophage precursors, i.e. 
ER-MPI2hIZO~, ER-MP12+20+ and ER-MPI2-2o"' 21 and are not found in the subsets 
containing morphologically identifiable precursors for the other hematopoietic lineages. In 
addition, the difference in time of appearance in culture between DC-like cells grown from 
the ER-MPI2hIZO- versus the ER-MPI2+20+ and ER-MPI2~2o"' bone marrow subsets 
suggests that ER-MPI2hI 20- DC precursors are less mature than ER-MPI2+20+ and ER-
MP12~2o"l DC precursors. This notion was supported by the difference in proliferative 
capacity of these three subsets. OM-CSF-stimulated culture of the distinct subsets in semi 
solid medium demonstrated that from the ER-MP12hIZO~ subset predominantly large 
colonies were generated, while from the ER-MP I 2+20+ subset predominantly clusters and 
some smaller colonies were grown. From the ER-MPIT2o"' subset primarily small clusters 
were generated (data not shown). Thus, the proliferative potential of the OM-CSF-respon-
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Fig/lre 2. Immunocytochemical anal}sis of MHC class II expression on cells obtained from day 6 GM-CSF-
stimulated cultures. DC-like cells (high level class II expression and typical dendritic morphology) from cultures 
grown from (A) ER-MP12hi20-, (B) ER-MPI2t20+' and (C) ER-MP12-2<fl bone marrow cells are shown. 
Macrophages were also present in the cultures (arrow) and differed from DC-like cells in morphology and class 
11 expression (lower levels). Magnification x 590. 
sive cells, as indicated by the sizes of the colonies/dusters formed, is the highest among 
ER-MPI2hi20- cells and the lowest among ER_MPI2-20hi cells. Together, our data suggest 
that GM-CSF-responsive bone marrow DC precursors follow a similar ER-MPI2!20-
defined developmental pathway as macrophage precursors, with the order ER-MPI2hi20-
-7 ER-MPI2+20+ -7 ER-MPI2-2ohl. 
ER-MP121d2o- DC precursors show high level e,'pressioll of ER-MP58 
Previously we showed that the majority of ER-MPI2hi20- early myeloid-committed cells 
can be purified from the other hematopoietic differentiation capacities present in this subset 
on the basis of differential expression of a third marker, ER_MP5822, Since we found that 
DC could also be generated from the ER-MPl2hi20- bone marrow subset, we examined 
the ER-MP58 expression by these early DC precursors. For this purpose ER-MPI2hi20-
bone marrow cells were fractionated according to their level of ER-MP58 expression and 
cultured in the presence of GM-CSF. Cultures were examined by microscope for the 
presence of DC-like cells at days 5, 7 and 14. DC-like cells could only be detected in 
cultures of the ER-MP58hi subset, starting from day 7 (Table 2). This onset of DC 
appearing in culture is similar to what is observed when the total ER-MPI2hi20- subset 
was cultured (see above). No DC-like cells could be grown from the ER-MP58m'd and ER-
MP58-no subsets under these culture conditions. Together, these data show that, like 
macrophage precursors, GM-CSF-responsive DC precursors present in the ER-MPI2hi20-
bone marrow subset are characterized by a high level ER-MP58 expression. 
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Table 2 DC-like cells generated from ER_MP12:hiZO- bone marrow subsets 
8M subset Overall cell growlhJ) DC-like cells visible in culture 
day 5 day 7 day 14 
+ + + 
a) During entire culture. h) From this subset only mncrophagcs and immature cells were generated. 
BOlle marrow progenitors maturing along the macrophage lineage ill vitro maintain the 
capacity fa generate DC 
To approach the question whether macrophagcs and DC share progenitors throughout their 
bone marrow development. or, alternatively, follow a phenotypically similar, parallel 
developmental pathway, we set out to culture'the ER-MPI2ni20- bone marrow subset 
sequentially with M-CSF ("primary culture") and GM-CSF ("secondary culture"). In these 
cultures, M-CSF-responsive precursor cells arc first induced to develop along the 
macrophage lineage ill vitro2l , The potential of these macrophage precursors to form DC-
like cells was then assessed by changing the growth stimulus to GM-CSF. After 4 days 
of M-CSF-stimulated liquid culture of the ER-MP58hi subset of ER-MPI2h;20- bone 
marrow cells, about 90% of the cultured cells expressed the ER-MP20 antigen (Fig. 3A), 
confirming ill vitro development along the macrophage Iineage21 , Changing the growth 
stimulus at this point to GM-CSF resulted in the appearance of DC-like cells in culture 
only I day later (Table 3). Apart from DC-like cells, macrophages (spindle-shaped or 
round plastic adherent cells) also developed in these cultures. After 9 days of GM-CSF-
stimulated secondary culture, 28% of the cells expressed MHC class II molecules at a high 
level and had typical DC morphology, as determined in immunocytochemistry (Table 3, 
Fig. 3A). Thus, ER-MPI2h;20-58h; bone marrow cells developing for 4 days along the 
macrophage lineage in an M-CSF-stimulated culture still have the potential to generate 
DC-like cells. 
When the ER_MP58m,d subset of the ER-MPI2h;20- bone marrow population was 
cultured for 4 days in the presence of M-CSF, about 70% of the cells expressed the ER-
MP20 antigen (Fig. 3B), compared to 90% in cultures of the ER-MP58h; cells of the ER-
MPI2h;20- subset (Fig. 3A). Upon subsequent GM-CSF-stimulated culture of the ER-
MP I 2h;20-58m,d cells, DC-like cells could be detected after 3 days of secondary culture 
(Table 3). After 9 days of GM-CSF-stimulated secondary culture, 28% of the cells had a 
high MHC class II expression and DC-like morphology (Table 3, Fig. 3B). Thus, after four 
days of primary culture of ER-MPI2iU20-58m,d cells in the presence of M-CSF, these cells 
also have the potential to generate DC-like cells. This is remarkable, as from ER-
MPI2h;20-58n"d cells put directly into GM-CSF-stimulated culture no DC-like cells could 
be generated (Table 2). However, this discrepancy can be explained by taking into account 
the observed difference in maturation stage between ER_MP58n"d and ER-MP58h; cells of 
the ER-MPI 2h;20- subset (explained below). 
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Figure 3. Development of (A) ER_MPI2hl20-58hi , (B) ER-MPI2hi20-58med, and (e) ER-MPI2+20+ bone marrow 
cells in primary M-eSF-stimulated and secondary OM-eSF-stimulated culture. Bonc marrow subsets were sorted 
and cultured for 4 or 5 days in the presence of M-CSF-containing conditioned medium. At thc end of the primary 
culture, ER-MPI2 and ER-MP20 expression was determined in two-color flow cytometry to assess thc maturity 
of thc cultured cells. Ncgative control limits are shown in each dot plot (vcrtical and horizontal lines); upon 
culture, these control values increase duc to increasing autofluorescence of the cells. Next, cells were grown for 
9 days in secondary rOM-eSF-stimulated cultures. Aftcr this period cultures were analyzed for the presence of 
DC-like cells (high class II expression and dendritic morphology). Mononuclear phagocytes were also present 
in these secondary cultures (arrow). Magnification (A) and (C) x 670, (B) x 1000. 
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Several data indicate that the ER_MPI2hi2WS8m,d cells that respond in these cultures 
are less mature than the ER_MPI2hi20-S8hi cells. First, a previous study indicated that in 
the ER-MPI2hi20- bone marrow subset, cells expressing ER-MPS8 at a high level have 
differentiated further along the myeloid lineage than cells with intennediate ER-MPS8 
expression22• Second, the percentage of ER-MP20+ cells found in M-CSF-stimulated 
cultures of ER_MPS8m'd cells is lower than that in cultures of ER_MPS8hi cells (70 versus 
90%, respectively). Since the ER-MP20 antigen is increasingly expressed upon maturation 
along the myeloid lineage2).3), and culture conditions were identical for both the ER-
MPS8m,d and ER_MPS8hi subsets, this difference in percentage positive cells supports the 
notion that ER_MPI2hi2WS8m,d bone marrow cells are less mature than ER_MPI2hi20-S8hi 
cells. As for optimal development along the monocyte/macrophage lineage about twice as 
much serum was required than for the generation of DC-like cells, we speculate that the 
higher serum concentrations, in combination with the M-CSF-containing conditioned 
medium used in the primary cultures induced maturation of early progenitor ceUs to Of 
beyond the point that they first became responsive to pure rGM-CSF. This would explain 
the finding that ER_MPI2hi20-S8m,d bone marrow cells do only respond to rGM-CSF after 
primary M-CSF-stimulated culture, while the more mature ER_MPI2hi2WS8hi bone marrow 
cells respond in both rGM-CSF- and M-CSF-stimulated cultures. 
The GM-CSF-stimulated secondary cultures of the ER-MPS8""d cells differed from 
cultures of the ER_MPS8hi cells of the ER_MPI2hi20- subset in the time of appearance of 
DC-like cells (day 3 versus day I, respectively). This is in accordance with the notion that 
ER-MPI2hi20-S8""d cells lag behind in maturation compared to ER_MPI2hi20-S8hi cells. 
Thus, cells obtained from ER_MPI2hi20-S8m,d primary cultures need more time to generate 
DC-like cells upon secondary culture in GM-CSF. However, another explanation for the 
difference in time of appearance of DC-like cells could be that the ER_MPI2hi20-S8m,d 
bone man-ow subset contains less OM-eSF-responsive progenitors capablc to develop into 
DC-like cells than the ER_MPI2hi20-S8hi subset. This would also result in an extended 
culture period before detectable numbers of DC-like cells are reached. However, the 
finding that DC-like cells could not be generated directly from the ER_MPI2hi20-S8m,d 
subset but only after M-CSF-stimulated primary culture argues against this explanation. 
To test whether bone marrow precursors which had developed further along the 
macrophage pathway ill \Iitro could still give rise to DC-like cens, we sorted the more 
mature ER-MPI2+20+ myeloid blast subset and cultured it for S days in the presence of 
M-CSF prior to secondary culture in GM-CSF. After M-CSF-stimulated culture 
approximately half of the cells expressed the ER-MP20 antigen (Fig. 3C). The other cells 
in culture were ER-MP20 negative. These ER-MP20- cells represented mature 
macrophages, and not early immature cells like in the ER-MPI 2hi20- cultures, as (i) they 
were high in forward and perpendicular light scatter (data not shown), indicative of a 
complex cell type like the mature macrophage with its numerous vacuoles, lysosomes etc. 
and (ii) they showed a high autofluorescence level, also characteristic of mature 
macrophages. When the day S M-CSF-derived cells were further cultured in GM-CSF, DC-
like cells could be detected after only one day of secondary culture and in increased 
numbers after three days of culture (Table 3). After 9 days of secondary cuiture, 71 % of 
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Table 3 Development of DC~like cells from in vitro generated macrophage precursors 
BM subset Duration of primary DC-like cells visible in % of MHC u++ cells 
M-CSF culture secondary GM-CSF culture with DC morphology 
before switch to (days after growth factor (immunocytochemistry) 
GM-CSF switch) 
day 1 day 3 day 9 
ER-MPI2hl20-S8hl 4 days ± + 28% 
ER-MPI2hi20-58tTh.-.1 4 days ±? + 28% 
ER-MPI2+20+ 5 days ± + 71% 
the cells examined in immunocytochemistry had a high MHC class II expression and a 
morphology characteristic for DC (Table 3, Fig. 3C). 11lUS, also within a cell population 
that has developed further along the macrophage lineage, cells with the capacity to develop 
into DC-like cells are still retained. Remarkably, the percentage of DC-like cells derived 
from the M-CSF-stimulated ER-MPI2+20+ cells is almost three times higher than that 
found with the ER-MPI2hi20' bone marrow subsets as starting populations (71 % versus 
28%). Most likely, this finding can be explained by the fact that the cells derived from the 
M-CSF-stimulated culture of the ER-MP12+20+ bone malTOW subset are more mature than 
the cells derived from primary culture of the two ER-MPI 2hi20' subsets. Upon secondary 
culture, the former cells cannot proliferate substantially anymore. Instead they either 
become adherent macrophages or non-adherent DC-like cells. This results in a relatively 
high percentage of DC-like cells in suspension. In contrast, most of the cells obtained from 
primary culture of the ER-MPI2hi2o- subsets still have a high proliferative potential. Thus, 
in secondary cultures, many non-adherent progenitor cells are formed, next to non-adherent 
DC-like cells and adherent macrophages. Consequently, a lower percentage of DC-like 
cells is found starting from the ER-MPI2hi20' subset. 
Summarizing, the data obtained in this study are in line with the hypothesis that over 
a prolonged stretch of mononuclear phagocyte development progenitors of the mononuclear 
phagocyte system may either develop into monacytes/macrophages or DC, depending on 
local concentrations of specific growth factors. However. additional clonal experiments are 
required to confinn this hypothesis. Furthermore, experiments verifying the DC nature of 
the DC-like cells generated in this study will have to be done, including the mixed 
lymphocyte reaction (MLR) and flow cytometric analysis of MHC class II expression and 
other markers such as NLDC-14S. Yet, as the culture conditions used in our study are 
similar to those of studies in literature in which the MLR activity of the DC was 
demonstrated32,33, we expect that the DC-like cells generated in our cultures wil1 also prove 
potent stimulators in MLR. Finally, it would be interesting to test sorted ER-MPI2120/58 
bone marrow subsets also for the presence of the lymphoid-related DC described by Wu 
et aL", as opposed to the presently studied myeloid DC. 
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Abstract 
Detailed assessment of bone marrow cel1ular composition is essential in evaluation of 
various experimental ill vivo systems, such as expression of transgencs, null mutations 
and stimulation of host defence in infection. Traditional morphological analysis of 
mouse bone marrow is laborious, requires specific cytological expertise, and is 
somewhat subjective. As an alternative, we examined whether double labeling of bone 
marrow with the anti-precursor monoclonal antibodies ER-MPI2 and ER-MP20 could 
be used for differential analysis by flow cytometry. as these antibodies divide mOllse 
bone marrow into six relatively homogeneous cell populations. Following a sublethal 
infection of mice with Listeria 11l0llocytogelles, we monitored changes in cellular 
composition of the bone marrow at various time points by three methods: differential 
morphological count; single-color flow cytometric analysis using markers for the 
myeloid, erythroid and lymphoid lineages; and double labeling with ER-MPI2 and ER-
MP20. As expected, the bone marrow composition changed dramatically during 
infection, leading to an increase of myeloid cells which peaked after I week infection. 
Data determined by ER-MPI2/20 flow cytometric analysis appeared to be in close 
agreement with both morphology and lineage marker analysis. In addition, ER-MPI2120 
analysis provided more detailed information with regard to the presence of early 
myeloid precursors compared to lineage marker analysis. These data show that flow 
cytometric analysis of bone marrow using ER-MPI2 and ER-MP20 monoclonal anti-
bodies provides a relatively simple, rapid and objective method for assessment of the 
cellular composition in the bone marrow of the mouse. 
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Introduction 
The bone marrow is the major site of adult hematopoiesis. Under steady state 
conditions, hematopoiesis is a continuous process in which a constant number of blood 
cells is generated each day. Perturbations in this process arc reflected in the cellular 
composition of the bone marrow and in evaluation of various experimental systems, 
quantitative analysis of bone marrow composition is required. For instance, the expres-
sion of transgenes, null mutations or application of immunomodulatory agents may 
have profound effects on. hematopoiesis'-6, Conventional methods for the assessment of 
bone marrow cellular composition are morphological analysis on May-Grunwald! 
Gicmsa stained bone marrow preparations or flow cytomctric analysis of lineage-
specific expression of cell surface molecules such as, in the mouse, B220 (B cells), 
CD3 (T cells), Gr-l (myeloid cells) and TER-119 (erythroid cells). When more detailed 
information on the presence of early myeloid progenitor stages is required, differential 
counting has the advantage over lineage marker analysis. However, this particular 
method requires specific cytological expertise, is somewhat subjective and is time 
consuming. 
In our search for novel markers for the identification of myeloid progenitor cells, 
we previously generated two monoclonal antibodies, ER-MP12 and ER-MP20, which in 
two-color flow cytometry identified different stages of myeloid progenitor cell develop-
mene. In addition, these monoclonal antibodies divided mouse bone marrow into six 
subsets with remarkable cell type homogeneity (Fig. 1)7.8. TIle ER-MP12h;20- subset 
consists primarily of blast cells, both morphologically undifferentiated blasts and blasts 
with lineage characteristics. The ER_MP12med20- subset contains mainly lymphoid cells 
and the ER-MPI2-20- subset erythroid cells. The ER-MPI2+20+ population consists of 
myeloid blasts, morphologically undifferentiated blasts (most of them of the myeloid 
lineage as indicated by myeloid marker expression; unpublished observation) and few 
4 
Bone marrow subset Prevailing cell type 
1. ER-MP12~J2o- Blast cells (71%), lymphoid cells (25%) 
OJ 2. ER-MP12":'<>'l2Q- Lymphoid cells (87%) 
a: 
~ 3. ER-MPl2""2o- Erythroid cells (91%) 
w 4. ER-MP12'20' MyeloJd progenitors (79%) 
6 5. ER-MP12""20-~..j Granulocytes (91%) 
6. ER-MP12"20" Monocyles (74%), myeloId progenitors (19%) 
ER-MP20 
Figure 1. Cellular composition of ER-MPI2120 bone marrow subsets. Cylocenlrifuge preparations of bone 
marrow subsets sorted on the basis of differentia] ER-MPI2 and ER-MP20 expression were stained with 
May-GriinwaldlGiemsa and prevailing cell type identified by differential cell counts1.8• 
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vat ion) and few erythroid progenitors. Band fomls and segmented cells of the 
granulocytic lineage are the prevailing cell types in the ER-MPIT20n"d subset, while 
monocytes form the vast majority of the ER-MP12-20hi bone marrow population. 
Together, these data suggested that ER-MP12120 analysis of bone marraw could 
provide a new, simple, rapid and quantitative method for differential analysis of mouse 
bone marrow. 
In the present study we aimed at validating the use of ER-MPI2120 subset analysis 
for assessment of cellular bone marrow composition in an experimental ill vivo model. 
To this end, mice were infected with a sublethal dose of Listeria monoc)'togelles and at 
various time points during infection bone marrow was analyzed for ER-MP12!20 subset 
composition in two-color flow cytometry. These data were compared with lineage 
marker expression and differential morphological counts. Our results show that data on 
cellular composition obtained from ER-MPI2120 analysis correlate closely with data 
obtained from either lineage marker analysis or differential morphological counting. 
The advantage of ER-MPI2120 analysis over the conventional composition analyses is 
that it gives more detailed infonnation on early precursor stages compared to lineage 
marker analysis, and that it is easier and faster than differential counting. 
Materials and methods 
Mice 
Specified pathogen-free, 11 to 13 weeks old female C57BLlKa mice were used (Harlan 
CPB, Austerlitz, The Netherlands). Experimental design and animal care were per-
fomled according to institutional guidelines. 
Bacteria 
Listeria mOlloc)'togelles strain EGD was used in this study (stored at -80°C in Todd-
Hewitt broth (Difco Laboratories, Detroit, MI, USA), containing 10% (v/v) glycerol). 
Bacteria were grown in Todd-Hewitt broth for 16 hour at 37°C and preserved on ice. 
Prior to inoculating the mice, bacteria were washed twice in phosphate buffered saline 
(PBS). 
E\lJerimelltal infection caused by L. mOJ1oc)'togenes 
Mice were infected by intravenous inoculation of 5xl03 CFU Listeria lIIollocytogelles. 
Pilot experiments had indicated that this dose caused a severe, but sublethal infection. 
At t=O, I hOllr, 1,2,3,7, 14,21 and 35 days mice were killed by CO2 exposure, and 
peripheral blood, spleen, liver and bone marrow were isolated to monitor the bacterial 
load in these organs. Peripheral blood samples were taken from the retra-orbital plexus. 
Serial IO-fold dilutions were prepared in phosphate-buffered saline (PBS) and from 
each dilution 0.2 ml was spread on a tryptone soya agar (TSA) plate (Oxoid Ltd., 
Basingstoke, England). Spleen and liver were homogenized in 20 ml PBS for 30 
seconds at 10.000 rpm in a VirTis homogenizer (The VirTis Co. Inc., Gardiner, New 
York) as described earlier9• Serial IO-fold dilutions were made in PBS and volumes of 
0.2 ml fram each dilution and 2 ml of the undiluted homogenate were spread on TSA 
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plates. The remainder of the homogenate was poured into plastic dishes, together with 
an equal volume of double concentrated TSA. Bone marrow cell suspensions were 
prepared from both femora and tibiae as described? Undiluted suspensions and serial 
lO-fold dilutions in PBS and undiluted suspensions were spread on TSA plates. After 
48 hours of culture at 37°C, bacterial colonies were counted. 
Phenotypic analysis of bone marrow compositio1l (flow c),/omeflY) 
The monoclonal antibodies used in this study are listed in Table I. MAbs were applied 
as hybridoma culture supernatants or as optimally titrated FITC (ER-MP20) or biotin 
(ER-MPI2) conjugates? Phenotypic analyses were performed as descrihed previously? 
In brief, for single~color analyses bone marrow cells were first incubated with 
hybridoma culture supernatant, washed, and subsequently incubated with rabbit anti-rat 
IgO F(ab)' 2 fragments conjugated to FITC (Cappel, Organon Teknika, Tumhout, 
Belgium), In two-color analyses, bone marrow cells were successively incubated with 
ER-MPI2-biotin, followed by ER-MP20-FITC together with streptavidin-tricolor 
(Caltag Laboratories, San Francisco, CAl. Incubations (10 minutes, room temperature) 
were perfonned in the presence of 20 mM NaN3 to prevent antibody internalization. 
Between incubations cells were washed twice in PBS supplemented with 0.5% (v/v) 
bovine serum albumin (Boseral, Organon Teknika) and 20 mM NaN3. Samples were 
analyzed using a FACScan (Becton Dickinson, Sunnyvale, CAl with Cell Quest 
software (Becton Dickinson), For inter-experiment instrument standardization, micro-
spheres of known fluorescence intensity (Flow Cytometry Standards, Research Triangle 
Park, NC) were measured in each individual experiment. 
TabJe 1 Monoclonal antibodies and their specificities 
Antibody Antigen 
ER-MPI2 CD31, PECAM-I 
ER-MP20 Ly-6C 
RA36B2 B220 
KT3 CD3 
TER-1I9 lER-1I9 
RB68C5 
. Expression in bone marrow 
Early hematopoietic progenitor and stem 
cells; lymphoid cells; no expression on late 
stages of erythroid, granulocytic and 
monocytic development 
Increasingly expressed upon maturation of 
granulocytes and lIlonocytes from colony-
fonning cell stages onwards; subset of T 
cells 
B cells and B precursors 
T cells 
Erythroid cells 
Increasingly expressed upon maturation of 
granulocytes from the colony-fomring 
stage; transiently expressed during 
monocytic development 
Reference 
7.8,10,29-
32 
21,29,33-36 
37 
38 
39 
36,40 
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Differellfial cOllllfs 
Bone marrow cells were centrifuged onto microscopic slides in a cytocentrifuge. Prepa-
rations were air-dried and fixed in methanol {Labscan Ltd., Dublin, Ireland) at room 
temperature for 10 minutes. Afterwards, cytospins were stained with May-GrUnwald! 
Giemsa (Merck, Darmstadt, FOR) and differentially counted. Per time point, bone 
marrow preparations of two mice were analyzed morphologically. 
Results 
In the present study we examined whether two-color flow cytometric analysis of bone 
marrow with ER-MPI2 and ER-MP20 monoclonal antibodies can be used as an 
alternative method for the assessment of cellular composition of mouse bone marrow. 
In an experimental infection with Listeria mOllocytogeJles, bone marrow composition 
was detemlined by ER-MPI2120 analysis, analysis of lineage marker expression and 
differential counting. In the first part of this section, changes in ER-MPI2120 bone 
marrow subset composition during infection are shown. In the second part, ER-
MP12120 data are compared with lineage marker and morphological analysis, in order 
to validate the use of ER-MP12/20 analysis for assessment of bone marrow cellular 
composition. 
Course 0/ in/ectioll 
To monitor the course of Listeria 1ll0Jlocytogelles infection, peripheral blood, liver, 
spleen and bone marrow were screened for the presence of viable bacteria at various 
time points after i.v. inoculation with 5xl03 bacteria. Peripheral blood was sterile at all 
time points examined. The bacterial loads in liver, spleen and bone marrow are shown 
in Fig. 2. One hour after inoculation, bacteria were trapped in liver and spleen but were 
not yet present in bone marrow. The peak of infection was measured at 72 hours in all 
three organs. After 2 weeks the spleen was sterile again. In liver and bone marrow, 
bacteria were no longer detectable at week 5. 
Extensive changes ill bOlle marrow compositioll detected by ER-MP12120 flow 
cytometric analysis during Listeria mOllocytogelles illfectioll 
Changes in bone marrow composition during infection, detected by ER-MPI2120 
analysis, are shown in Fig. 3. One hour after injection of the bacteria, no changes in 
ER-MPI2120 profile were detected. At day I, the percentage of ER-MPIT2o"i cells, 
i.e. monocytes, was clearly diminished and the percentage of ER-MP 12-20m,d cells, i.e. 
band and segmented granulocytes, also seemed decreased. This decrease in percentages 
of monocytes and granulocytes continued till day 3, with a final 70% decrease 
compared to control values. At the next time point measured, one week after infection, 
monocytes (ER-MPI2-20hi) and late stages of granulocytic development (ER-
MPI2-20m,d) had returned, and comprised approximately half of the bone marrow. This 
return was preceded by an increase in the ER-MPI2+20+ myeloid precursor population, 
from day 2 till day 7. Thus, one week after infection, bone marrow consisted almost 
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Figure 2. Load of Listeria 1JI00lOcyloge1les in liver (0). spleen (0) and bone marrow (d). Mice were injected 
intravenously with 5 x 103 Listeria 1II00IOc),iogenes. At I hour and I, 2, 3, 7, 14, 21 and 35 days after 
infection peripheral blood and organs were isolated to determine the number of viable bacteria present. 
Peripheral blood was found sterile at all time points tested. Data are the mean ± SD of 6 mice per lime point. 
At day 14, the liver of 3 out of 6, and bone marrow of 4 out of 6 mice was sterile. At day 21, liver and bone 
marrow of 3 out of 6 mice were sterile. 
exclusively of ER-MP12+20+, ER_MPI2-20mod and ER-MPIT20h; cells, i.e. immature 
and mature myeloid cells. Erythroid cells (ER-MP12-20-) and lymphoid cells (ER-
MPI2mod20-) had disappeared within three and seven days after infection, respectively. 
nvo weeks after infection a predominance of more mature myeloid cells (ER-
MPIT20""d and ER-MPIT20h;) was still seen, while the erythroid (ER-MPI2-20-) and 
lymphoid (ER-MPI2""d20-) populations were being restored. Three weeks after in-
fection, bone marrow composition was almost as in controls although an elevation in 
ER-MPI2-20""d granulocytes and ER-MP12-20h; monocytes was seen till 5 weeks after 
onset of the infection. 
Comparison between ER-MP 12120 analysis and COllvellfiolla{ analyses of bOlle marrow 
composition 
To validate the use of flow cytometric ER-MPI2120 analysis as an alternative method 
for the assessment of cel1ular bone marrow composition. this method was compared 
with conventional composition analysis by lineage marker analysis and differential 
counting. For this purpose, hone marrow cells of each mouse were analyzed by flow 
cytometry also for the expression of the lineage markers Or-l (myeloid cells), B220 
and CD3 (lymphoid cells), and TER-119 (erythroid cells). In addition, bone marrow of 
two mice per time point was differentially counted on May-Grtinwald/Gicmsa stained 
cytocentrifuge preparations. For comparison of the number of myeloid cells detected by 
each method, the total number of ER-MPI2+20+, ER_MPI2-20med and ER-MPI2-2d" 
cells (representing primarily immature myeloid progenitors, band and segmented 
granulocytes, and monocytic cells, respectively) was compared with (i) the number of 
01'-1+ cells and (ii) the total number of myeloid cells as determined by differential 
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Figllre 3. Row cytometric analysis of ER-MPI2 and ER-MP20 bone marrow subsets in the course of 
infection with Listeria mOllocytogenes. Gates used for analysis are shown; at each lime point, gates were set 
on the basis of ER-MPI2120 expression in uninfected control mice. Percentages are the mean of 6 mice per 
time point. 
counting (Le. the total of immature myeloid progenitors, band fonn and segmented 
neutrophils, monoeytes, and eosinophils). For comparison of the number of lymphoid 
cells, the total of ER-MPI2ffi,d20- (mainly lymphoid cells) and ER-MPI2hI20- cells 
(early blasts) was used. These ER-MPI2hI20- cells were included in the lymphoid 
population as under steady state conditions more than half of these cells were found to 
express the B220 Ag, indicative of their B lineage identitylO. In addition, this 
population was reported to contain progenitors of the Band T cell lineagelO-12. The 
number of lymphoid cells obtained by ER-MPI2120 analysis was compared with (i) the 
total number of B220+ and CD3+ cells and (ii) the number of lymphoid cells 
dctcnnined by morphological examination of the bone marrow. For comparison of the 
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erythroid population size detennined by the various methods, the number of ER-
MP 12-20- cells was compared with (i) TER-119+ cells and (ii) the number of mor-
phologically identified erythroid cells. 
Comparable bone marrow composition data obtailled throughout infection using 
differellt allalysis lIIethods: In Fig. 4 the kinetics of myeloid, lymphoid and erythroid 
cell populations during infection are shown, as detected by each of the three analysis 
methods. Absolute cell counts were calculated from the myeloid, lymphoid and 
erythroid population frequencies and the total number of bone marrow cells obtained 
from each mouse (from 2 femora and 2 tibiae; Fig. 4A). Comparable changes in 
myeloid, lymphoid and erythroid cell numbers were detected by either ER-MPI2120 
analysis, lineage marker analysis or differential counting (Fig. 4A-C). All three methods 
used showed an overall one-third decrease in total myeloid cells in bone marrow during 
A 100 
TNBC 
75 
50 
75 
myeloid 
0 .. 21 
" " 
Figllre ~. Changes in bone 
B 40 marrow composition in the 
course of infection with Listeria 
ll- 30 I1/Ol/ocylogelles detected by ER-e 
R MP12120, lineage markers, or 
~ differential counting. Myeloid 
.c 
" 
(A), lymphoid (B) and erythroid E 
0 (C) bone marrow population c 
OJ 10 sizes as dctcmlined by ER-0 
MPI2I20 analysis (0), lineage 
lymphoid marker analysis (0) and dif-
" " " 
ferential counting (A). Total 
C 40 nucleated bone marrow cell 
(TNBC) numbers are given at 
30 each time point for comparison 
in graph A (+). Data arc the 
mean of 6 mice per time point. 
20 Standard deviations ranged be-
tween 0.1 and 9.3 x 10' for 
10 subpopulation sizes and between 
3 nod 18 x 10' for total bone 
erythroid marrow counts (obtained from 2 
0 femora nod 2 tibiae of each 0 
" 
21 
" " days after infection mouse). 
BOlle marrow compositioll ill Listeria monocytogenesis illfected mice 121 
the first two days of infection (Fig. 4A). After this initial decrease, the number of 
myeloid cells increased and peaked at day 7 with approximately twice the control 
levels. All three methods showed that at this time point the bone marrow consists 
almost exclusively of myeloid cells (Fig. 4A-C). From day 7 onwards, myeloid cell 
numbers gradually decreased again, but were still slighlly elevated at week S (Fig. 4A). 
After a strong decline at day 7, lymphoid cells had returned to control numbers by day 
21 (Fig. 4B). Similarly, the number of erythroid cells, which was minimal at days 3 
and 7, was largely restored again by day 14 (Fig. 4C). Thus, throughout the infection, 
data on bone marrow composition obtained from ER-MP12120 analysis are comparable 
to the data obtained from lineage marker or morphological analysis. 
High correlation behveell ER-MP 12120 analysis of bone marrow composition and 
lineage marker analysis or differential counting: Linear regression analysis showed a 
high and significant correlation between ER-MPI2120 analysis of bone marrow 
composition and data obtained by lineage marker analysis for all populations (I' > 0.9, p 
< 0.0001; Fig. SA). Percentages of myeloid, lymphoid, and erythroid cells obtained by 
differential counting also correlated strongly with percentages obtained by ER-MP12/20 
bone marrow analysis (r=0.87, p < 0.0001; Fig. SB). These data indicate that ER-
MP12120 bone marrow subset analysis can replace lineage marker analysis and 
differential counting in the measurement of total myeloid, lymphoid, and erythroid bone 
marrow cell populations. 
Discussion 
In the present study we aimed at validating the use of ER-MP12/20 two-color flow 
cytometric analysis as a simple, rapid and objective method for the assessment of 
cellular bone marrow composition in the mouse. For this purpose, bone marrow com-
position was determined by ER-MPI2120 subset analysis, lineage marker analysis and 
differential counting, under both steady state and experimental conditions. Sublethal 
Listeria mOllocytogelles infection was used as the experimental system as this is a well-
characterized model in which significant shifts in myeloid progenitor cell numbers have 
been reported13-16. 
Mqjor changes in both the relative and absolute numbers of myeloid, erythroid and 
lymphoid cells were observed in the first week of infection. In the first three days a 
decrease in ER-MP12-20hi monocytic and ER-MPlT20""d granulocytic cells was seen. 
Previously, mobilization of mOl1ocytes and granulocytes into the circulation and tissues 
was demonstrated early in infection I7-2o. Thus, the decrease in ER-MP12-20hi and ER-
MP12-20""d bone marrow cells is probably due to an increased efflux of these cells 
into the bloodstream and peripheral tissues. The demand for myeloid cells in the 
periphery is reflected in the increased production of the immediate progenitors of these 
cells from day 2 to day 7 (ER-MPI2+20+ expanded), leading to an almost complete 
myeloid bone marrow composition by day 7. This increase in myelopoiesis occurred 
initially at the expense of erythro- (day 2 to 7) and later also lymphopoiesis (day 3 to 
7). From one week onwards, ER-MP12/20 bone marrow subset composition gradually 
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Figure 5. Diagrams showing linear regression analysis for the correlation between the percentages of myeloid, 
lymphoid, and erythroid cells detemlined by (A) ER-MPJ2/20 versus lineage marker analysis and (0) ER-
MPI2120 analysis versus differential counting. Datu arc from a total of 54 (A) or 18 (B) mice. p < 0.0001 for 
all analyses. 
returned to normal. Thus, in this model of Listeria mOlloc)'togelles infection, dramatic 
shifts in bone marrow composition are seen, allowing the examination of the validity of 
ER-MP12/20 subset analysis over a broad range of values. 
Throughout the infection, data on myeloid, lymphoid, and erythroid population sizes 
obtained from ER-MPI2120 subset analysis were comparable to the data obtained from 
lineage marker andlor morphological analysis. This is substantiated by the high cor-
relations found between ER-MP12120 bone marrow subset and lineage marker analysis 
(r> 0.9), as well as ER-MPI2120 and morphological analysis (r=0.87). Together, these 
data validate the usc of ER-MPI2120 bone marrow subset analysis as an alternative 
method to determine bone marrow composition. ER-MPI2120 bone marrow subset 
analysis has the advantage over lineage marker analysis that it gives additional 
infonnation on shifts in myeloid progenitor subsets. For example, the decrease in the 
monocytic (ER-MPIT2o";) and granulocytic (ER-MPI2-20""d) subsets detected by ER-
MP12120 analysis at day I after infection could not be detected by analysis of Gr-I 
expression. The advantage of ER-MP12/20 subset analysis over differential counting is 
that it does not require specific expertise on morphological recognition of mouse bone 
marrow cells and that it is less time consuming. 
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Small variations were observed between the myeloid and lymphoid population sizes 
determined either by ER-MP12/20 or lineage marker analysis. These variations are 
inherent to the methods used. Consistently, a slightly higher number of myeloid cells 
was obtained from ER-MP12120 subset analysis compared to lineage marker analysis. 
This difference is most likely due to the fact that not all ER-MPI2+20+ cells express 
the Or-l antigen (approximately 80% Gr-I-positive cells can be detected by flow 
cytometry, data not shown). In assessing the lymphoid population, ER-MPI2120 
analysis occasionally results in lower numbers of lymphoid cells than does lineage 
marker analysis. This is especially the case early in infection, when a peak in lymphoid 
cells is seen (day 2). A conceivable explanation for this finding involves the nature of 
the ER-MP20 antigen, Ly-6C. Ly-6C has been shown to be expressed by a subset of T 
cells21 . These Ly-6C (ER-MP20) expressing cells will not fall in the ER-MPI2h;2o- and 
ER-MPI2m,d2o- subsets used to determine the percentage of lymphoid cells. Thus, such 
T cells will be missed in the ER-MP12/20 analysis, but will be detected by CD3 
expression. Although the percentage of Ly-6C+ T cells is very low (total T cells already 
less than 4%) under steady state conditions, this percentage may increase under 
experimental conditions. This caveat should be kept in mind in cases where changes in 
T cell popUlation sizes are expected. 
In all three hematopoietic lineages, some variations were found between data 
obtained from ER-MPI2120 subset analysis versus differential counting during the first 
three days of infection. Later on, the lymphoid bone marrow popUlation was 
overestimated compared to ER-MP12120 subset and lineage marker analysis. Overall, 
data on bone marrow composition obtained on the basis of morphology differed more 
from ER-MPI2120 subset analysis than lineage marker analysis did. This is not 
surprising. as the latter two methods are based on the same technique. i.e. now 
cytometric detection of cell surface markers. Compared to this technique. morphological 
analysis can lead to different results when for example the stage at which cells are first 
recognized differs between the methods. 
The myeloid subsets distinguished by ER-MPI2120 analysis differ from the myeloid 
subsets distinguished in differential counting. In the latter method, myeloid cells were 
classified as either immature myeloid progenitors, band and segmented neutrophils. 
monocytes, or eosinophils. The ER-MPI2+20+, ER-MPI2-20m,d and ER-MPI2-20h; 
subsets, however, represent phenotypically distinct developmental stages of the myeloid 
lineage. The ER-MPI2+20+ subset was found to contain mainly immature cells 
(undifferentiated blasts and immature myeloid progenitors). as well as among others a 
few band and segmented cells and a few monocytes7. This subset contains clonable 
progenitors for both the granulocytic and monocytic lineages (ref. 7 and data not 
shown). The myeloid nature of the large majority of this subset was deferred from the 
finding that approximately 80% of the cells express the myeloid marker Or-l 
(unpublished observation). The ER_MPI2-20med subset consists virtually exclusively of 
band and segmented neutrophils, end stages of neutrophilic development. No distinction 
can be made between band and segmented neutrophils on the basis of ER-MPI2120 
expression levels. Cells of the monocytic/macrophage lineage, on the other hand. can be 
readily distinguished from granulocytic cells on the basis of their high level of ER-
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MP20 expression (ER-MPI2-2o"i). Morphologically, approximately three quarters of 
this ER-MPlr20hi subset consist of monocytic cells and one quarter of immature 
myeloid progenitors. These immature myeloid progenitors are ceBs with a ring-shaped 
nucleus. Such cells (not found in humans) are traditionally assigned to the granulocytic 
lineage. However, recently a subtype of mouse bone marrow cells with ring-shaped 
nuclei was detected by H. Biermann, C. Sorg and C. Sunderkotter (personal 
communication). The morphological characteristic of this cell type is a small 
cytoplasmic center in the nucleus, with a diameter smaller than the width of the ring of 
nucleoplasm. Remarkably, several of such cells were found to express monocyte! 
macrophage-related markers like ER-HR3, F4!80 and MHC class II. In contrast, these 
markers were absent from virtually all other cells with ring-shaped nuclei. These data 
suggest that (at least part of) this new cell subtype belongs to the monocyte! 
macrophage lineage. Interestingly, examination of May-Griinwald/Gicmsa stained 
cytospins of the sorted ER-MP12-2o'" subset revealed that all cells with a ring-shaped 
nucleus present in this bone marrow fraction were of the mononuclear type with the 
small cytoplasmic center in the nucleus. This finding suggests that the ER-MP12-2o"i 
subset contains progenitors of the monocytic lineage only. Taken together, the ER-
MP12+20+, ER-MPI2-20""d and ER-MPIT20hi subsets represent different stages of 
myeloid development with a high lineage homogeneity rather than the different classes 
of myeloid progenitors identified by differential counting. 
Remarkably, the ER-MPI2hi20- subset, which was also shown to contain early 
progenitors of the myeloid lineages7, did not increase in the course of infection, whi1e 
the other myeloid cell-containing subsets did. A possible explanation for this 
phenomenon could be that under these "hematopoietic stress" conditions, the ER-
MPl2hiZO- stage is a very short-lived stage, and that progenitors leave this stage shortly 
after commitment to the myeloid lineages. Increased production of myeloid cells would 
then only be reflected in an increase of myeloid progenitors at later stages in 
development. The observed increase in ER-MPI2+20+ cells from day 2 to day 7 would 
fit with this hypothesis. Alternatively, under these inflammatory conditions, a 
phenotypically different route may be followed in which ER-MPI2+20+ myeloid 
progenitors develop directly from ER_MPI2m,d20- 8 pi uri- and multipotent stem cells. 
Confirmation of this notion awaits further experimentation. 
How stable is the expression of ER-MP12 and ER-MP20 antigens by the various 
bone marrow subpopulations? Within the first two days of Listeria infection, significant 
increases of IFN-y levels have been reported22,23. Increased levels of IFN-y are known 
to have profound effects on the expression of certain cell surface markers. Thus, it 
could be argued that the observed decrease in the ER-MPIT20hi and ER-MPI2-20""d 
subsets in the first days of infection is not due to an efflux of these cells into the blood 
stream, but to an upregulated ER-MP12 expression as a result of increased IFN-y 
levels. However, several findings argue against this possibility. First, at day I no 
increase in ER-MP12+20+ popUlation size is observed, while this would have been 
expected if the total 8.5% decrease seen in the ER-MPIT20hi and ER_MPITZOm,d 
populations sizes would have been the result of elevated ER-MPI2 expression levels. 
Second, in experiments using various ER-MP12-expressing cell lines we could not 
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upregulate ER-MPI2 expression by either IFN-y or several other stimuli (unpublished 
observations). Third, although ER-MP20 (Ly-6C) is readily inducible by IFN-y on 
certain cell types24,25, we did not observe increased expression of this marker on bone 
marrow cells in the present study. Together, these data argue against upregulation of 
ER-MP12 expression on bone marrow hematopoietic cells during infection with Listeria 
mOllocytogenes. 
In several studies, ER-MPI2 and/or ER-MP20 have been successfully used to detect 
changes in bone marrow composition under various experimental conditions26-28 • To 
prevent inaccurate use of these antibodies we want to stress that only the combination 
of ER-MPI2 and ER-MP20 in two-color flow cytometric analysis of bone marrow cell 
suspensions allows for the specific identification of (I) an early blast cell subset 
containing early progenitors for all hematopoietic lineages as well as some hemato-
poietic stem cell subsets (ER-MPI 2hi20-), (2) a lymphoid population, also containing 
hematopoietic stem cells (ER-MPI2""d20-), (3) an erythroid population (ER-
MPIT20-), (4) a subset with mainly progenitors for both granulocytes and monocytes 
(ER-MPI2+20+), (5) a granulocytic population (ER_MPIT20m,d) and (6) a monocytic 
(ER-MP 12-20hi) population 7.8. 
We lI'ould like 10 thal/k Tar mil o~ for the preparatioll of the figures a/Jd Judith Rosmalen allti !Vim Hop fur 
statistical analysis. This study was supported by grallt 901-05-253 of fhe Netherlands Orgalliwlioll jdr 
Sciel/tific Research (NWO). 
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Abstract 
In experimental studies in mice, dietary supplementation with n-3 faUy acids (FA) 
alleviates inflammation and increases resistance to infection. Nevertheless, TNF production 
capacity was found to be increased in n-3 FA-fed mice. We previously found increased 
relative spleen weights in n~3 FA-fed mice. Here, the nature of this increased spleen size 
was further investigated. Splcen cellularity was significantly increased in mice fed n-3 FA 
(fish oil 15% w/w), compared to controls fed corn oil (15%) or nonnallab chow (p<O.05). 
Experiments with T-cell deficient nude mice and experiments employing macrophage 
depletion through liposomal dichloromethylene-biphosphonate (CI2MDP), revealed that the 
increase in splcen cellularity is T-cell independent and largely due to macrophage accu-
mulation in the spleen. Accumulation of marginal zone and red pulp macrophages was 
histologically and immunohistochemically confirmed. N-3 FA induced peripheral blood 
monocytosis and an aspccific increase in bone marrow cellularity. Post-endotoxin circulat-
ing TNF concentrations were significantly increased in n-3 FA-fed mice compared to 
controls. Splenectomy did not abolish this increase in circulating TNF. However, after 
macrophage depletion through liposomal CI2MDP, circulating TNF was not detectable after 
endotoxin challenge. Circulating concentrations of colony-stimulating factor-I (CSF-I) did 
not differ between the various experimental groups. It is suggested that the cellular changes 
observed relate to increased constitutive production of TNF. 
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Introduction 
N-3 fatty acids (FA) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA) are poly-unsaturated FA in which the last double bond is located between the third 
and fourth carbon atom from the methyl end of the fatty acid chain. Dietary supplemen-
tation with n-3 FA results in modification of the fatty acid composition of the cell 
membranes, thereby reducing the production and biological activity of prostaglandins and 
lcukotrienes l , More recently, dietary supplementation with 0-3 FA has been associated with 
modulations in the production of the pro-inflammatory cytokines interleukin-l (IL-l) and 
tumor necrosis factor (TNF), the principal polypeptide mediators of inflammation'·3. 
In cxperhnental studies, dietary supplementation with 11-3 FA has been shown to 
alleviate inflammation in various c1inical disease states and in animal models4- II , 
Preliminary evidence indicates that dietary n-3 fatty acid supplementation may increase 
resistance to infection in multi-trauma patients12• N-3 FA increase survival following 
endotoxic shock or infections with live microorganisms in various animal modcls13•18, and 
dietary n-3 FA increase IL-la and TNF production capacity of mouse peritoneal 
cells 15.19,20. In the course of our experiments in mice, we noticed a 1.5-fold increase in 
relative spleen weight in 11-3 FA-fed mice compared to controls. Similar observations have 
been reported by other groups studying mice or rats21 -23 . 
To elucidate the mechanism of the enhanced resistance to infections and possibly relate 
this to the increased spleen weight in mice, we studied the effects of dietary n-3 FA on 
the cellular composition of spleens, peripheral blood and bone marrow. Also, the effects 
of dietary n-3 FA on circulating concentrations of endotoxin-induced TNF and steady-state 
colony-stimulating factor-l (CSF-l) were investigated. 
Materials and methods 
Mice 
In most experiments. 6 weeks old female Swiss mice, approximate weight 25 g were used. 
The animals were housed in plastic cages (type II and type 1lI, Macrolon, Beyer en Egge-
laar, the Netherlands), under specific pathogen free conditions at 23 ± 2°C and 7 
ventilations/h. In some experiments, 1l00IDai female Balb/c and T-cell deficient female 
Balb/c nude mice (nulnu) were used. Nude mice were housed in cages covered with 
sterilized filter bonnets. 
Diet 
Mice were fed a fat-free standard reference diet as a dry powder, supplemented with 14% 
fish oil concentrate and 1 % corn oil (fish-oil group; FO), 15% corn oil (CO), or nonnal 
lab chow. The FO concentrate used was EPAX 3000 TO, a kind gift of Pronova, Bergen, 
Norway. The FO concentrate contained 37.1% n-3 FA, i.e. 17.7% EPA and 14.4% DHA 
(w/w). D-alpha tocopherol (0.67 mg/g) and a natural mix of tocopherols (0.525 mg/g) were 
added to avoid autooxidation. CO was a commercialy available preparation (MazoJa). 1 
% CO was added to the FO diet to avoid essential fatty acid deficiency. The FO 
concentrate was kept under strict anaerobic conditions until preparation of the diet to avoid 
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autooxidation. Diets were prepared at least twice per week, and kept at 4°C until adminis-
tration. 
Spleen analysis 
The mice were anesthesized with ether and blood was taken from the retrobulbar vessels 
after eye extraction. The animals were killed by neck dislocation and spleens were 
removed and weighed. Total body weight was detennined immediately before bleeding, 
and relative spleen weight was calculated afterwards. A suspension of spleen cells was 
made over a nylon filter, and celIs were counted with a Coulter counter. The effect of 
dietary n-3 FA on spleen weight was determined in normal Swiss mice, nOlTIlal Batb/e 
mice and T-celI deficient nude Balb/c mice (nu/nu). 
Spleen cells were phenotypically characterized with flowcytometry using a set of mono-
clonal antibodies specific for mouse celIs: 59-AD 2.2 detecting Thy I (T-Iymphocytes), 
RA3 6B2 detecting B220 (B-Iymphocytes), H129.19 detecting MT4 (CD4-positive T-
lymphocytes), 53-6.72 detecting Ly-2 (CD8-positive T-Iymphocytes), KT3 (CD3-positive 
T-Iymphocytes), and F4/80 (macrophages). Details concerning these antibodies can be 
found in Leenen et al. 24. 
After immunohistochemical staining of spleen sections with RA3 6B2 (anti-B220), a 
monoc1onal antibody specific for mouse B-cel1s, the relative surface area of white pulp was 
quantitated using a Leitz Diaplan light microscope and a VideopJan image processing sys-
tem. 
To analyze the role of mature phagocytic macrophages in the increase in spleen size, 
mice were fed FO for 0, 2, or 4 weeks. Subsequently the animals were injected'intra-
venously in the tail vein with I mg of liposomal dichloromethylene-biphosphonate 
(CI2MDP or clodronate), 24 h before LPS challenge, to deplete macrophages25. Control 
animals receiving the same diet were injected simultaneously with saline. Liposomal 
CI2MDP was prepared as described25. Spleen histology was studied in treated and untreated 
animals to verify macrophage depletion. 
Peripheral blood cells 
Peripheral blood celI count was performed by separately detennining hematocrit and the 
total white blood celIs count (using Coulter counter). Differential white blood celI count 
was perfonned by quantifying the light scatter profile of nucleated celIs. 
Bone marrow analysis 
Bone marrow was obtained from both femora of each mouse by flushing the femur shafts 
with 3 ml culture medium (RPMI, Dutch modification, Flow, Irvine, Scotland). Nucleated 
ce1ls were counted with a Coulter counter. Soft-agar cultures of bone marrow cells were 
stimulated with macrophage colony-stimulating factor (M-CSF) for 2 weeks and the 
number of macrophage precursors in the original preparation was quantitated by counting 
the number of macrophage colonies and clusters «50 celIs); macrophage colony forming 
celIs (M-CFC), and macrophage cluster fonning celIs (M-clustFC) are given per 10' 
nucleated bone marrow celIs (NBMC)26. NBMC were phenotypicalIy characterized with 
flowcytometry using monoclonal antibodies detecting antigens of mouse macrophage and 
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granulocyte precursors. The monoclonal antibodies were produced at the Department of 
Immunology, Erasmus University, Rotterdam, Netherlands, as described27 . The following 
monoclonal antibodies were used: ER-MPI2 and ER-MP20, identifying subpopulations of 
macrophage precursors, ER-MP58, identifying myeloid cells, and ER-MP2I, identifying 
transferrin-receptor expressing cells28. 
Post endotoxin circulatillg TN F 
1.5 h after i.p. administration of 10 ~g lipopolysaccharide (E. coli, serotype 055:B5, 
Sigma, St. Louis) (LPS), mice were anesthesized with ether and blood was taken from the 
retrobulbar vesscls aftcr eye extraction. Blood samples (approximately I ml) were mixed 
with 100 ~I EDTA-solution (21.4 mg/ml EDTA in HP) and kept on ice until centri-
fugation at 1500 g during 5 min. Resultant plasma was isolated and stored at _20°C until 
assay. 
TNFo: was measured by ELISA using TN3, a hamster monoclonal antibody specific 
for murine TNFa and lymphotoxin, as described29,30, 
In separate experiments, the effect of splenectomy on post-endotoxin circulating TNF 
was studied. Splenectomy was performed after ether anesthesia in four week old mice, two 
weeks before the animals were started on the experimental diets. 
CSF-J 
CSF-I was determined in unstimulated serum samples by specific RIA as described in 
detail elsewhere3). This assay is based on the competition by CSF-l for the interaction 
between 125I-labeled, purified mouse L cell CSF-I glycoprotein with a rabbit polyc1onal 
antibody to purified L cell CSF_1 32 and is more sensitive than the conventional CSF-I 
bioassay based on bone marrow colony fonnation. Assays were carried out in duplicate on 
20 l-tl samples. The concentration of CSF-I in units/ml (I unit= 12 pg) was determined with 
reference to a standard curve prepared using a stable, partially purified L cell CSF-I 
preparation. 
Statistical analysis 
Differences between groups were analyzed using the Kruskal-Wallis non-parametric 
ANaYA test, corrected for ties. Results were considered statistically significant at P-value 
< .05. 
Results 
Effects of FO sllpplelllelllatioll all spleell cel/lllarit)' 
The effects of dietary n-3 FA on spleen, peripheral blood, and bone marrow cells arc 
summarized in Table 1. The following experiments were done to elucidate the mechanisms 
of the increased spleen weight in FO fed mice. After four weeks of dietary supple-
mentation with FO or CO, experimental Swiss mice were compared with control animals 
on normal lab chow. FO fed mice had significantly increased relative spleen weights (P 
= 0.0 I) and spleen cellularity (P = 0.02). In separate experiments, time-effect relationships 
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in these responses were investigated. Mice were studied simultaneously after 0, 2, 4, and 
6 weeks of dietary FO supplementation. Increases in spleen weight were most prominent 
after 2 weeks and appeared somewhat blunted after 6 weeks (Fig. I A). Similar results were 
obtained in normal Dalble mice. To investigate whether the increase in spleen size was 
accounted for or mediated by T-cells, T-cell deficient female Balblc mice were fed FO for 
0, 2, or 4 weeks. Relative spleen weight was significantly increased from 2 weeks on, 
indicating that the increase in spleen weight was independent of the presence of T-cells 
(results not shown). 
Table 1 Effect of dietary n-3 FA on spleen, peripheral blood, and bone marrow cells 
Diet group 
Fish oil Com oil Normal P 
Spleen 
Relative spleen weight (mg/g) 5.9 ± 0.5 4.S ± 0.3 4.6 ± 0.2 0.01 
Splecn cellularity (x J08) 2.7 ± 0.2 2.0 ± 0.2 1.4 ± 0.5 0.02 
B220 positive spleen cells (%) 41 ± 4 36 ± 2 31 ±6 0.04 
Peripheral blood 
Hematocrit 43 ± 2.6 42 ± 3.2 43 ± 1.6 NS 
White blood cell count (x J06/mL) 12.2 ± 4.0 9.1 ± 1.9 7.9± 1.3 NS 
Lymphocytes (%) 55 ± 8 69± 4 64 ± 5 NS 
Granulocytes (%) 34 ± S 25 ± 4 31 ± 6 NS 
Monocytes (%) II ± 2 6±1 5 ± I 0.02 
Bone marrow 
Cellularity (x J06) 24 ± 5 21 ± 7 13 ± 5 0.02 
M-CFC 58 ± 15 51 ± 17 77 ± 20 NS 
(# macrophage precursorsl104 NBMC) 
M-clustFC 94 ± 22 SO ± 18 98 ± 27 NS 
(# macrophage precursors/IO~ NBMe) 
ER_MP2I hl (erythroid cells) (%) 22 ± 5 25 ± 3 22 ± 5 NS 
ER-MP5ShI (mycloid cells) (%) 50 ± 7 50 ± 2 54 ± 6 NS 
ER-MPI2h120- 1.2 ± 0.3 1.7 ± 0.2 1.6 ± 0.5 NS 
(conunitted progenitors) (%) 
ER-MPI2+20+ 5.4 ± 1.2 5.6 ± 0.5 5.0 ± 1.2 NS 
(immature myeloid precursors) (%) 
ER-MPI2-:1o'" 5.7 ± 0.9 6.2 ± 0.8 5.7 ± 1.2 NS 
(monocytes) (%) 
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Figure 1. Timc~cffcct relationships of dietary n-3 FA on relative spleen weight (A) and on post-endotoxin circula-
ting TNF (B). Relative spleen weight was significantly increased from 2 weeks on fish-oil diet on, as was post-
endotoxin circulating TNF (11=12). 
Phenotypical characterization of spleen cells using a set of monoclonal antibodies, 
revealed no percentual differences in T-Iymphocytes or macrophages between the various 
dietary groups. However, Fa fed mice had a small but significant increase in B220 
positive B-lymphocytes (Table I). 
Pretreatment with liposomal Cl2MDP 24 h before endotoxin challenge did not signifi-
cantly affect spleen weight. However, in mice that had been on Fa diet for 2 or 4 weeks, 
liposomal Cl2MDP resulted in a decrease in spleen weight (Fig. 2A). In these Fa fed mice, 
treatment with liposomal Cl,MDP resulted in spleen weights that were not significantly 
different from mice that had been on nonnal diet only. Depiction of marginal zone and red 
pulp macrophages was histologically confirmed but accurate quantitation of F4/80 positive 
macrophages was not possible in cell suspensions, where their numbers were equal in 
control and Fa fed mice. However, for other reasons (see below), the results indicate that 
the increase in spleen weight in FO fed mice is mainly attributable to an increase in the 
splenic macrophage popUlation that is depleted by pretreatment with lipo·somal CI2MDP. 
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Figure 2. Balb/c micc were fed fish oil for 0, 2, or 4 weeks. At the end of the die! period, subsets of mice were 
injected i.v. with liposomal CI2MDP 24 h before LPS challenge. In contrast to mice injected with saline, animals 
injected with liposomal CI2MDP did not show a significant increase in relative spleen weight following 2 or 4 
weeks of fish-oil supplementation (A). Post-endotoxin circulating TNF was not detectable in the Jiposomal 
Cli.1DP-treated mice (B). * Indicates a statistically significant difference compared to mice that had no fish oil 
diet. 
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To a lesser extent, B-lymphocytes seem to contribute to the increased spleen cellularity 
in FO fed mice. Quantification of the relative surface area of red and white pulp in spleen 
sections, indicated a decrease in T and B-cell containing white pulp (Fig. 3). A significant 
number of B220-positive B-cells, however, is also present in the red pulp. We therefore 
conclude that FO fed mice had a significantly increased content of red-pulp area, 
containing mainly macrophages. F4/80 staining of spleen sections, identifying the red pulp 
areas, confirmed the relative increase of the red pulp area in the FO fed mice. 
The effect of FO slIpplelllelllatioll all peripheral blood cells 
To investigate a possible relation between circulating blood cells and changes in spleen 
cellularity, peripheral blood cells were quantitated. Hematocrit did not differ between the 
various treatment groups. White blood cells count was higher in FO fed mice, but this 
difference did not reach statistical significance. Analysis of the light-scatter profile of 
peripheral blood cells showed a significant increase in percentage of monocytes in FO fed 
mice (P = 0.02, 11=6). 
The effect of FO supplementation all bane marrow cells 
Possible relations between changes in spleen and peripheral blood cellularity and the 
cellular composition of bone marrow were investigated. Bone marrow cellularity was 
significantly increased in FO fed mice compared with mice fed CO or nomml lab chow. 
This increase in bone marrow cellularity was equally distributed over the various 
hemopoietic lineages, since differential flow cytometric analysis of bone marrow cells, 
using ER-MPI2 and ER-MP20 monoclonal antibodies, showed no significant differences 
between the various experimental groups (Table 1). Moreover, soft agar cultures of bone 
marrow cells did not reveal a relative increase in macrophage precursors, measured as M-
CFC or M-clustFC. 
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Figure 3. Spleen sections were stained for B220, an antigen specifically expressed by mouse B cells. The relative 
surface area of white pulp was quantitated lIsing a Leitz Diaplan light microscope and a Videoplan image 
processing system. The boundaries of white pulp areas could be established easily since B 220 staining is 
confluent in the peripheral B cell zones of the white pulp but only scattered in the red pulp_ Relative surface areas 
are expressed as mean ± SD. 
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The effect of FO slIpplemelltatiall all post-endotoxin TNF 
To investigate the suggested increase in mononuclear phagocyte functionality, we measured 
circulating TNF concentrations after endotoxin challenge. PostMcndotoxin concentrations 
of circulating TNF were significantly higher in FO-fed mice than in control mice. Post-
endotoxin TNF was 10.4 ± 6.6 nglml in FO-fed mice, 2.2 ± 1.4 in CO-fed mice, and 2.7 
± 1.3 in mice fed nonnal diet (mean ± standard deviation, P < 0.05). In separate 
experiments, time-effect relationships in TNF production and FO diet were investigated. 
Similar to the increase in spleen weight, increases in post-endotoxin circulating TNF were 
most prominent after 2 weeks of FO diet, and appeared somewhat blunted after 6 weeks 
(Fig. IB). Post-endotoxin TNF in T-cell deficient nude Balblc mice was significantly 
increased from 2 weeks on, indicating that the increase in post-endotoxin circulating TNF 
was independent of the presence of T-cells (results not shown). 
Splenectomy, performed 2 weeks before starting on the FO supplemented diet, did not 
influence the increase in post-endotoxin circulating TNF concentrations after 2 and 4 
weeks of diet: at both timepoints, post-endotoxin circulating TNF concentrations were 
significantly increased compared to baseline (results not shown). At baseline and at 2 and 
4 weeks of dietary FO supplementation, post-endotoxin circulating TNF was not detectable 
in liposomal Cl2MDP-treated mice (Fig. 2B). These observations suggest that splenic 
macrophages, despite their accumulation after dietary FO supplementation, are not the most 
important contributors to the production of circulating TNF. On the other hand, the 
macrophage population that is depleted by Iiposomal CI2MDP and that does not reside in 
the spleen, appears to be the most important producer of post-endotoxin circulating TNF. 
The effect of FO supplementatioll all circulating COllcelltratiollS of CSF-J 
The mononuclear phagocyte growth factor, CSF-I, is required for the development of the 
majority of mouse macrophages33 . To accurately measure circulating concentrations of 
CSF-I, serum samples were subjected to a mouse CSF-I specific RIA. In biological 
samples, tltis RIA detects only biologically active CSF_I l2.J", including both glycoprotein 
and proteoglycan fonns35 . Circulating concentrations of immunoreactive CSF-l did not 
differ between the various diet group: 702 ± 89 U/ml in FO-fed mice, 753 ± 96 in CO-fed 
mice, and 802 ± 158 in mice fed normal diet (mean ± standard deviation, p ;:::; 0.40). 
Discussion 
The present study shows that dietary n-3 FA supplementation has a significant effect on 
the generation and distribution of mononuclear phagocytes in mice: n-3 FA induce a 
generalized increase in bone marrow cellularity, peripheral blood monocytosis, and 
accumulation of macrophages in the spleen leading to an increase in spleen size. What 
could be the mechanism of these n-3 FA-induced changes? 
The aspecific increase in bone marrow cellularity without preferential stimulation of 
monocytopoiesis is in accordance with our observation on CSF-I: this speci fic monocyte 
growth factor was not increased in the n-3 FA fed mice. The generalized increase in bone 
marrow cel1ularity suggests that earlier, broad spectrum hematopoietic growth factors such 
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as interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) 
are involved. The production of these factors is largely regulated by pro-inflammatory 
cytokines including IL_I 36•37. We have previously shown that IL-lo: production capacity 
is increased in mice after d"ietary n-3 FAls. Increased constitutive production of this 
cytokine may be involved in the increased bone marrow cellularity observed in the present 
study. Moreover, Pelus and others have shown that PGE2 has an important modulatory 
effect on hematopoiesis in mice: exogenous administration ofPGE2 reduced nucleated bone 
marrow and splenic cellularity, while blockadc of PGE, biosynthesis increased bone 
marrow and splenic cellularity, especially in the presence of IL-l a 3S.41 . These observations 
may partly explain the results obtained in the present study, since dietary supplementation 
with n-3 FA in mice basicaHy leads to increased IL-Ia and a decreased PGE2 production 
capacity. 
Peripheral blood monocytosis induced by dietary n-3 FA has not been described before, 
but may be induced through a feed-back mechanism following the accumulation of 
macrophages in the red pulp of the spleen. It is apparently not due to increased concentra-
tions of CSF-l. This is in accordance with the observation that the number of red pulp 
macrophages is only slightly reduccd in CSF-l deficient op/op mice4'. Other factors, 
including IL-3, GM-CSF, and the pro-inflammatory cytokines may be considered. The 
results of our experimcnts with macrophage depletion using liposomal Cl,MDP suggest 
that the observed increase in splecn size following dietary Fa supplementation is largely 
due to accumulation of macrophages in the spleen. The immunohistochemical staining of 
spleen sections with B220 showed a decrease in the relative surface area of white pulp in 
the Fa-fed mice, thcrcby supporting the concept of accumulation of red-pulp macrophages 
in Fa-fed mice. As regulator cells, macrophages are responsible for the growth of 
lymphoid organs such as the spleen. Since TNF is an important growth factor for lymphoid 
organs, increased endogenous TNF production in Fa-fed mice may contribute to this 
effect43 . The phenotypical characterization of spleen cell suspensions using a set of 
monoclonal antibodies is not suitable for the assessment of the number of macrophages in 
the spleen, since especially tissue-fixed macrophages are lost in the process of making a 
cell suspension over a nylon filter. We therefore regard the concept that dietary Fa 
supplementation leads to macrophage accumulation in the spleen as valid. 
The increase in spleen size after dietary n-3 FA appeared to be accompanied by 
increased circulating concentrations of post-endotoxin TNF. We and others have previousy 
shown that peritoneal macrophagcs of mice fed n-3 FA have increased TNF production 
capacity at the level of the single cell I S,'OA'. Since splenectomy did not affect the increased 
TNF concentrations foHowing dietary n-3 FA, macrophage accumulation in the spleen is 
not responsible for the increased TNF concentrations. Interestingly, macrophage depletion 
by liposomal CI,MDP completely abolished post-endotoxin circulating TNF. It might be 
expected that Kupffer cells of the liver, due to their sinusoidal location, might be a major 
target for the uptake of liposomal CI2MDP. In fact, recent evidence indicates that 
macrophage depletion in mice results in a 50-70% reduction in TNF mRNA in the Jiver 
following endotoxin challenge". Therefore, the Kuppfer cells may be the most important 
contributors to the production of post-endotoxin TNF. Similar to peritoneal macrophages, 
Kuppfer cells may have increased TNF production capacity at the single cell level 
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following dietary n-3 FA. We did not assess the number of Kupffer cells. The small 
increase in relative liver weight in FO-fed mice does not rule out a substantial increase in 
the number of Kupffer cells. 
In conclusion, dietary n-3 FA supplementation in mice induces an aspecific increase 
in bone marrow cellularity. peripheral blood monocytosis, accumulation of macrophages 
in the spleen. and increased post-endotoxin circulating concentrations of TNF. The 
mechanism of these changes remains to be elucidated. 
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Background of the study 
Mature macrophages fOlm a phenotypically and functionally heterogeneous population 
of cells, widely distributed throughout the body. In the concept of the mononuclear 
phagocyte system, the extensive heterogeneity of these cells is thought to be generated 
at the level of the monocyte entering the tissue microenvironments I. However, 
throughout the years data have accumulated in favor of additional origins of mono-
nuclear phagocyte heterogeneity, such as the generation of separate, self-maintained 
macrophage lineages already in ontogeny, or the existence of macrophage sublineages 
at the level of precursors in bone maITOW or monocytes in blood2-4. Data suggesting the 
existence of distinct differentiation lineages in the bone marrow, each giving rise to 
different types of mature macrophages, have originally been reported by Bursurker and 
Goldman5,6. However, studies to examine this notion in more detail, have been 
seriously hampered by the limited characterization and low frequency of macrophage 
precursors, and, in general, myeloid-committed progenitors in the bone maITOw. One 
way to approach this difficulty is to identify cell surface markers that can be used to 
isolate macrophage progenitors from mouse bone maITOW by fluorescence-activated cell 
sorting. For this purpose, a panel of monoclonal antibodies has been generated pre-
viously against immortalized macrophage progenitor cells7,8. One of these antibodies, 
ER-MP58, was found to detect all M-CSF-responsive bone marrow cells, while two 
others, ER-MPI2 and ER-MP20, were shown to detect phenotypic heterogeneity among 
macrophage precursors8• It was not clear, however, whether the observed heterogeneity 
in macrophage precursor phenotype in bone maITOW reflected the existence of macro-
phage sublineages, or different stages in maturation along a linear differentiation 
pathway. The aim of the studies described in this thesis was (i) to isolate phenotypic-
ally distinct macrophage precursor subsets from mouse bone maITOW using the anti-
bodies from the previously produced panel in order to investigate the nature of the 
observed phenotypic heterogeneity, and (ii) to separate and purify myeloid/macrophage 
progenitors from bone maITOW cell suspensions with other or broader hematopoietic 
differentiation potential, in order to facilitate studies on the processes involved in 
commitment to the myeloid/mononuclear phagocyte lineage. 
Identification of macrophage progenitor subsets in mouse bone 
marrow on the basis of differential ER.MP12, ER·MP20, and ER· 
MP58 monoclonal antibody binding 
To identify different "Subpopulatiolls of macrophage precursors in the bone marrow of 
the mouse, the reactivity of the ER-MPI2 and ER-MP20 monoclonal antibodies with 
M-CSF-responsive macrophage precursors was assessed in two-color flow cytometry. 
Using these antibodies, six phenotypically distinct bone marrow subsets could be 
discerned9. In chapter 3 we showed that M-CSF-responsive macrophage progenitors 
were confined to three of these subsets, the ER-MPI2hi20-, ER-MPI2+20+, and ER-
MP12-2o"i, in a frequency of 1:8, 1:9, and 1:2 plated cells, respectively. Together these 
subsets comprised about 15% of nucleated bone malTOW cells. Interestingly, the ER-
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MPl2h;20-, ER-MPI2+20+, and ER-MPI2-20h; M-CSF-responsive macrophage precur-
sors differed in their proliferative capacity. The highest proliferative potential was 
found among ER-MPI2h;20- cells, and loss of proliferative potential appeared to 
coincide with an upregulation of ER·MP20 expression. These data were suggestive of a 
difference in maturation stage between the ER-MPI2h;20-, ER-MPI2+20+, and ER-
MPIZ-2o"; subsets. This notion was confirmed by assessing the phenotypic develop-
ment of the putatively least mature ER-MPI2h;20- precursors at different time points 
during M-CSF-stimulated culture. The developing cells successively passed through 
ER-MPI2+20+ and ER-MP12~20hi stages before final maturation into mature macro-
phages. Therefore, we concluded that the three phenotypically distinct M-CSF-respon-
sive bone marrow macrophage progenitor subsets most likely represent successive 
stages along a maturation pathway in the order ER-MPI2h;20- ~ ER-MPI2+20+ ~ 
ER-MPI2-20h;. To our knowledge, this combination of ER-MPI2 and ER-MP20 
monoclonal antibodies provides the tirst positive identification of discrete, successive 
stages of M-CSF-responsivc bone marrow mononuclear phagocyte development. 
In addition to M-CSF-responsive macrophage progenitors, both the ER-MPl2h;20-
and ER-MP12+20+ subsets also contain immature hematopoietic cells with other 
functionally defined differentiation capacities. In the ER-MPI2h;20- subset these are: 
primitive hematopoietic stem cells (detennined both in the CAFC and LTRA assay)lO, 
CFU-S-day 12 10, progenitor cells with thymus-repopulating potential (chapter 4), cells 
capable to confer cady peripheral blood reconstitution in the erythroid lO• and myeloid, 
Band T cell lineages (chapter 4) upon intravenous transfer into irradiated recipients, 
and CFU-C'o. It should be noted that these hematopoietic cells are not confined to the 
ER-MPI2h;20- subset; the ER_MPI2mod20- bone marrow population also contains these 
stem and progenitor cell subsets (ref. 10 and chapter 4). In addition, the ER-MPI2+20+ 
subset contains also some CFU-C, but no more primitive progenitorsJO. Morphological 
analysis of the ER-MPI2+20+ subset further showed that it contains recognizable 
precursors of the granulocytic, erythroid, and lymphoid lineages (chapter 3). However, 
as about 80% of the ER-MPI2+20+ cells express the myeloid antigen Or-I (unpublished 
observation), the m'\iority of this subset belongs to the myeloid lineages. Thus, although 
the ER-MPl2h;20- and ER-MPI2+20+ bone malTOW subsets are both highly enriched for 
macrophage precursors, additional cell surface markers are required to separate early 
macrophage precursors from other hematopoietic progenitors. We consider the ER-
MPI2-20h; subset of high lineage homogeneity, as (i) only monocytic cells and their 
putative precursors arc found in this subset (discussed in chapter 7) and (ii) virtually all 
cells express the mononuclear phagocyte marker F4/80 (unpublished observations), 
which has been reported on late stages of bone marrow mononuclear phagocyte 
development". 
As stated above, of the three macrophage precursor-containing bone marrow subsets, 
only the ER-MPI2h;20- subset contained early progenitor cells with other or broader 
than myeloid differentiation capacities. Since the presence of in particular multi- or 
pluripotent cells can seriously interfere in studies on early macrophage development, we 
searched for additional cell surface markers allowing the separation of myeloid-
committed cells from other hematopoietic stem and progenitor cells present in the ER-
General discussion 145 
MP12hi20- subset. In chapter 5 we showed that by using ER-MP58 monoclonal anti-
body previously found to detect all M-CSF-responsive progenitors in mouse bone 
malTow8, early myeloid-committed cells can be separated from other hematopoietic 
progenitor and stem cells residing in the ER-MPI2h;20- bone marrow population. This 
conclusion is based on functional data obtained ill vitro as well as ill vivo. M-CSF- and 
GM-CSF-responsive cells were predominantly found in the subpopulation of ER-
MP12h120- cells with a high level ER-MP58 expression (at average 84% and 59% of all 
recovered M-CFC and GM-CFC, respectively). On the basis of this high ER-MP58 
expression, these myeloid precursors could be separated from the large majority of cells 
with the capacity to develop along the B cell lineage (ER_MP58m,d), the T cell lineage 
(ER-MP58-no or ER_MP58m,d), and the erythroid lineage (ER-MP58""d). Primitive 
hematopoietic stem cells (CAFC-d28/35) were not found among cells with high level 
ER-MP58 expression. Thus, with three-color cell sorting using ER-MP58, combined 
with ER-MPI2 and ER-MP20 monoclonal antibodies, mouse bone marrow cells 
committed to the myeloid lineage can be separated from progenitor cells with other 
and/or broader differentiation capacities. 
One might argue that the ER-MP58 monoclonal antibody used to label the bone 
marrow cells blocks the antigen and thereby abrogates differentiation in the lymphoid 
and erythroid lineages. Such a phenomenon could underlie the apparent absence of 
lymphoid and erythroid progenitors from the ER-MP58h; subpopulation of ER-
MPI2h;20- cells. Although we cannot exclude this possibility fonnally, several data 
argue against it. First, ER-MPI2hi20- progenitor cells with proven capacity to develop 
along the lymphoid and erythroid lineages do express the ER-MP58 antigen, albeit at 
an intermediate instead of a high level (chapter 5). Second, the light scatter characteris-
tics of the ER-MP58 subsets of the ER-MPI2hi20- population correspond with the 
observed differentiation capacities: ER_MP58-no cells appear to be a population of small 
lymphocytic cells, while the ER_MP58m,d and ER-MP58h; cells are characterized by 
more blast-like light scatter characteristics. The somewhat higher sideward scatter of 
the ER-MP58hl cells compared to ER-MP58""d cells is suggestive of a myeloid nature 
of the ER-MP58h; cells (data not shown). Third, in total bone marrow, morphologically 
recognizable stages of lymphoid and erythroid development are characterized by a 
negative to low ER-MP58 expression, whereas cells in different stages of myeloid 
development express the antigen at a high level (chapter 5). Together, these data make 
it very unlikely that cells with a lymphoid or erythroid differentiation capacity would 
reside among ER-MP58hi cells in the ER-MPI2hi20- subset. However, definitive proof 
on this issue requires the functional characterization of the ER-MP58 antigen. 
ER-MP12 monoclonal antibody recognizes PECAM-I/CD31 
Only recently, the ER-MPI2 antigen has been identified as the platelet endothelial cell 
adhesion molecule PECAM-I/CD31 12. PECAM-I/CD31 is a transmembrane glyco-
protein of the immunoglobulin gene superfamily of cell adhesion molecules 13· 16. Its 
expression has been studied most extensively in human (see for a review Watt et a1,17), 
where it has been reported on platelets13,1··19, endothelial cells2o•21 , neutrophilsI4.1 •. 22.23, 
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monocytes 14,18,22, bone marrow macrophages24, T lymphocyte subsets25 ,26, granulocytc-
macrophage prccursors22, and CD34+ hematopoietic progenitor cells in bone marrow27 
and cord blood2S• In an inflammation model in the mouse, PECAM-I/CD31 was shown 
to be essential for the transendothelial migration of leukocytes29, However, the expres-
sion of PECAM-I on mouse hematopoietic cells is less well documented than in 
human30,3l, TIle work described in this thesis, together with previous studies using ER-
MPI2 monoclonal antibody,,32,33 provide a comprehensive picture of ER-
MPI2IPECAM-I expression in mouse bone marrow hematopoiesis. The majority of the 
most primitive hematopoietic stem cells (CAFC-day 28/35 and LTRC) expresses ER-
MPI2IPECAM-I at an intermediate level 10. Upon stem cell maturation, ER-MPI2/ 
PECAM-t expression increases to a high level on the majority of less primitive 
progenitor cells (CAFC-day 5)10 and most ill vitro clonable progenitors (chapter 3 and 
ref. 10). Late stages of myeloid development (monocytes and band/segmented neutro-
phils) as well as late stages of erythroid development (polychromatophilic erythroblasts 
and nonnoblasts) do not, or only at a low level express the antigen (chapters 3 and 7; 
ref. 10). In human, downregulation of PECAM-I expression has also been reported for 
the postproliferative stages of granulocyte development, although in human PECAM-I 
continues to be expressed on those cells2l • In mouse T cell development, ER-MPI2/ 
PECAM-I is expressed at a high level on cells with the capacity to home to and 
repopulate the thymus of irradiated mice (chapters 4 and 5), and at an intemlCdiate 
level on mature T cells!o. During B cell development, ER-MPI2/PECAM-I expression 
is transiently upregulated in the CFU-pre-B stage (chapter 5). However, the large 
majority of B220-positivc cells in the bone marrow is characterized by an intermediate 
ER-MPI2IPECAM-I expression level (chapter 4 and ref. 10). In conclusion, the pattern 
of PECAM-I expression in the mouse hematopoietic system as detected by ER-MPI2 
monoclonal antibody staining in general confinl1s and extends the data on PECAM-l 
expression in human. Differences in epitopes recognized by anti-human and anti-mouse 
PECAM-i monoclonal antibodies might explain discrepancies in expression levels 
detected on late stages of myeloid development in human versus mouse. Cell type-
specific PECAM-I epitope expression, as a result of differences in splice variant 
expression or glycosylation, have previously been reported17 . In addition, such varia-
tions in epitope expression might also exist between human and mouse PECAM-l. 
Based on the broad expression of this adhesion molecule among human hemato-
poietic and stromal bone marrow components, a central role for PECAM-lICD31 in the 
regulation of hematopoiesis has been suggested!?'''. First, PECAM-I might be involved 
in the formation of the stromal cell - extracellular matrix network in which hemato-
poietic precursors develop!? Second, PECAM-I could be involved in homotypic 
adhesion of hematopoietic progenitor cells to stromal macrophages which produce an 
array of hematopoietic regulatory molecules34 . Alternatively, hematopoietic progenitors 
may bind in a heterotypic manner via PECAM-I to heparan sulfate proteoglycans on 
stromal cells or in the extracellular matrix. Heparan sulfate is known to bind and 
thereby concentrate certain hematopoietic growth factors in the extracellular matrix35,36. 
Together, in this way PECAM-I could be involved in guiding hematopoietic cells 
through the bone marrow microenvironmental niches that support early hematopoiesis. 
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It should be noted however, that in the mouse heterotypic adhesion has not yet been 
observed". Third, PECAM-I might be involved in regulating the release of mature 
hematopoietic progenitors from the bone marrow into the circulation 17,23. Future 
experiments, e.g. ill vivo antibody blocking studies or the generation of PECAM-I 
knock out mice, will have to reveal the validity of these hypotheses. 
ER·MP12 and ER·MP20 labeling of mouse bone marrow provides a 
flow cytometric alternative to differential counting 
We found that the combillatioll of ER-MPI2 and ER-MPZO monoclonal antibodies 
divides mouse bone marrow into six subsets with remarkable cell type homogeneity 
(chapter 3 and ref. 10). These are (I) an early blast cell population containing early 
progenitors for all hematopoietic lineages as well as some hematopoietic stem cell 
subsets (ER-MPIZh;ZO-), (Z) a lymphoid population, which also contains hematopoietic 
stem cells (ER_MPIZm,dZO-), (3) an erythroid population (ER-MPIT20-), (4) a subset 
with mainly progenitors for both granulocytes and monocytes (ER-MPI2+20+), (5) a 
granulocytic population (ER-MPI 2-:20m,d) and (6) a monocytic (ER-MPI2-Zo";) 
population. This finding prompted us to examine whether ER-MPI2120 subset analysis 
could be used as an alternativc method for the asscssment of cel1ular bone marrow 
composition. In chapter 7 we demonstrated the validity of this method in an cxperimen· 
tal ill vivo model. Data on myeloid, lymphoid, and erythroid population sizes obtained 
from ER-MPI2120 subset analysis conelated strongly with data obtained from flow 
cytometric analysis of lineage marker cxpression Of from morphological analysis of 
May·GrUnwald/Giemsa stained bone marrow cytospins. TIle advantage of ER·MP12120 
subset analysis over differential counting is that it does 110t require specific expertisc on 
morphological recognition of mouse bone marrow cells, that it is objectivc, and less 
time consuming. Compared to lineage marker analysis, ER·MP12120 analysis gives 
additional infomlation on subsets of myeloid progenitors, whereas this information is 
difficult to obtain by analysis using other markers, e.g. Gr-!. 
The myeloid subsets discerned by ER-MPI2120 analysis differ from those distin-
guished by differential counting. By morphological analysis immature myeloid progeni-
tors, band and segmented neutrophils, monocytes, and eosinophils are distinguished. 
The ER-MP I 2+20+, ER-MPIT20""d and ER-MPI Z-20h; subsets however, represent 
phenotypically distinct developmental stages of the myeloid lineage, with a high lineage 
homogeneity in the ER-MPI2-20""d (granulocytic) and ER-MPI2-20h; (monocytic) 
subsets, rather than the different classes of myeloid progenitors identified by differential 
counting. The ER-MPI2+20+ subset contains colony- and cluster-fonning cells of both 
the monocyte/macrophage and granulocyte lineages (chapter 3 and unpublished obser-
vations). As in the granulocytic ER-MPIT20""d subset no proliferation could be 
observed in GM-CSF-stimulated cultures (chapter 6), we conclude that this subset 
contains postproliferative (i.e. post-myelocyte) stages of granulocyte development only. 
Morphological analysis of this subset, revealing over 90% band and segmented neutro-
phils (chapter 3, ref. 10), supports this notion. In the monocytic ER-MPIZ-2o"; subset 
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only small (primarily < 5 cells) clusters were fonned (chapter 3). As monoblasts have 
been reported to divide once to give rise to promonocytes, which in turn also divide 
once to give risc to monocytes37, we conclude that the ER-MP12-20hi subset contains 
cells from the monoblast stage onwards, with the majority of this subset consisting of 
monocytic cells (chapter 3, ref. 10). 
In chapter 8, ER-MP12/20 bone marrow subset analysis was used to detemline 
cellular bone marrow composition in a study on the effects of dietary fish oil supple-
mentation in mice. Dietary fish oil supplementation has been shown to enhance 
resistance to infections in various animal models38. To elucidate the mechanism of 
enhanced resistance to infections, the effect of dietary fish oil on the cellular composi-
tion of, among others, bone marrow was examined. An increase in bone marrow 
cellularity was observed in mice fed fish oil, compared with mice fed nonnal lab chow. 
However, no changes in bone marrow composition were detected by ER-MPI2120 or 
lineage specific marker analysis. Moreover, in agreement with the ER-MPI2120 subset 
analysis, M-CSF-stimulated soft agar cultures of bone marrow cells did not reveal 
changes in macrophage colony- or cluster-forming cell frequency. Thus, dietary fish oil 
supplementation in mice induced an aspecific increase in bone marrow cellularity, 
without changing its composition. It should be mentioned that ER-MPI2120 subset 
analysis (as well as lineage marker and morphological analysis) relies on phenotypic 
characteristics of bone marrow cells. Thus, when in an experimental model no changes 
in cellular composition can be detected by ER-MPI2120 (or conventional) bone marrow 
analysis, this does not formany exclude functional alterations of the cells. Nevertheless, 
the data on bone marrow composition obtained in chapter 8 extend and support the use 
of ER-MPI2120 subset analysis as an alternative method to determine cellular bone 
marrow composition in experimental mouse models. 
Does mononuclear phagocyte heterogeneity originate already at the 
level of precursor cells in the bone mal'l'ow? 
To approach the question whether mononuclear phagocyte heterogeneity is generated 
also at the level of precursor cells in the bone marrow, we set out to identify macro-
phage precursor ceBs in mouse bone marrow. In this study, we showed the existence of 
three phenotypically distinct macrophage precursor subsets, detected on the basis of 
their differential ER-MPI2 and ER-MP20 antibody binding. Upon examination of the 
nature of the observed phenotypic heterogeneity, it was found that these subsets reflect 
successive stages of M-CSF-responsive mononuclear phagocyte development (chapter 
3). Thus, the phenotypic heterogeneity detected among macrophage precursors with ER-
MPI2 and ER-MP20 monoclonal antibodies in two-color flow cytometry, does not 
reflect distinct precursor subsets which will give rise to different lineages of mature 
macl'Ophages. However, these data do not imply that such precursor subsets are non-
existent. Rather, the ER-MPI2 and ER-MP20 monoclonal antibodies provide new tools 
to search for macrophage precursor heterogeneity within three discrete, successive 
stages of bone marrow mononuclear phagocyte development. In a preliminary study, we 
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have detected in three-color flow cytometry additional phenotypic heterogeneity among 
the monocytic ER-MP12-20"; subset, using several of the mononuclear phagocyte 
markers described in chapter 2 (unpublished data). It will be interesting to extend this 
study and investigate whether separate precursors, e.g. for DC, can be identified in this 
way. In analyses of the ER-MPI2h;20- subset, the ER-MP58 monoclonal antibody 
should be included to separate the myeloid-committed progenitors from muIti- or 
pluripotent progenitor and stem cells present in this popUlation (chapter 5). This is 
important as the presence of such multi- or pluripotent cells may influence the outcome 
of functional experiments with isolated bone marrow subsets. 
Given the vast heterogeneity in the mononuclear phagocyte system, it is difficult to 
define strictly separated subsets of mature end cells, which is a prerequisite for unambi-
guous identification of lineage-specific precursors. However, the DC forms a good 
starting point to explore the existence of separate differcntiation lineages within the 
mononuclcar phagocyte system as this mature cell can be readily distinguished from 
other end stages of mononuclcar phagocyte developmcnt on the basis of its characteris-
tic "dendritic" morphology, high MHC class II expression and T cell-stimulating 
activity in thc mixed leukocyte reaction. 
So far, three possible precursors for DC have becn suggested, which appear to exist 
next to each other. First, a Iineagc relationship with thc myeloid lineage has been 
shown by identification of a common class II-negative granulocyte!macrophage/DC pro-
gcnitor'9. Beyond this stagc, a lineage relation with the mononuclear phagocyte system 
was demonstrated by identification of bipotent macrophage/DC precursors along the 
myelomonocytic pathwalo-43. Second, a separate DC progcnitor has been reported in 
human41 ,42,44. This progenitor was shown to express CDla as a specific marker and has 
becn suggested to give rise to Langerhans cells41 •42. Such a progenitor has not yet been 
identified in the mouse. Third, a lymphoid origin for DC has been reported45•46. In the 
mouse, lymphoid DC were recently shown to differ from myeloid DC in that they 
express CD8o:46. These CD8o:-positive DC were found to induce only a limited T cell 
proliferation compared to CD8a-negative DC47 and may even induce apoptosis in CD4+ 
T cells4'. Thus, DC are specialized end cells of the mononuclear phagocyte system. In 
addition, other pathways for DC development exist for specific types of mature DC. 
As different stages of myeloid development can be isolated from other hemato-
poietic cells on the basis of ER-MPI2120/58 fractionation of bone marrow, we were 
interested in examining in which of the ER-MPI2/20/58-defined bone marrow subsets 
GM-CSF-responsive DC precursors reside (chapter 6). Microscopic inspection of 
cellular morphology and immunocytochemical analysis of MHC class II expression 
revealed that .DC-Iike ceBs were generated from bone marrow subsets containing 
precursors of the macrophage lineage (Le. ER-MPI2h;20-58hl , ER-MP I 2+20+, and ER-
MP12-2o";, while no such cells could be grown from the lymphoid, erythroid, or 
granulocytic subsets. These data suggest that bone marrow DC and macrophage 
precursors follow the same ER-MPI2120/58-defined maturation pathway. Indeed we 
showed that cells with the capacity to differentiate into DC-like cells are still present in 
day 4 to 5 M-CSF-stimulated cultures of sorted ER-MPI2120 bone marrow subsets. 
These experiments are in line with the hypothesis that over a prolonged developmental 
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stretch precursors of the mononuclear phagocyte system may either develop into 
monocytcs/macrophages or DC, depending on local concentrations of specific growth 
factors. However, as no clonal assays were applied in this study, it is also possible that 
the DC-like ceHs are (in part) generated from a separate DC-precursor with an ER-
MP 12120 phenotype identical to the developing mononuclear phagocytes. Conclusive 
data on this issue require further experimentation. 
Early ER-MPI2hi20- GM-CSF-responsive DC precursors can be separated from 
lymphoid progenitors present in that subset on the basis of differential ER-MP58 
expression (chapters 5 and 6). Therefore it will be interesting to test the ER_MP58-no, 
ER_MP58m'd and ER_MP58hi subsets of the ER_MPI2hi20- bone matTOW population for 
the presence of lymphoid-related DC precursors'6, as opposed to the currently studied 
myeloid-related DC precursors. Possibly, progenitors for lymphoid-related DC can be 
separated from those of myeloid-related DC on the basis of differential ER-MP58 
expression. 
Conclusion and future directions 
The studies conducted in this thesis have advanced the phenotypic ideatification of 
early stages of mononuclear phagocyte development. On the basis of differential ER-
MP12 and ER-MP20 expression three successive stages in development can currently 
be isolated from mouse bone marrow: i.e. ER_MPI2hi20- ~ ER-MPI2+20+ ~ ER-
MP1T20hi • In addition, with three-color ceH sorting using ER-MP58, combined with 
ER-MPI2 and ER-MP20 monoclonal antibodies, early ill vitro colony-forming myeloid-
committed ceHs can be separated on the basis of differential ER-MP58 expression from 
progenitor cells with other or broader differentiation capacities. To our knowledge. the 
combination of ER-MPI2 and ER-MP20 monoclonal antibodies provides the first 
positive identification of discrete, successive stages of M-CSF-responsive bone malTOW 
mononuclear phagocyte development. In addition, including ER-MP58 in the ER-
MPI2120 combination aHows for the separation of early myeloid-committed cells from 
other hematopoietic progenitors. We expect that the ER-MPI2, ER-MP20 and ER-
MP58 antibodies will prove valuable tools in (i) further elucidating the origins of 
mononuclear phagocyte heterogeneity, and (ii) studies on the processes involved in 
commitment to the myeloid/mononuclear phagocyte lineage. In addition, as bone 
marrow is divided into six subsets with remarkably high lineage homogeneity in two-
color flow cytometry using ER-MPI2 and ER-MP20 monoclonal antibodies, the 
combination of these two antibodies can be used as a relatively simple, rapid and 
objective method for the determination of ceHular bone marrow composition. In Fig. I 
a summary of presently available data on ER-MPI2, ER-MP20, aad ER-MP58 antigen 
expression dudng hematopoietic differentiation in mouse bone marrow is presented. 
Sublineages of the mOl/onuclear phagocyte system 
Multi-parameter ftowcytometric analysis of bone man'O\v with ER-MPI2120/58 in com-
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Figllre 1. Schematic representation of differential ER-MPI2, ER-MP20, and ER-MP58 expression during 
hematopoiesis in adult bone marrow, summarizing currently available data. LTRC: long-term repopulating 
cell; DC: dendritic cell; CFU-GM: colony-forming unit-granulocyte/macrophage; CFU-M: colony-fonning 
unit-macrophage; M$: macrophage; CFU·G: colony-fonning unit-granulocyte; PMN: polymorphonuclear 
granulocyte; CFU-E: colony-fonning unit-erythroid; E: erythrocyte; CFU-pre-B: colony-fomling unit pre-B. 
CFU-pre-B could be generated from ER-MPI2hI20- and ER_MPI2m,-.120· bone marrow subsets only. From the 
other ER-MP12!20 subsets no CFU·pre-B were grown (unpublished data). 
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bination with other, subHneage specific antibodies may lead to the identification of 
precursors of hematopoietic ceUs related to the mononuclear phagocyte system, e.g. 
precursors of DC49,50, osteoclasts51 , natural kiHer cel1s52-54, and CDS-positive B 
cells"·56. Identification of such precursor cells would facilitate studies on the processes 
involved in sublineage commitment, e.g. the role of specific cytokines and differentially 
expressed genes. Likewise, it will be interesting to search for separate precursors for 
bone marrow-derived macrophages which differ in e.g. antigen presentation, phagocytic 
capacity, cytotoxicity, cytokine production. or ;11 vivo localization pattern after 
intravenous transfer into conditioned recipient mice57,58, 
In recent years many mutant mice have been described which show a defect in the 
mononuclear phagocyte system59,60. In several of these mice specific mononuclear 
phagocyte subpopulations are affected. For instance in the M-CSF -/- op/op mouse, 
peritoneal macrophages, osteoclasts and spleen methallophils are almost completely 
absent, while other macrophage populations are only partially or not at all affected61 .62. 
Furthermore, mice with a nuB mutation in the c·fos proto· oncogene completely lack 
osteoclasts due to a block early in osteoclast differentiation63 . Phenotypic examination 
of the bone marrow of these and other mutant mice may aid in the identification of 
possible sublineage specific precursor cells, as particular precursor subsets may be 
absent from such mice. 
Myeloid commitment 
We showed that on the basis of three-color cell sorting using ER-MP58, combined with 
ER-MPI2 and ER-MP20 monoclonal antibodies, cells committed to the myeloid lineage 
can be separated from progenitor cells with other or broader differentiation capacities. 
At present, it is largely unknown what the crucial events are in lineage·commitment of 
hematopoietic progenitor cells. Therefore, identification of genes which are differen-
tially and specifically expressed by ER-MP58hi myeloid-committed cells versus other 
ER_MP58-no and ER_MP58m'd progenitor cells, may shed light on the fate detennining 
steps in commitment of progenitor cells. In addition, this approach probably will 
provide new functional markers for monitoring the differentiation of myeloid cells. 
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Mature rnacrophages fonn a functionally and phenotypically heterogeneous population 
of cells widely distributed throughout the body. Several mechanisms contributing to 
mature macrophage heterogeneity have been suggested. 111ese are (i) induction of 
heterogeneity by local conditions or stimuli encountered in peripheral tissues; (ii) the 
existence of self-maintained, bone marrow-independent macrophage populations gener-
ated early in ontogeny; and (iii) heterogeneity resulting from differences at the macro-
phage precursor level. At present, many questions still exist concerning the precise 
contribution of each of these mechanisms to mature macrophage heterogeneity. 
In depth studies on the existence of distinct macrophage precursors in bone marrow 
have been seriously hampered by limited characterization and low frequency of macro-
phage precursors, and, in general, myeloid-committed progenitors in mouse bone 
manow. Therefore, the aims of this thesis were (i) to identify different stages of bone 
marrow mononuclear phagocyte development using anti-macrophage precursor mono-
clonal antibodies previously generated in our laboratory, and (ii) to separate early 
myeloid-committed progenitor cells from other hematopoietic progenitors in order to 
facilitate studies on the processes involved in commitment to the myeloid/mononuclear 
phagocyte lineage. 
In chapter 2 a selection of the cun'entIy available anti-mouse mononuclear phago-
cyte antibodies is reviewed. 111cse markers can be divided into four categories: (i) 
markers expressed by immature mononuclear phagocytes, (ii) markers expressed by 
mature macrophages in general, (iii) markers expressed by macrophage subsets, and (iv) 
markers expressed by IFN-y-stimulated macrophages. Since very few antibodies are 
fully specific for one stage of macrophage development, combinations of these antibod-
ies are often required to determine from the cellular phenotype whether macrophages 
are immature, mature, belong to a particular subset, or are stimulated or not. A more 
precise detennination of the developmental stage of macrophages depends on a better 
insight into the developmental relationships between the various members of the mono-
nuclear phagocyte system and the phenotypic hallmarks that identify related cells. 
To extend the identification of macrophage precursors in mouse bone marrow we 
examined in chapter 3 (i) whether the anti-macrophage precursor monoclonal anti-
bodies ER-MPI2 and ER-MP20 detected phenotypic heterogeneity among macrophage 
precursors in two-color flow cytometric analysis of mouse bone marrow, and, if so, (ii) 
whether that phenotypic heterogeneity reflected different maturation stages or the 
existence of macrophage sublineages. Upon double labeling of bone marrow with ER-
MP12 and ER-MP20 antibodies, six phenotypically distinct bone marrow subsets can be 
discerned. Fluorescence-activated cell sorting followed by M-CSF-stimulatcd culture in 
soft agar revealed that macrophage precursors were confined to the ER-MP12hi20-, ER-
MPI2+20+, and ER-MP12-20ru bone marrow subsets. Moreover, we found evidence that 
the macrophage precursors present in these subsets represent successive stages along a 
maturation pathway with the order ER-MPI2h;20- -'> ER-MPI2+20+ -'> ER-MPlT20h;. 
In chapter 4 we examined the ER-MPI2120 phenotype of cells with the capacity to 
home to and repopulate the thymus upon intravenous transfer into sublethally ilTadiated 
recipient mice. Our data indicated that cells with the capacity to repopulate the thymus 
within three weeks after transfer, reside in the ER_MPI2hi20- subset and are to a lesser 
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extent found among ER-MPI2m,d20- bone marrow cells. The other ER-MPI2120 bone 
marrow subsets do not contain such thymus repopulating progenitor cells. Analysis of 
peripheral blood reconstitution in mice transferred with the ER-MPI2h;20- and ER-
MPI2""d20- subsets revealed that multipotent hematopoietic stem cells and/or progeni-
tor cells of the B and myeloid lineages are also present among ER-MPI2M20- and ER-
MP J 2med20- bone marrow cells. 
In chapter 5 we examined whether the myeloid-committed cells found in the ER-
MP 12h;20- subset can be distinguished and purified from the other hematopoietic stem 
and progenitor cells residing in this subset. For this purpose, bone marrow cells were 
triple labeled with ER-MPI2120 and ER-MP58, an antibody detecting all M-CSF-
responsive progenitors in mouse bone marrow. With this monoclonal antibody the ER-
MPI2h;20- population could be divided into three subfractions. On the basis of func-
tional data obtained ill' vitro and ill vivo we concluded that early myeloid-committed 
cells can be separated from other hematopoietic progenitor and stem cells on the basis 
of their high level ER-MP58 expression. 
On the basis of the experiments described in chapters 3, 4 and 5, we concluded that 
the combination of ER-MP12/20 and ER-MP58 monoclonal antibodies can be used to 
isolate successive stages of mononuclear phagocyte development from mouse bone 
marrow. As OM-eSF-responsive DC precursors arc at least in part linked to the mono-
cyte/macrophage lineage, we investigated the ER-MP12/20158 phenotype of bone 
marrow DC precursors. In chapter 6 we showed that DC precursors responsive to GM-
CSF ill vitro, indeed have the same ER-MPI2!20158-defined phenotype as progenitors 
of the macrophage lineage. Moreover, we found that DC precursors follow the same 
ER-MP12120-defined maturation pathway as macrophage precursors. The data obtained 
in this study arc in line with the hypothesis that over a prolonged stretch of mono-
nuc1ear phagocyte development, progenitors of the mononuclear phagocyte system may 
either develop into monocytes/macrophages or DC, depending on local concentrations 
of specific gro.wth factors. However, additional clonal experiments are needed to 
confirm this hypothesis. 
From the initial experiments described in chapter 3 we had learned that the six ER-
MP12120-defined bone marrow subsets show a remarkable hematopoietic lineage homo-
geneity. Therefore we set out to examine whether the combination of these monoc1onal 
antibodies in two-color flow cytometry can be used as an alternative method to deter-
mine the cellular composition of mouse bone marrow under both steady state and 
experimental conditions (chapter 7). Changes in bone marrow cellular composition 
were monitored in a sublethal infection with Listeria mOllocytogelles. Data obtained 
from ER-MPI2120 bone marrow subset analysis were compared with data obtained 
from analysis of lineage marker expression and data from conventional morphological 
analysis. Bone marrow composition determined by ER-MP12/20 analysis appeared to 
be in close agreement with morphology and lineage marker analysis. indicating that 
ER-MP12/20 subset analysis provides a relatively simple, rapid and quantitative alter-
native for assessment of the cellular composition in the bone marrow of the mouse. 
In chapter 8, ER-MP12/20 bone marrow subset analysis was used to detennine 
cellular bone marrow composition in a study on the effects of dietary fish oil supple-
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mentation in mice. Fish oil consumption has been shown previously to enhance resis-
tance to infections in various animal models. Examination of the cellular composition 
or bone marrow was part of the analyses performed to shed light onto the mecha-
nism(s) behind the enhanced resistance. An increase in bone man-ow cellularity was 
observed in mice red fish oil. compared with mice red normal lab chow. However. no 
changes in bone marrow composition were detected by ER-MPI2!20 or lineage specific 
marker analysis. Moreover. in agreement with the ER-MPI2!20 subset analysis. M-
eSF-stimulated soft agar cultures of bone man-ow cells did not reveal changes in 
macrophage colony- or cluster-forming cell frequency. Thus, the data on bone marrow 
composition obtained in chapter 8 extend and support the use of ER-MPI2!20 subset 
analysis as an alternative method to determine cellular bone marrow composition in 
experimental mouse models. 
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Macrofagen vonnen een functioneel en fenotypisch heterogene populatie celleu, die 
wijd is verspreid door het lichaam. Mechanismen die verondersteld worden bij te 
dragen aan het genereren van deze brede diversiteit zijn o.a. (i) inductie van hetero-
geniteit door lokale omstandigheden of stimuli in de perifere weefsels, (ii) het bestaan 
van zichzelf instandhoudende, van beenmerg onafhankelijke macrofaagpopulaties die al 
tijdens de embryonale ontwikkeling gcgencreerd zijn, en (iii) vonning van verschillende 
subpopulaties macrofaagvoorlopercellen die uitgroeien tot verschillende typen rijpe 
macrofagen. 
Diepgaand onderzoek naar het bestaan van verschi1lende typen macrofaagvoorloper-
cellen werd tot dusver bemoeilijkt door een beperkte fenotypische karakterisering en 
een lage frequentie van deze voorlopercellen, en meer algemeen van myeloi'd-
gecommitteerde voorlopercellen in het beenmerg. Het doel van dit proefschrift was 
derhalve (i) om in het beenmerg verschillende stadia in de ontwikkeling van mono-
nucleaire fagocyten te identificeren met behulp van in ons laboratorium geproduceerde 
monoklonale antistoffen tegen macrofaagvoorlopercellen, en (ii) om vroege myeloi'd-
gecommitteerde voorlopercellen te scheiden van andere hernatopoietische voorloper-
cellen ten behoeve van studies naar de processen betrokken bij "commitment" naar de 
myeloide/macrofaag differentiatierichting. 
In hoofdstuk 2 is een selectie van de thans beschikbare antistoffen beschreven, 
gericht legen muis mononucleaire fagocyten. De markers, gedetecteerd door deze 
antistoffen kunnen worden onderverdeeld in vier categorieen: (i) markers, karakteristiek 
voor onrijpe rnononucleaire fagocyten, (ii) markers voor rijpe macrofagen in het 
algemeen, (iii) markers voor macrofaagsubpopulaties, en (iv) markers aanwezig op IFN-
y-gestimuleerde macrofagen. Aangezien slechts enkele van deze antistoffen volledig 
specifiek zijn voor een bepaald stadium van macrofaagontwikkeling, zijn combinaties 
van deze antistoffen nodig om uit het cellulaire fenotype te kunnen afteiden of 
macrofagen onrijp dan wei verder ontwikkeld zijn, of ze behoren tot een bepaald 
subtype, of al dan niet gestimuleerd zijn. Een meer exaete bepating van het stadium van 
ontwikkeling vereist een beter inzicht in de voorloper - nakomeling relaties tussen de 
verschillende cellen van het mononucleaire fagocyte'lsysteem en in de fenotypische 
karakteristieken van gerelateerde cellen. 
Voor een verdere identificatie van macrofaagvoorlopercellen in het beenmerg van de 
muis hebben we in hoofdstuk 3 onderzocht of (i) de anti-macrofaagvoorlopercel anti-
stoffen ER-MPI2 en ER-MP2o in twee-kleuren-ftowcytometrische analyse fenotypisehe 
heterogeniteit detecteren onder macrofaagvoorlopercellen en, indien dit het geval is, (ii) 
of deze fenotypische heterogeniteit een afspiegeling is van verschillende ontwikke-
lings stadia van mononucleaire fagocyten of cen reftectie van verschiHende macrofaag-
sUblijnen. Zes fenotypisch verschillende celpopulaties kunnen worden onderscheiden na 
dubbelkleuring van beenmerg met ER-MP12 en ER-MP2o antistoffen. Fluorescentie-
geaetiveerde celsortering, gevolgd door M-CSF-gestimuleerde kweek in soft-agar, 
toonde aan dat maerofaagvoorlopercellen slechts aanwczig zijn in de ER-MPI2hi20-, 
ER-MP I 2+20+, en ER-MP12-20h; beenmergpopulaties. Onze data lVezen er verder op 
dat de maerofaagvoorJopercellen, die aanwezig waren in deze subpopulaties, opecn~ 
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volgende stadia vertegcnwoordigen in cen maturatiesequentie met de volgorde ER-
MP12hi20- --7 ER-MPI2+20+ --7 ER-MPI2-20hi . 
In hoofdsluk 4 hebben we het ER-MP 12120 fenolype onderzoeht van hematopoi-
etische voor1opercellcn die het vennogen hebben om na intraveneuzc injectic de thymus 
van sublethaal bestraalde muizen te repopuleren. De data toonden aan dat cellen die in 
staat zijn om binnen drie weken de thymus te rcpopuleren voornamelijk te vinden zijn 
in de ER-MPI2hi20- beenmergcelpopulatie en in mindere mate in de ER-MPI2""d20-
populatie. De overige ER-MPI2120 beenmergpopulaties bevatten geen thymusrepopu-
lerende cellen. Analyse van perifeer bloed van met ER-MPI2hi20- en ER_MPI2m,d20-
beenmergceHen gei'njccteerde muizen liet zien dat multipotente hematopoietische stam-
cellen enlof voorlopercellen voar de B en myelo'ide differentiatie1ijnen eveneens 
aanwezig zijn in de ER_MPI2hi20- en ER-MPI2m,d20- beenmergeelpopulaties. 
In hoofdsluk 5 hebben we onderzoeht of de myelold-geeommitteerde cellen aanwe-
zig in de ER-MPI2hi20- sUbpopulatie kunnen worden onderseheiden en gesepareerd van 
de overige hematopoictische stam- en voorlopcrcellen in deze beenmergcclpopulatie. 
Hiertoe werden beenmergeellen gekleurd met zowel ER-MP12/20 als met ER-MP58, 
cen antistof die aue M-CSF-responsieve voorlopercellen herkent in het beenmerg van 
de muis. Met de ER-MP58 antistof kon de ER_MPI2hi20- populatie worden onderver-
deeld in drie subpopulaties. Functionele data verkregcn uit ill vitro en ill vivo test-
systemen toonden aan dat vroege ER-MPI2hi20- myeloi'd-gecommitteerde voorlopereel-
len op basis van hun hoge ER-MP58 expressie kunnen worden gescheiden van andere 
hematopoietische voorloper- en stamcelIcn. 
De eonclusie van de studies beschreven in de hoofdstukken 3 tot en met 5 luidde 
dat met de eombinatie van ER-MPI2120 ell ER-MP58 monoklonale antistoffen opeen-
volgende stadia van mononucleaire fagocytontwikkeling kunnen worden gelsoleerd uit 
het beenmerg van de muis. Aangezien oak GM-CSF-responsieve dendritische eel (DC) 
voorlopers voor tenminste een deel tot de monocytlmacrofaag differentiatielijn behoren. 
hebben we het ER-MP12/20158 fenotype onderzocht van DC voorlopereellen. In 
hoofdsluk 6 hebbell we aangetoond dat DC voorlopercelIen, die voor hun ill vitro 
ontwikkeling afhankelijk zijn van GM-CSF, hetzelfde ER-MP12120158 fenotype hebben 
als voorlopercellen van de macrofaagdifferentiatielijn. Bovendien doorlopen deze celIen 
in beenmerg dezelfde ER-MPI2120-gedefinieerde maturatiesequentie. De data verkregen 
in deze studie onderstcunen de hypothese dat voorlopercellcn van het mononucleaire 
fagocytensysteem zich gedurende een langere peri ode van hun ontwikkeling kunnen 
uitgroeien tot monocytenlmaerofagen enerzijds of DC anderzijds, afhankelijk van lokale 
concentraties specifieke groeifactoren. Bevestiging van deze hypothese vereist echter 
aanvullende klonalc experimenten. 
De zes ER-MPI2120 beenmergsubpopulaties worden gekenmerkt door een opmerke-
lijke homogeniteit ill hematopoietisehe differentiatieriehting (hoofdstuk 3). Dit vormde 
de aanleidillg tot onderzoek naar de bruikbaarheid van ER-MPI2120 flowcytometrisehe 
beenmerganalyse als alternatieve methode voor het bepalen van cellulaire 
beenmergcompositie (hoofdsluk 7). Hiertoe zijn veranderingen in eellulaire 
beenmergcompositie gevolgd in muizcn met een sublethale infectie met Listeria 
lI1ollocylogelles. Data verkregen uit analyse van ER-MPI2120 beenmergsubpopulaties 
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werden vergeleken met data verkregen uit analyse van differentiatielijnspecifieke 
markers en uit conventionele morfologische analyse. Beenrnergcompositiedata afgeleid 
uit ER-MPI2120 analyse bleken sterk te correleren met data uit zowel differentiatielijn-
specifieke markeranalyse als ook morfologische analyse. Op grond van de gevonden 
data concludeerden we dat ER-MPI2120 ftowcytometrische analyse van beenmerg een 
relatief eenvoudig, snel, en kwantitatief alternatief is voor analyse van de ce1lulaire 
beenmergcompositie in de muis. 
Hoofdsluk 8 bevat een studie naar de effecten van visolicconsumptie op het 
immuunsysteem in de muis. Hierin is ER-MPI2120 analyse gebruikt voor het bepalen 
van de cellulaire beenmergcompositie. In het verleden is in verschillende experimentele 
dicrmodellen aangetoond dat visolieconsumptie de weerstand tegen infecties verhoogt. 
Analyse van de cellulaire beenmergcompositie vormde onderdeel van het onderzoek 
naar de mechanismcn die tcn grondslag liggen aan deze verhoogde wcerstand. Muizen 
op visoHedieet vertoonden een toename in becnmergcelaantallen vergeleken met COIl-
trolemuizen. Echter, noch ER-MPI2120 analyse, noch differentiatielijn-specifieke 
markeranalyse detecteerde veranderingen in beenmergcompositie. Functionele analyse 
van macrofaagvoorlopercellen in M-CSF-gestirnuleerde beenmergkweken liet eveneens 
geen veranderingen zien in aantallen kolonie- of clustervonnende voorlopercellen. De 
data bevestigen en ondersteunen het gebruik van ER-MPI2120 beenmerganalyse als 
altematieve methode voor het vaststellen van beenmergcompositie in experimentele 
muismodellen. 
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Abbl'eviations 
AOM 
BM 
BSA 
CAFC 
CFC 
CFU-C 
CFU-OM 
CFU-M 
CFU-pre-B 
CFU-S 
Cl2MDP 
CO 
CFC 
OM-CFC 
M-CFC 
CSF 
DAB 
DC 
DHA 
DMEM 
EPA 
FA 
FACS 
FCS 
FITC 
Fo 
FO 
HSC 
HPP-CFC 
HRP 
IFN 
Ig 
IL 
IMDM 
i.v. 
LCM 
Lin 
LPS 
LTRC 
kDa 
mAb 
MESF 
MHC 
aorta~gonads-mesonephros 
bone matTOW 
bovine serum albumin 
coblestone area-fonning cell 
colony-forming cell 
colony- forming unit in culture 
colony-fonning unit-granulocyte/macrophage 
colony-forming unit-macrophage 
colony-forming unit-pre-B 
colony-fOlming unit-spleen 
dichloromethylene-biphosphate 
corn oil 
colony-fomling cell 
granulocyte/macrophage colony-forming cell 
macrophage colony-forming cell 
colony-stimulating factor 
diaminobenzidinc 
dendritic cell 
docosahexaenoic acid 
Dulbecco's modified Eagle's medium 
eicosapentaenoic acid 
fatty acid 
fluorescence-activated cell sorter 
fctal calf serum 
fluorescein isothiocyanate 
Forssman glycolipid antigen 
fish oil 
hematopoietic stem cell 
high proliferative potential colony-forming cell 
horseradish peroxidase 
interferon 
immunoglobulin 
interleukin 
Iscove's modified Dulbecco's medium 
intravenous 
L cell-conditioned medium 
lineage-specific cell surface markers 
lipopolysaccharide 
long-teml repopulating cell 
kilo Dalton 
monoclonal antibody 
molecules equivalent to soluble FITC 
major histocompatibility complex 
MLR 
MRA 
NK 
NMS 
NOD 
P 
PBS 
PI-linked 
PHSC 
r 
RT 
SAV-PE 
SAV-TC 
SD 
SEM 
STRC 
TCR 
TNF 
TSA 
mixed leukocyte reaction 
marrow-repopulating ability 
natural killer 
nannal mouse serum 
non-obese diabetic 
probability 
phosphate-buffered saline 
phospho-inositol-linked 
pluripotent hematopoietic stem cell 
correlation coefficient 
room temperature 
streptavidin-conjugated phycoerythrin 
streptavidin-conjugated tricolor 
standard deviation 
standard error of the mean 
short-term repopulating cell 
T cell receptor 
tumor necrosis factor 
tryptone soya agar 
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